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SUMMARY
Candida albicans and related Candida species are common members of the 
normal flora in humans; however, they are opportunistic pathogens and may cause 
superficial or systemic disease. Candidaemia is the most extensively studied 
nosocomial invasive fungal infection, and recent data show that Candida species 
are the fourth most commonly recovered blood culture isolates. It is now clear that 
this kind of infection is often due to the formation of Candida biofilms on 
catheters and other indwelling medical devices. This project investigates the role 
of quorum sensing in Candida biofilm formation, and the effect of prostaglandins,
COX inhibitors and the combined effect of COX inhibitors with antifungal agents 
on biofilm development. Additional investigations monitor prostaglandin 
production by planktonic cells and biofilms of Candida albicans,
.VÛ-
Quorum sensing is known to be involved in bacterial biofilm formation, and 
in Candida, two signal molecules (famesol and tyrosol) were recently identified.
In this study the effects of famesol on gemi-tube and biofilm formation were 
investigated. Famesol totally prevented germ-tube fonnation and inhibited biofilm 
formation by 30 % when ImM famesol was added at an early stage. Scanning 
electron microscopy revealed that only yeast cells were formed in biofilms grown 
in the presence of famesol. Supematants from biofilms formed after 24h and 48h 
inliibited genn-tube formation by 10 % and 29 %, respectively, indicating that 
they contained famesol or famesol-like activity.
It has been reported that planktonic cultures of C. albicans produce tyrosol, 
another quorum-sensing molecule. In this study, HPLC confinned that tyrosol was 
produced by both planktonic cells and biofilms of C. albicans, and biofilms 
produced significantly higher levels of tyrosol than planktonic cells. Overall, the 
results demonstrated that biofilm development in C. albicans is under the control 
of at least two quomm-sensing molecules. Famesol acts as a negative signal and 
inhibits hyphal production. Tyi'osol acts as a positive signal and promotes hyphal 
production. A
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Prostaglandins are now known to be produced by C  albicans and may play 
an important role in fungal colonization. Their synthesis in mammalian cells is 
decreased by inhibitors of the cyclooxygenase isoenzymes required for 
prostaglandin formation. In this study, the effects of nonsteroidal anti­
inflammatory drugs (all cyclooxygenase inhibitors) on biofilm formation by three 
strains of C. albicans were investigated. Seven out of nine drugs tested at a 
concentration of 1 mM inliibited biofilm formation. Aspirin, etodolac and 
diclofenac produced the greatest effects, with aspirin causing up to 95% 
inliibition. Suiwiving cells had a wrinkled appearance, as judged by scanning 
electron microscopy, and consisted of both yeasts and hyphae.
The effect of aspirin on viability of both biofilm and planktonic cells was pH 
dependent, with the greatest effect at pH 3 or in unbuffered yeast nitrogen base 
medium. The effect o f aspirin on metabolic activity and viability of mature C. 
albicans biofilms was similarly pH dependent. At pH 3, aspirin inhibited 
metabolic activity of mature C. albicans biofilms more than fluconazole or a 
mixture of fluconazole and aspirin. This study also demonstrated that both 
biofilms and planktonic cells of C. albicans synthesize extracellular 
prostaglandin(s) during gi'owth at 37°C, but biofilm cells secrete significantly 
more when production is determined on the basis of cell dry weight. Prostaglandin 
synthesis by both cell types was sensitive to the cyclooxygenase inliibitors aspirin, 
diclofenac and etodolac. A moiphological mutant blocked in two signalling 
pathways {cphl/cphl efgl/efgl) produced prostaglandin levels similar to those of 
the parent strain but formed yeast-only biofilms.
Unicellular organisms such as fungi have been reported to interact with 
hormones, such as fungal sex hormones and mammalian hormones. In this study 
the effect of several steroids including progesterone, corticosterone, 
dexamethasone, prednisolone, hydrocortisone and estradiol on C. albicans 
biofilm development was investigated. The results showed that biofilm fonnation 
was not affected by any of these compounds. However, at IpM  some steroids 
such as progesterone and dexamethasone inhibited germ-tube formation by more 
than 25%. At 100 to 1000 pM, all steroids inhibited germ-tube formation.
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Introduction
1. Candida and Candidosis
1.1 Candida species
Mycoses caused by opportunistic fungal pathogens have increased 
dramatically in recent years and the most regularly encountered species are 
members of the genus Candida. C  albicans is by far the most common Candida 
species causing infections in humans, followed by C  glabrata^ C. parapsilosis, C. 
tropicalis, C. krusei, and C. guilliermondii (Pfaller et a l,  1998; Pfaller et a l,
2001). C. dubliniensis is a new, recently described species, which was originally 
isolated fi'om severe oral lesions in subjects infected with human 
immunodeficiency virus (HIV) and was therefore suspected of increased virulence 
(Moran et a l, 1997).
C. albicans is a fungus which may develop into a number of different 
morphological forms, including yeasts, hyphae and pseudohyphae. This change 
depends on environmental conditions. The ability to fomi hyphae is generally 
considered to be an impoiiant virulence factor since hyphae are able to penetrate 
tissue more easily. Candida infection is known as candidosis or candidiasis 
(Odds, 1988; Bodey, 1993).
1.2 Candida infections
Candida species are usually hannless members o f the flora of the skin, 
mucous membranes, or gastrointestinal tract; under normal circumstances they do 
not produce clinical disease (Odds, 1988). However, they may become 
opportunistic pathogens under certain conditions. The increased incidence of 
Candida infection has been attributed to widespread use of antibiotics (Mitchell, 
1998; Sanchez-Maitinez and Perez-Maitin, 2001; Epstein et a l,  2002), the rise of
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AIDS, a larger number of organ transplantations (Haynes, 2001), and the common 
use of invasive devices (catheters, artificial joints and valves), all o f which 
increase a patient's susceptibility to infection. Candidosis in clinical disease 
includes two types of infection, superficial and systemic.
1.2.1 Superficial candidosis
Superficial candidosis includes cutaneous and mucosal Candida infections 
which are common and affect both immunocompromised and non­
immunocompromised hosts. These infections involve the skin, nails, and oral and 
vaginal mucous membranes. For example, Candida paronychia is one of the most 
common infections o f persons whose hands are frequently immersed in water. The 
most common oropharyngeal candidoses are oral tlirush and denture-induced 
stomatitis. Oral tlirush consists of white discrete plaques on an erythematous 
background on the buccal mucosa, throat, and tongue. This infection most 
commonly affects newborns, the elderly, and diabetics. In the absence of other 
known causes of immune suppression, oral tlirush in an adult is highly suggestive 
of HIV infection (Dronda et a l,  1996).
Denture stomatitis, presenting as either a smooth or gianular erythema 
confined to the denture bearing area of the hard palate is often associated with 
angular cheilitis. Symptoms vary, ranging fi'om none to a sore and painful mouth, 
with a burning tongue and altered taste (Webb et a l, 1998). C. albicans has been 
described as the organism most often isolated fiom denture stomatitis (Sangeorzan 
et a l,  1994; Rioboo-Crespo Mdel et a l,  2005). However, other organisms such as 
C  dubliniensis and C. glabrata have emerged as causative agents among 
immunocompromised patients (Redding, 2001).
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In woman, vaginal candidosis is another common infection; three quarters of 
all healthy women of child-hearing age experience at least one episode of vaginal 
candidosis, and approximately 5% of women with a primary episode subsequently 
develop distressing vaginal candidosis especially during pregnancy (Calderone,
2002). Although in the past C. albicans was recognized as the most frequent 
aetiological agent of vaginal infections, an increasing percentage of infections are 
now ascribed to non-C. albicans species, such as C. tropicalis, C. glabrata and C  
parapsilosis (Karaca et a l,  2005), which are usually less sensitive to the most 
commonly used antifungal agents (White et a l, 2001).
1.2.2 Systemic candidosis
The second type o f Candida infection is systemic candidosis. Systemic 
invasion by C  albicans is a very serious condition and occurs in patients with 
profound immunodeficiency. This immunodeficiency is usually secondary to 
AIDS, chemotherapy for malignant disease or terminal leukemia. These patients 
can have lesions in the lungs, liver, kidney, or be suffering frrom urinary tract 
infection, endocarditis, meningitis, or candidemia. The diagnosis is usually made 
by history, the demonstration of lesions and the appearance of circulating Candida 
antigens (Odds, 1988). Infections caused by non-C. albicans species have 
increased dramatically in the last five years due to inherent resistance to 
fluconazole by some of these species (Hobson, 2003). Therapy for serious 
Candida infections has been difficult because of the limited number of antifungal 
agents available. Although long the mainstay of treatment, amphotericin B is 
associated with toxicities (side effects) and requires intravenous administration. In 
addition, not long after the introduction of fluconazole, reports of clinical failure
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in association with elevated MICs of fluconazole therapy began to appear. In most 
cases patients were suspected to be infected with an inherently azole-resistant 
species such as C. glabrata or C  Icrusei (Rex et a l, 1995). The fi*equency of 
various species of Candida causing bloodstream infections has been investigated 
over a three-year period (1997-1999). It was found that the rank order of the 
various species differed according to geographic location. For example, in the 
United States yeast bloodstream infections were caused primarily by C. albicans, 
followed by C  glabrata, C. parapsilosis and C  tropicalis, whereas in Latin 
America yeast bloodstream infections were caused by C. albicans, followed by C. 
parapsilosis, C. glabrata and C. tropicalis (Pfaller et a l,  2001).
1.2.3 Implant-associated Candida infections
The rapid development of modem medicine has led to the challenging 
problem of implant-associated infections. For example, catheter-related infections 
increased in incidence during the past decade, causing significant morbidity and 
mortality. Catheter insertions are often succeeded by bacterial or Candida 
adhesion and subsequent colonization of the catheter (Nicolle, 2005). A direct link 
has been demonstrated between nosocomial bloodstream infections and long-term 
indwelling intravascular catheter usage, especially in intensive care unit patients. 
Implant-associated infeetions often represent a diagnostic challenge due to the 
lack of consensus definition of what constitutes an infection, and in all cases the 
treatment of catheter-related sepsis is based on catheter removal (Worthington and 
Elliott, 2005).
The skin around the insertion site is the most common portal of entiy. For 
example, in the case of vascular catheters, skin organisms migrate from the skin
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insertion site along the external surface of the catheter and colonize the distal tip 
causing a bloodstream infection. The mortality rate of Candida catheter- 
associated infection is high and these organisms now rank as the fourth most 
common cause of bloodstream infection (Kojic and Darouiche, 2004). Unlike 
intravascular and urinary catheters, other devices such as hip and knee joint 
prostheses are not considered to be so liable to Candida infection (Kojic and 
Darouiche, 2004).
Several studies have led to proposals for improving the performance of 
catheters by reducing the microbial colonization of catheter surfaces. These 
include hydrophilie coatings (Schierholz et al., 1999a; Schierholz et a l, 1999b) or 
using catheters containing antimicrobial agents. Future preventative strategies 
may also include the application of low voltage electric cuirent in combination 
with antimicrobials (Elliott and Tebbs, 1998).
1.3 Predisposing factors for Candida infection
Pathogenesis involves a complex inteirelationship between Candida speeies 
and the host (van Burik and Magee, 2001). There is no single factor that causes or 
permits C  albicans to be an agent of diseases that range from superficial to 
invasive human infection (Latge and Calderone, 2002). However, it is indigenous 
to humans and a part o f the normal flora, and under conditions favouring its 
proliferation it can strike as a fonnidable pathogen.
There are numerous predisposing factors that lead Candida infections. First, 
disturbance of the epithelial bander may occur as a result o f indwelling catheters, 
peritoneal dialysis, burns, ulcers, trauma, or surgery (Kontoyiannis et a l,  2001). 
Second, defects or dysfunction of mononuclear phagocytes plus other cells may
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be caused by chemotherapy, radiotherapy, aplastic anaemia, chionic 
granulomatous disease and diabetes mellitus (Singh, 2001; Bodey et al., 2002). 
Third, defects or dysfunction of T-lymphocyte cell-mediated immunity may be 
caused by Hodgkins disease, transplantation, leukaemia and eorticosteroids 
(Gosden et a l,  1997). Finally, suppression of the normal human flora may result 
from treatment with broad spectrum antibiotics allowing Candida to proliferate 
(Charles et a l, 2005).
1.4 Treatment and antifungal agents
Treatment of superficial and systemic Candida infections is limited to four 
classes of antifungal agents; these are polyenes, fluorinated pyidmidines, azoles 
and the recent class of echinocandins (Fromtling, 1988; Slavin et a l, 2004). 
Polyene drugs are fungicidal and have the broadest spectmm of activity of any 
clinically useful antifungal agent. Amphotericin B is the only drug of this type 
used for systemic infections, but it has both acute and cluonic side effects such as 
nephrotoxicity (Odds, 1988). This agent binds sterol components in the cell 
membrane and alters the membrane permeability, allowing leakage of cytoplasmic 
components (Rex et a l ,  1993; Schmitt, 1993). Although amphotericin B has been
used for several deeades, new developments have been undertaken to reduce its 
nephrotoxicity which can lead to acute renal failure. As a result, three lipid
less nephrotoxicity than the classical amphotericin B (Wingard and Leather,
2004).
foiinulations of amphotericin B are now licensed, all o f which show substantially
."IJ;
5-Fluorocytosine (5FC) is the only antifungal compound available in the 
fluorinated pyrimidine class and is fungicidal, with a limited activity spectrum. I
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This drug interferes with pyi'imidine metabolism of RNA at one or multiple 
enzymatic sites. It is most often used clinically in combination with amphotericin 
B because of the rapid development of resistance.
Azoles are the third class of antifungal agents and all members of this class 
are fungistatic (Wamock, 1992). They include ketoconazole, miconazole, 
clotrimazole, itraconazole and fluconazole. Azole antifungal agents prevent the 
synthesis of ergosterol (Warnock, 1992), a major component of fungal plasma 
membranes, by inhibiting the cytochrome P-450-dependent enzyme, lanosterol 
demethylase (Fromtling, 1988). This enzyme also plays an important role in 
cholesterol synthesis in all eukaryotic cells (Odds, 1988). In the past few years, 
new azoles have been produced, including voriconazole which shows a wider 
spectrum of activity against yeasts and filamentous fungi (Canuto and Rodero, 
2002).
Caspofungin is the first promising member of the echinocandins, the newest 
class of antifungal agents. It inliibits the synthesis of P-l,3-D-glucan in the cell 
wall of numerous pathogenic flingi such as Candida and Aspergillus species. This 
represents a novel and unique target which is not found in mammalian cells. 
Therefore caspofungin is capable of selective toxicity. For example, recent in vitro 
studies suggested that caspofungin is less nephrotoxic than amphotericin B 
(Wegner et a l, 2005).
Despite recent progress, there are still relatively few antifungal drugs, 
especially when compared with the number of antibacterial drugs (Fromtling, 
1988). Drug targets that distinguish pathogen from host are more difficult to 
identify in fungi than in bacteria, at least in part because fungal cells, like animal
Introduction
ceils, are eukaryotic, whereas bacteria are much more distantly related to their 
human hosts (Bodey, 1993). Because many potential antifungal drug targets have 
homologues of similar function and susceptibility to inhibition in humans, toxic 
side effects dramatically reduce the number of antifungal agents that ean be used 
therapeutically (Graybill, 1992).
2, Virulence factors of Candida species
2.1 Adhesion
Adhesion of C, albicans to host cells is believed to represent a fungal 
vimlence factor and a significant step in the development o f candidosis (Odds, 
1988; Bodey, 1993). Therefore there is a strong conelation between virulence and 
adhesion of C. albicans to host cells. Moreover, adhesive properties of the 
different Candida species match their virulence ranking. Adhesion to epithelial 
and endothelial cells, fibrin-platelet matrices, bacteria, neutrophils and vaginal 
mucosae has been extensively studied and a close correlation was observed 
between the adhesion of various Candida species and their ability to cause disease 
(Robert et a l, 2000).
C  albicans can also bind to several extracellular matrix proteins of 
mammalian cells, such as fibronectin, laminin and fibrinogen (Fromtling, 1988). 
Many studies have shown that several factors influence adhesion in vitro. For 
example, the composition of the growth medium can affect adhesion; yeasts 
grown in medium containing 500 mM galactose or glucose were significantly 
more adherent than organisms grown in a low concentration (50 mM) of glucose 
(McCourtie and Douglas, 1984; Pizzo et a l, 2000). Adherence to exfoliated
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epithelial cells can vary significantly between epithelial-cell donors, from day to 
day with the same donor, and with changes in the menstrual cycle (Theaker et a l, 
1993). Pre-treatment of C  albicans cells with whole saliva promotes adherence to 
cultured epithelial cells (Holmes et a l, 2002). Sub-inhibitory concentrations of 
antifungal agents such as amphotericin B inliibit C. albicans adherence to 
polystyrene and fibrinogen surfaces, while improving adherence to surfaces 
coated with extracellular matrix gel (Imbert et a l, 2002).
2.1.1 Adhesins and host cell receptors
The cell surface of C. albicans is the key factor for the contact between this 
yeast and host defences. The host response to Candida infection is the result of a 
complex interaction between the pathogen and the host's innate and adaptive 
immune system. Cell-mediated immunity is widely considered to be critical for 
the successful outcome of fungal infections. Physical interactions o f this fungus 
with the host are mediated at the cell surface, and cell wall constituents implicated 
in binding have been designated adhesins (Masuoka, 2004). There are several 
types of host -  pathogen interactions; these include protein-protein, protein- 
carbohydrate and carbohydrate-carbohydrate interactions (Pendrak and Klotz, 
1995).
The major components of the cell wall are glucan, chitin, and 
mannoproteins. The outer, surface mannoproteins have been implieated in 
adhesion to host tissues and ligands. Cell surface mannoproteins contain both O- 
and A-linked oligosaccharides (Calderone, 2002). Recent evidence has shown that 
both oligosaccharides can seiwe as adhesins in the attaclunent of C  albicans yeast 
cells to the host. C. albicans mutants deleted in M NTl and/or MNT2 genes which
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are involved in the fonnation o f O-linked oligosaccharides showed significantly 
reduced adhesion to human buccal epithelial cells and were less virulent 
(Buunnan et a i, 1998; Munro et al., 2005). A C. albicans null mutant lacking the 
OCHl gene had a clear defect in the A-glycan outer chain and coiTCSpondingly 
displayed a weakened cell wall. The A-glycan outer chain was shown to be 
necessary for normal host-fungal interactions and virulence (Bates et a l, 2006).
In early studies, exfoliated buccal epithelial cells were the most widely used 
human cell types in C  albicans adherence experiments. Consequently, many 
receptors for Candida on these buccal cells have been proposed. For example, 
fibronectin was the first molecule to be recognized as a receptor for C. albicans 
(Skerl et a l, 1984), The role of glycosphingolipids as adhesion receptors for C. 
albicans was examined; Jimenez-Lucho et a/. (1990) showed yeast cells of C  
albicans bound specifically to lactosylceramide. Lactosylceramide is a major 
glycosphingolipid in these epithelial cells and the only one to which the yeasts 
bound. As lactosylceramide is widely distributed in epithelial tissues, the authors 
suggested that this glycosphingolipid may be the receptor for yeast colonization 
and disseminated disease in humans (Jimenez-Lucho et a l, 1990).
Interaction with components of the complement system is an important 
aspect of the pathogenesis of infection by C. albicans. Pseudohyphal but not yeast 
foims of C. albicans possess both iC3b and C3d receptors indicating that the 
expression of the functionally active iC3b receptor on C  albicans may be 
involved in the virulence of the organism, possibly by mediating adherence to 
mammalian cells such as neutrophils cells (Alaei et a l, 1993). Moreover, candidal 
lectin-like epithelial adhesins that recognize L-fucose or GlcNAc have been
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reported (Critchley and Douglas, 1987a; Critcliley and Douglas, 1987b). The 
binding of some C. albicans strains to buccal epithelial cells was inhibited by 
fucose, but in other strains it was inhibited by glucosamine or GlcNAc, suggesting 
strain-specific receptors.
Synthesis of the lectin-like material increased when organisms were grown 
on galactose (McCourtie and Douglas, 1985). Fucose has been shown to bind to 
C. albicans germ-tube tips (Vardar-Unlu et a l,  1998). An L-fucose-binding 
protein was purified by affinity cliromatography with the blood group H 
trisaccharide antigen which suggested that blood group antigens may act as 
epithelial cell receptors for C. albicans (Cameron and Douglas, 1996).
2.2 Dimorphism
The ability to switch between a yeast-like foim and a filamentous form is a 
well known characteristic of C. albicans. (Odds, 1988; Mitchell, 1998; Liu, 2001). 
In pathogenic fungi, this capacity has been correlated with virulence because 
during the infection process, dimorphic transitions are often required. For example 
C  albicans mutant strains defective in germ-tube formation show decreased tissue 
invasion in an immunosuppressed animal model (Riggle et a l, 1999). 
Morphogeiietie transformation of C. albicans is triggered by serum components, 
N-acetyglucosamine, and an elevated temperature. The organism switches from a 
unicellular yeast form to a multicellular hyphal fonn that supports the penetration 
o f host cells or tissues (Ramon et a l, 1999).
In the host, hyphae may be suited to breach barriers, whereas the yeast form 
is more easily disseminated. Both yeast cells and filaments are found at infection 
sites, so it is reasonable to assume that both contribute to pathogenesis. The
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hyphal fonn is important for penetrating tissue surfaces and escaping from host 
cells following internalization; these mechanisms enable hyphal invasion of 
epithelial and endothelial surfaces (Kumamoto and Vinces, 2005). Therefore, 
understanding the meehanisms for this morphogenetie switch should provide an 
insight into the pathogenicity o f this fungus (Odds, 1988). During hyphal growth 
in C. albicans, cell surface expansion is restricted to a small region at the hyphal 
tip. This apical growth zone is active during the entire hyphal growth period (Liu,
2001). Increasing evidence supports the view that hyphal growth is a response to 
nutrient deprivation, and that filamentous gi'owth enables the fungus to forage for 
nutrients more effectively (Ramon et al., 1999).
2.3 Production of extracellular enzymes
The ability of C. albicans to produce extracellular hydrolytic enzymes such 
as secreted aspartyl proteinases (SAP), phospholipases and lipases, is an important 
factor which contributes to C. albicans virulence. For example, C. albicans 
isolates from patients with vaginal or oral candidosis produced more proteinases 
than C. albicans isolates from asymptomatic earners (Naglik et a l,  2003). The 
role of seereted aspartyl proteinases enzymes in C. albicans infection is linked 
directly to virulence frmctions including hydrolysing proteins of host cell 
membranes, adhesion, and tissue invasion (Calderone, 2002). Secreted aspartyl 
proteinases are usually active at acidic pH. However, it has been demonstrated 
that aspartyl proteinases of C. albicans have at least 10 members (Sap 1-10). Sap 
2 and Sap 4-6 have been reported to be more active at neutral pH (Wagner et a l, 
1995), whereas Sapl-3 have their highest activity at lower pH values. These 
different pH optima of the Sap isoenzymes provide C. albicans with a range of 
proteolytic activity from pH 2.0 to 7.0. Different pH values can optimize different
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proteinase enzymes which may explain the ability of C. albicans to infect a 
variety of tissues, as in vaginal (acidic pH) or oral candidosis (neutral pH) 
(Schaller et a l,  2005).
Four types of phospholipases have been reported in C  albicans - 
phospholipases A, B, C, and D ~ but only the PLBl and PLB2 gene products have 
been detected extracellularly. Although PLBl is thought to account for most of 
the secreted phospholipase B activity in C albicans, PLB2 contributes in a minor 
way because a PTR7-deficient strain still produces residual amounts of 
phospholipase B activity. Of the four types of phospholipase identified, PLB 1 
and PLDl have been shown to be required for virulence. In C. albicans the 
expression of this type of hydrolytic enzyme can be affected by several 
environmental factors, such as temperature, pH, and growth phase of C. albicans. 
Furthermore, it was found that yeast cells or hyphae expressed higher levels of 
PLBl mRNA than germ-tube forming cells (Hoover et a l,  1998). Non-C. 
albicans species such as C. tropicalis, C. glabrata and C. parapsilosis have been 
reported to produce phospholipases (Fu et a l, 1997). Although deletion of PLBl 
did not produce any detectable effects on candidal adherence to human endothelial 
or epithelial cells, the ability of the C. albicans mutants lacking PLBl to penetrate 
host cells was dramatically reduced. Therefore, phospholipase B may well 
contribute to the pathogenicity of C. albicans by abetting the fungus in damaging 
and traversing host cell membranes, processes which likely increase the rapidity 
of disseminated infection (Leidich et a l, 1998).
In comparison to proteinases and phospholipases, little was known about 
Candida lipases or esterases until recently. Now, however, a range of lipase genes
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(L /Pl-10) has been identified in C. albicans (Hube et a l, 2000; Schofield et a l,
2005), as well as in other Candida species such as C  parapsilosis (Neugnot et a l,
2002; Stehr et a l,  2003). This enzyme enabled C. albicans to glow on lipids as 
the sole source of carbon (Roustan et a l, 2005). Moreover, secreted lipolytic 
enzymes of C  albicans have been discussed as virulence factors. Lipase genes 
constitute a large gene family that may have evolved to adapt to the peiinanent 
association of C. albicans with the human or animal host and may also have |
important functions during persistence and infection processes. It was found that 
lipase gene expression depended on the stage of infection rather than on the organ i
localization (Hube et a l , 2000).
2.4 C. albicans transcription factors i
Inside the host, Candida species have to interact with different 
microenviromnents characterized by many conditions such as nutrient availability, 
pH, and temperature (Calderone, 2002). Therefore Candida has to respond to 
these new situations by means of signal transduction pathways such as the 
mitogen-activated protein kinase (MAP kinase) pathway. The enzymes in these 
pathways are involved in regulating growth and differentiation processes by 
sensing enviromuental changes and transducing the signals detected at the cell 
surface to the interior of the cell by sequential protein activation (Brown and 
Gow, 1999). Since these signalling pathways were studied earlier in 
Saccharomyces cerevisiae, most investigations of mitogen-activated protein 
kinase (MAP kinase) signalling in C. albicans have used S. cerevisiae as a 
comparative model organism.
,1
3
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In C. albicans, morphological switching from yeasts to hyphae is dependent 
on stimulation of regulatory pathways. Several signalling pathways that regulate 
morphogenesis have been identified, including various transcription factors that 
either activate or repress hypha-specific genes. Two well-characterized pathways 
include the MAP kinase cascade and cAMP-dependent protein kinase pathway 
that regulate the transcription factors Cphl and Efgl, respectively (Stoldt et a l, 
1997; Banuett, 1998). The cphl/cphl mutant of C. albicans shows delayed 
initiation of filamentous growth on Spider agar plates, relative to wild-type cells, 
but shows wild-type levels of filamentous growth in response to liquid serum 
treatment (Liu et a l, 1994). In contrast, efgl/efgl mutant cells are strongly 
attenuated in responding to serum, showing no germ tubes or hyphae within 2  h of 
being introduced to 20% serum at 37°C. Additionally it was found that efgl/efgl 
mutant cells were reduced in vimlence when evaluated in a mouse model 
experiment, as was the double mutant strain efgl/efgl cphl/cphl. This 
observation suggested that EFGl and CPHl together account for the pathways 
that activate filamentous growth in C  albicans (Lo et a l ,  1997; Stoldt et a l, 
1997).
3. Microbial bio films
Biofilms are microbial communities characterized by cells that are 
irreversibly attached to a substratum or interface or to each other, are embedded in 
a matrix of extracellular polymeric substances that they have produced, and 
exhibit an altered phenotype with respect to growth rate and gene transcription 
(Donlan, 2002; Hall-Stoodley and Stoodley, 2002). It is clear that microorganisms 
undergo profound changes during their transition from planktonic (fi'ee-
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swimming) organisms to cells that are part of a complex, surface-attached 
community (Costerton, 1995), Biofilms can be defined simply and broadly as 
communities of microorganisms that are attached to a surface.
Using tools such as the scamiing electron microscope and, more recently, 
the confocal laser scanning microscope (Moller et a l, 1996), bio film researchers 
now understand that biofilms are not unstructured, homogeneous deposits of cells 
and are phenotypieally different from planktonic cells (Kolenbrander, 1997;
Baillie and Douglas, 1998a; Okabe et a l, 2001; Donlan and Costerton, 2002).
Bacterial bio films are the most commonly studied because of their role in 
colonizing medical implants such as prosthetic heart valves and joint 
replacements. Biofilms can comprise a single microbial species or multiple 
microbial species and ean form on a range of biotic and abiotic surfaces (Donlan 
and Costerton, 2002). However, when they are nutrient deprived, biofilm cells can 
detach from the surface and return to a planktonic mode of gi'owth; this behaviour 
may be the first step towards colonization of another surface (Stickler et a l, 1998;
Hunt et a l, 2003). Recent reports suggest different strategies by which cells from 
bacterial biofilms disperse or detach; for example, in Pseudomonas aeruginosa 
bio film cells disperse by twitching motility (s wanning), but in S. aureus biofilms 
cells disperse by rolling motility (clumping) (Hall-Stoodley and Stoodley, 2005).
1
Adherence is the first stage in the development of a biofilm on biomaterials 
in device-related infections. It may be influenced by many factors such as 
biomaterial surface characteristics, growth conditions and biomaterial surface
catheter-related infections are a major cause of morbidity and mortality in the
chemistry. Donelli and Francolini (2001) have reported that intravascular
__
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United States. More than 200,000 nosocomial bloodstream infections occur each 
year in the United States; most o f these infections are related to different types of 
intravascular devices - in particular, the nontumielled central venous catheter 
(Donelli and Francolini, 2001). The risk factors for intravenous catheter-related 
infections vary according to the type o f catheter, the hospital size or unit, the 
location o f the site of catheter insertion, and the duration of catheter placement.
4. Candida biofilms
The first report o f biofilm formation by Candida species in vitro was by 
Hawser and Douglas (1994). A model system was devised for studying Candida 
biofilms glowing on the surface of small disks of catheter material. Since that 
time, a variety of model systems have been developed.
4.1 Biofilm model systems
Most methods for examining growth of Candida biofilms have been 
modified fiom those used in early studies on bacterial biofilms. The catheter disk 
model was the first to be used; adhered cells of Candida were allowed to grow on 
the surface of polyvinyl chloride (PVC) catheter disks and biofilm activity was 
monitored quantitatively by MTT or XTT tétrazolium salt reduction which is a 
colorimetric method, or by measuring biofilm cell dry weight (Hawser and 
Douglas, 1994). In other studies, a denture acrylic strip model was established to 
investigate C  albicans biofilms (Nikawa et a l, 1996; Chandra et a l,  2001b), 
while microtitre plates (96-well) were used to examine Candida biofilms in the 
presence of antifimgal agents because large numbers of biofilm samples can be 
processed in this way (Ramage et a l,  2001b). Candida biofilms have also been
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evaluated under liquid flow conditions which relate to many biofilms formed in 
vivo\ for example, the perfused biofilm fermenter (Baillie and Douglas, 1998a) , 
the cylindrical cellulose filter (Baillie and Douglas, 1998b) and more recently the 
CDC biofilm reactor system (Honraet et a i,  2005) are systems used for 
developing biofilms under flow conditions. Recently, C  albicans bio films were 
investigated in vivo by using a rat central venous catheter model (Andes et a l,
2004) and a rabbit central venous catheter model (Schinabeck et a l, 2004).
4.2 Factors affecting the ability of Candida to form biofilms
Several in vitro studies have demonstrated a variety of factors affecting 
biofilm fonnation. Using the catheter disk model, Hawser and Douglas (1994) 
showed that there was some correlation between the ability to fonn biofilms and 
pathogenicity when different Candida species were investigated. For example, 
isolates of C  parapsilosis, C. pseudotropicalis and C  glabrata all gave 
significantly less biofilm growth than the more pathogenic C. albicans. This 
observation was confirmed by another report (Kulm et a l , 2002a) which showed 
that C. albicans produces quantitatively larger and qualitatively more complex 
biofihns than other species, in particular, C. parapsilosis. Moreover, minimal 
variations in biofilm production among invasive C. albicans isolates were 
obseiwed, but significant differences between invasive and noninvasive isolates 
were seen (Kuhn et a l, 2002a). Recently, it has been shown that there is a 
correlation between biofilm production by different C  parapsilosis strains and 
strain genotype. A majority of C. parapsilosis isolates from the bloodstream, 
hands of health-care workers, and all other sites from patients belonged to one 
genotype group and had the ability to produce biofilms, while other strains had 
different genotypes and failed to produce biofilms (Song et a l ,  2005).
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The nature of the catheter material used in vitro can also affect biofilm 
formation by C. albicans. For instance, evaluation of various catheter materials 
showed that biofilm formation by C. albicans was slightly increased on latex or 
silicone elastomer, compared with polyvinyl chloride, but substantially decreased 
on polyurethane or 100% silicone (Hawser and Douglas, 1994). In vivo, implants 
rapidly adsorb host proteins, which foim a conditioning film on the surface. 
Nikawa et al. (1996) examined the effect of modification o f denture aciylic 
surfaces on biofilm fonnation by C  albicans; they found that biofilm formation 
was promoted when the surfaces were pre-coated with saliva or serum.
4.3 Biofilm ultrastructure
After 48h, C. albicans biofilms on catheter disks consist of a dense network 
of yeasts, genn tubes, pseudohyphae, and hyphae as examined by scanning 
electron microscopy (Hawser and Douglas, 1994). A subsequent study 
demonstrated that C. albicans biofilms produce more extracellular matrix material 
when incubated with gentle shaking instead of statically (Hawser et a l, 1998). 
Biofihns o f C. albicans on catheter disks produce two layers: a thin, basal yeast 
layer and a thicker, hyphal layer (Fig. 1). The basal yeast layer is thought to play 
an important role in anchoring the biofihn of C. albicans to the surface (Baillie 
and Douglas, 1999b; Douglas, 2003). Subsequent studies confirmed that in vivo 
C. albicans biofihn stmcture was similar to biofilm architecture for in vitro 
models, but that in addition, host cells were embedded in the extracellular matrix 
(Andes et a l, 2004).
Using fluorescence and confocal scamiing laser microscopy, Chandra and et 
al (2 0 0 1 ) demonstrated that biofihn formation proceeds through thiee distinct
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developmental phases. These growth phases transform adherent blastospores to 
well-defined cellular communities encased in a polysaccharide matrix (Chandra et 
a l, 2001a). However, C. albicans blofilms have a morphology different from that 
of other species, consisting of a basal blastospore layer with a dense overlying 
matrix composed of exopolysaccharides and hyphae. In contrast, C. parapsilosis 
biofilms are composed exclusively of clumped blastospores (Kuhn et a l,  2002a).
Unlike the scanning electron microscope, confocal scanning laser 
microscopy used with fluorescent dyes allows the examination of living biofilms 
in a fully hydrated eondition. When examined by this technique, C. albicans 
biofilms displayed complex three-dimensional structures consisting of 
microcolonies of yeasts and hyphae embedded in matrix material, interlaced with 
water channels which maintain a mechanism for nutrient circulation inside the 
biofihn (Ramage et a l,  2001c; Fig 1).
Recent investigations at the level of morphogenetie signalling pathways 
have provided evidence of a role for these pathways in controlling the structure of
'C. albicans biofilms. Mutant strains of C  albicans lacking the EFGl gene were 
incapable of producing hyphae or fonning biofilms (Ramage et a l,  2002b). In 
another study, mutants lacking the transcription factors Efgl and Cphl colonized 
polyurethane catheters very poorly compared to the wild type strain (Lewis et a l ,
2002). On the other hand, in a recent report it was shown that efgl/cphl mutants 
produced yeast-only biofilms on a glass surface (Garcia-Sanchez et a l, 2004).
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Figure 1
Stages ill the formation of a C. albicans biofilm
Stages in the formation of a C. albicans biofilm on a polyvinylchloride (PVC) 
catheter surface. (A) Catheter surface with an adsorbed conditioning film of host 
proteins (black dots). (B) Initial yeast (red) adhesion to the surface. (C) Formation of 
the basal layers of yeast microcolonies. These anchor each microcolony to the 
surface. (D) Completion of microcolony formation by addition of the upper, mainly 
hyphal layer and matrix material (yellow) that surrounds both yeasts (red) and hyphae 
(green). Mature biofilms contain numerous microcolonies with interspersed water 
channels to allow circulation of nutrients. On other surfaces (e.g. cellulose fibres) 
micro colonies consisting entirely of yeast cells are produced (Douglas, 2003).
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4.3.1 Mixed fungal-bacterial biofilms
Although most studies have investigated the structure of Candida biofilms 
formed by a single species, mixed species fungal-bacterial biofilms have been 
reported. For example, in an in vitro model of mixed species biofilms, two 
different strains of Staphylococcus epidermidis, a slime-producing wild type and a 
slime-negative mutant, showed extensive interactions with C. albicans. These 
interactions were more easily seen with the slime-negative mutant. Staphylococci 
were present beneath and above the yeast and hyphal layers, and were clearly 
adherent to both morphological forms of the fungus. All three species when 
giown individually showed maximum biofihn growth up to 24 h, but mixed 
species biofilms continued to giow up to 48 h (Adam et al., 2002).
Another report investigated the interactions between C. albicans and 12 
other species of Candida and bacteria in biofilms. The number o f cells within 
biofilms grown in a polystyione tube model was measured after adding C. 
albicans to preformed biofilms of the other microorganisms, and vice versa. The 
number of cells of C. albicans within the growing biofilms decreased significantly 
when the fungus was added to prefonned biofilms of Candida species and 
bacteria except with C. parapsilosis, C. glabrata or P. aeruginosa (a slime 
producer). Flowever, when C. parapsilosis, S. epidermidis (a slime-negative 
strain) or Serratia marcescens was added to prefonned biofilms of C. albicans, 
the number of cells o f these microorganisms increased in the growing biofilms 
(El-Azizi et al., 2004). The authors concluded that biofilms of C. albicans are 
capable of holding other microorganisms and more likely to be heterogeneous 
with other bacteria and fungi in the environment and on medical devices.
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4.4 D rug resistance of biofilms
The dmg resistance of Candida biofilms has been demonstrated by several 
studies. Hawser and Douglas (1995) showed that biofilms fonned by C. albicans 
and other Candida species were resistant to the action of five clinically important 
antifungal agents, including amphotericin B and fluconazole, when compared 
with planktonic cells. Drug concentrations required to reduce metabolic activity 
by 50% were five to eight times higher for biofilms than for planktonic cells, and 
30-2000 times higher than the corresponding minimum inliibitoiy concentrations 
(MICs) (Hawser and Douglas, 1995). A subsequent study used a cylindrical 
cellulose filter method to investigate biofilm formation by C. albicans at low 
giowth rate under iron- and glucose- limitation. It was found that both biofilm 
types were resistant to amphotericin B, but daughter cells fiom iron-limited 
biofilms were significantly more susceptible to the dmg than those fr om glucose- 
limited biofilms (Baillie and Douglas, 1998b). A microtitre-based colorimetric 
assay has also been used for susceptibility testing of Candida biofilms. Ramage et 
al. (2001b) confimied that biofilms from different C. albicans strains were 
resistant to amphotericin B and fluconazole. Amphotericin B was up to 32 times 
less active against biofilms than against planktonic cells. However, amphotericin 
B still demonstrated some activity against C. albicans biofilms, as indicated by the 
biofilm MIC50 values (Ramage et a l,  2 0 0 1 b).
Subsequent studies showed that biofilms formed by C. albicans on denture 
acrylic are highly resistant to antifungal agents such as fluconazole, nystatin, 
amphotericin B and chlorhexidine (Chandra et a l, 2001b). Similarly, biofilms 
formed by C. albicans and C. parapsilosis on silicone were reported to be 
resistant two new triazoles (voriconazole and ravuconazole). In contrast, lipid
24___________   Introduction
formulations of amphotericin B (liposomal amphotericin B and amphotericin B 
lipid complex), and echinocandins such as caspofungin and micafungin, showed 
activity against Candida biofilnis (Bachmann et al., 2002; Kuhn et a l , 2002b).
4.5 Possible mechanisms of biofilm drug resistance
The mechanisms by which Candida biofilms are resistant to antifungal 
agents remain to be elucidated. Possible mechanisms include: restricted drug 
penetration tlnough biofilm matrix material; a slow growth rate which can 
produce phenotypic changes; and differential gene expression when biofilms 
interact with different surfaces (Mah and O'Toole, 2001). The presence of 
“persister” cells has also been suggested recently (Lewis, 2005).
4.5.1 Restricted drug  penetration through biofilm m atrix m aterial
Matrix material, which is one of the distinguishing characteristics of 
biofilms, has long been held to have a role in preventing the diffusion of 
antibiotics into microbial biofilms and acting as a diffusion bam er (Stewart, 1996; 
Gilbert et a l,  2002). To determine whether the matrix material is involved in the 
resistance of Candida biofilms, Baillie and Douglas (2000) compared the 
susceptibility of Candida biofilms grown statically (which possessed a sparse 
matrix) with those of biofilms incubated with gentle shaking (which produced 
copious amounts of matrix material). The extent of matrix fonnation did not 
significantly affect the susceptibility of C. albicans biofilms to amphotericin B , 
flucytosine or fluconazole (Baillie and Douglas, 2000). However, other 
investigations with biofilms produced under flow conditions suggested that matrix 
material may have a minor role in biofilm resistance, since resuspended cells 
(which had lost most of their matrix material) were 2 0 % less resistant to
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amphotericin B than intact biofilms (Baillie and Douglas, 1998a; Baillie and
Douglas, 1998b). «
Other studies have been earned out in which antifungal penetration has been 
.assessed by detecting the concentration of the drug able to penetrate the biofilm. 
Al-Fattani and Douglas (2004) used a filter disk assay to investigate the 
penetration of flucytosine, fluconazole, amphotericin B, and voriconazole tlirough 
single- and mixed-species biofilms containing Candida. They found that 
fluconazole penueated all single-species Candida biofilms more rapidly than 
flucytosine. Either drug showed similar diffusion rates tlii'ough biofilms of three 
strains of C. albicans. However, the rates of drug diffusion through biofilms of C  
glabrata or C. krusei were faster than those through biofilms of C. parapsilosis or 
C. tropicalis. In all cases, after 3 to 6  h the drug concentration at the distal edge of 
the biofilm was very high but failed to produce complete killing of biofilm cells 
(Al-Fattani and Douglas, 2004). Related obseiwations were subsequently reported 
with a similar model system; fluconazole and flucytosine demonstrated similar 
levels of perfusion, while amphotericin B showed the lowest penetration tlirough 
biofilms of C. albicans, C. parapsilosis, and C. l<rusei (Samaranayake et a l,
2005). However, both investigations indicated that poor antifungal penetration is 
not a major drug resistance mechanism for Candida biofilms.
4.5.2 Slow growth rate
Slow or no growth is generally accompanied by an increase in the resistance 
of microorganisms to antibiotics. Cells growing in biofilms are usually exposed to 
some form of nutrient limitation. Therefore it has been suggested that 
physiological changes resulting from a slow growth rate can account for the
26 Introduction
resistance of bio films to antimicrobial agents (Mah and O'Toole, 2001). This 
possibility has been investigated in Candida biofilnis; a perfused bio film 
femienter was used by Baillie and Douglas (1998a) to assess whether the growth 
rate of C. albicans biofilms could affect their susceptibility to antifungal agents. 
The method used allowed gi'owth-rate control of adherent microbial populations. 
It was found that biofilms fonned at different growth rates were resistant to 
amphotericin B, whereas planktonic cells were resistant only at very low growth 
rates (Baillie and Douglas, 1998a). Subsequent studies showed that C. albicans 
biofilms grown on cylindrical cellulose filters under iron- and glucose-limitation 
were equally resistant to amphotericin B. However, daughter cells from iron- 
limited bio films were significantly more susceptible to the drug than those from 
glucose-limited biofilms (Baillie and Douglas, 1998b).
4.5.3 Differential gene expression
The multidrug resistance phenotype in planktonic cells o f C  albicans has 
previously been shown to be due to overexpression of several genes known to be 
involved in azole resistance, including CDRl, CDR2 and M DRl. These genes are 
upregulated leading to the activation of plasma membrane efflux systems which 
pump the drugs fi*om the cells. Overexpression of drug efflux pumps has been 
demonstrated in C. albicans biofilms. However, strains caiiying single or double 
mutations in these genes retained a resistant phenotype during biofilm gi'owth 
(Ramage et a l, 2002c). Subsequent studies by Mukherjee et a l (2003) showed 
that biofilms formed by C. albicans Cdrl /Cdr2 and Cdrl /Cdr2/ M drl double 
and triple mutants, respectively, were more susceptible to fluconazole than the 
wild-type strain, but at later time points ( 1 2  and 48 h), all the strains became
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resistant to fluconazole. These obsei*vations indicate a lack of involvement of 
efflux pumps in resistance at late stages of bio film formation, while demonstrating 
that additional, as yet unidentified, resistance mechanisms are involved in 
Candida biofilm formation.
Recently, differential gene expression was investigated in planktonic cells of 
C. albicans and biofilm-associated cells grown in vivo in a rat model system. 
Using quantitative RT-PCR it was found that there was no difference in 
expression of the azole target enzyme gene E R G ll, or M D Rl, between planktonic 
cells and biofilm-associated cells. However, mRNAs horn both of the ATP- 
binding cassette pumps, CDRl and CDR2, were significantly increased in the 
biofilm state, CDR2 was the most remarkably affected, with a nearly 10-fold 
increase in expression (Andes et a l,  2004).
4.5.4 “Persister” cells
“Persister” is the term used for subpopulations of microorganisms known for 
high tolerance to killing by antibiotics or that neither gi'ow nor die in the presence 
of antibiotics. Lewis (2001) suggested that that there are phenotypic changes in 
microbial bio films which result in the expression of biofilm-specific resistance 
genes or the presence of persister cells. The dynamics of persister formation are 
clearly more complex in biofilms. It has been suggested that persisters can 
accumulate within the biofilm, although the production of persisters near the 
surface of the biofilm is outpaced by reproduction of susceptible bacteria. 
Therefore persister cells may be contributing factors in the time-dependent 
tolerance o f both planktonic cells and biofilms to high concentrations 
antimicrobial agents (Harrison et a l, 2005; Roberts and Stewart, 2005).
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Recently, it has been suggested that biofilms can produce more persister 
cells than can planktonic organisms (Lewis, 2005). In addition, it has been shown 
that the h'aetion of persister cells in bacterial biofilms increased during incubation 
and that more persister cells were obseiwed in thicker biofilms (Roberts and 
Stewart, 2005). Since the hypothesis of persister cells in bacterial biofilms has not 
been thoroughly investigated, it is not known whether the same hypothesis can be 
applied to Candida bio films.
5. Quorum sensing
Quorum sensing was first described in 1970 by Nealson et al. in planktonic 
cells o f the luminescent marine bacterium Vibrio fischeri. This bacterium 
produces a diffusible compound, termed an autoinducer, that accumulates in the 
surrounding environment during growth. At low cell densities the autoinducer is 
at low concentrations, and at high cell densities the autoinducer can accumulate to 
a concentration sufficient for activation of the lux genes (responsible for light 
production). At that time this report led to the theory of cooperative behaviour 
between cells of V. fischeri in response to the accumulation of secreted 
autoinducer signalling molecules (Nealson and Hastings, 1979). It is now clear 
that some of the functions of biofilms depend on the ability of the bacteria and 
microcolonies within the biofilm to communicate with one another. Quorum 
sensing is dependent on cell density and involves the regulation of expression of 
specific genes through the accumulation of signalling compounds that mediate 
intercellular communication (Miller and Bassler, 2001). With few cells, signalling 
compounds may be produced at low levels; however, autoinduction leads to 
increased concentration as cell density increases. Once the signalling compounds
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reach a threshold level (quorum cell density), gene expression is activated (Finch 
et a l, 1998).
Cell signalling has been studied extensively in luminescent bacteria and 
appears to be mediated by an acyl homoserine lactone (AHL) encoded by the lux I 
gene. A similar system has been shown to exist in certain other Gram-negative 
species (Nilsson et a l,  2001). The high cell concentrations in biofilms present an 
ideal situation for quorum sensing, as even small microcolonies may induce gene 
expression since the signalling compounds may be concentrated within the 
microcolony and are not degraded (McLean et a l, 1997).
In Gram-positive bacteria, quomm sensing uses peptides (oligopeptides) as 
signals that are the ligands of membrane receptors (histidine kinases) or that 
interact with other proteins which in turn regulate the activity of the response 
regulator of signal transduction pathways (Miller and Bassler, 2001). For instance, 
in Staphylococcus aureus, the agr locus is responsible for controlling virulence 
gene expression via quorum sensing. At low cell density, the bacteria express 
protein factors that promote attachment and colonization, whereas at high cell 
density, the bacteria repress these traits and initiate secretion of toxins and 
pro teas es that are presumably required for dissemination (Lyon and Novick, 
2004).
Quorum sensing may give biofilms their distinct properties. For example,
'expression of genes for antibiotic resistance at high cell densities may provide '
protection. Quorum sensing also has the potential to influence community 
structure by encouraging the growth of species beneficial to the biofilm. It is also 
possible that the physiological properties of bacteria in the community or biofilm
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may be altered through quorum sensing (Kjelleberg and Molin, 2002). Novel 
antimicrobial strategies could be designed based on infonuation garnered from 
studies of quorum sensing, which suggests that research on quomm sensing could 
have enormous practical applications (Davies et a l,  1998; Finch et a l,  1998).
5.1 Quorum sensing in Candida by farnesol
In C. albicans the ability to switch between yeast, pseudohypha, and hypha 
is an important characteristic. This morphological transition appears to be 
integrated with different types of enviromnental signal to assess whether 
conditions are the most favourable for growth in a specific cellular morphology 
(Odds, 1988; Brown and Gow, 1999). For example, C  albicans can be converted 
from a cellular yeast to a filamentous form in vitro by exposure to semm or N- 
acetylglucosamine (Niimi et a l, 1997). Moreover, the switching between different 
morphologies depends on the cells’ metabolism and physiology, as well as 
division and polarity. For this reason, cells must communicate with each other as 
communities (Mitchell, 1998; Sanchez-Martinez and Perez-Martin, 2001).
Reeently, a quorum sensing system was reported in C. albicans that is
I
Imediated by farnesol (C15H26O; molecular weight, 222; Hornby et a l,  2001; Fig
i2A). This was the first study to identify an extraeellular molecule which mediates 
a eukaryotic quomm-sensing system and which can be removed from cells of C. 
albicans by washing. Farnesol eould block the induction o f genu tubes by tliree 
chemically distinct triggers (L-proline, N-acetylglueosamine, and serum) 
preventing the yeast-to-mycelium conversion. It was also shown that farnesol 
alters cell morphology but does not alter giowth rate (Hornby et a l, 2001). 
However, the farnesol concentration needed to inhibit gemi-tube foimation varied
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depending on the conditions used. For instance, a low farnesol concentration (1-2 
pM) was needed to inhibit geim-tube foimation in defined medium, while a 
higher farnesol concentration (150 and 250 pM) was required when germ-tube 
foimation was perfonned in 10 and 20% serum (Mosel et a l, 2005).
During chlamydospore morphogenesis, cells switch to filamentous growth 
and then develop elongated suspensor cells that give rise to chlamydospores. 
These chlamydospore cells are distinct from tine hyphae in that they are wider 
and are not inhibited by the quorum-sensing factor farnesol. Instead, farnesol 
increases chlamydospore production, indicating that farnesol can also have a 
positive role (Martin et a l, 2005). Farnesol could also play an important role in 
protecting C. albicans cells from oxidative stress. Westwater et a l  (2005) 
demonstrated that conditioned medium from a C. albicans stationary-phase 
culture is able to protect yeast cells from both hydrogen peroxide and superoxide 
anion-generating agents. Exponential-phase yeast cells preexposed to conditioned
medium or culture with added exogenous farnesol were able to survive levels of 
oxidative stress that would normally kill actively gi’owing yeast cells (Westwater 
et a l, 2Q05).
.Another study by Oh et a l  (2001) involved the synthesis and evaluation of 
famesoic acid derivatives as morphogenic regulatory agents. This gi’oup found 
that the substance capable of regulating the yeast-to-hyphal morphological 
transition is famesoic acid. However, farnesol was more active than farnesoic acid 
as an inhibitor of this transition, but was less selective, because it affected yeast 
cell gi'owth too (Oh et a l,  2001).
:
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Figure 2
Quorum sensing molecules in C  albicans
A. Farnesol (a Ci5 isoprenoid alcohol) inhibits hyphal production
B. Tyi'osol ( 2-[4"hydroxy phenethyl] ethanol) promotes hyphal production
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It was subsequently found that this observation was obtained with only one 
C. albicans strain (10231) which produces famesoic acid and does not produces 
farnesol (Hornby and Nickerson, 2004). Unlike famesoic acid which does not 
affect the growth of C  albicans but inhibits gemi-tube formation, famesoic acid 
derivatives inhibit germ-tube formation as well as growth of C. albicans (Kim et 
a l, 2002b). Another study demonstrated that protein-famesyl transferase 
inhibitors inhibit germ-tube fonnation in semm but do not affect the growth of the 
yeast form of C  albicans (McGeady et a l , 2002).
Subsequent studies showed that out of forty natural and synthetic famesol 
analogues, famesol was the most active at inhibiting genn-tube formation by C. 
albicans, although famesol from different sources showed different activity 
against genn-tube formation (Shchepin et a l, 2003). Moreover, fluorescent 
famesol analogues were developed and thought to be constmctive tools to study 
famesol binding proteins and famesol phannacokinetics (Shchepin et a l, 2005). 
Additionally, it was found that farnesol production by C. albicans could be 
stimulated up to 8-fold by treating planktonic cells with sterol biosynthetic 
inhibitors like zaragozic acid and azole antifungal agents (Hornby et a l, 2003; 
Homby and Nickerson, 2004).
Famesol activity has been described in other fungi. For example, famesol- 
treated cells of S. cerevisiae were characterized by a transition from budded to 
unbudded cells with significant loss of intracellular diacylglycerol (DAG). 
Moreover, it was found that this famesol effect could be abolished by addition of 
a DAG analogue such as l-oleoyl-2-acetyl-sn-glycerol (OAG) (Machida et a l, 
1999). On the other hand, farnesol did not produce a morphological change in the
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dimorphic fungus, Ceratocystis ulmi, which causes Dutch elm disease (Homby et 
al., 2004).
5.1.1 Farnesol and biofilms
C. albicans biofilm growth was inhibited in the presence of famesol added 
at an early stage, and it was shown that famesol inhibition was time-dependent.
For example, preincubation with 300 pM famesol completely inhibited biofilm ii
formation whereas adding famesol at the same concentration after 2 h of 
adherence time did not affect biofilm formation (Ramage et a l, 2002a). This |
finding was similar to the effect of famesol on germ-tube formation. When 
famesol was added at time zero, yeast cells failed to produce geim tubes.
However, adding famesol to 90-min mature germ tubes did not block germ-tube ’i
ielongation (Mosel et a l,  2005). Supernatants from mature biofilms inhibited the filamentation of planktonic cells grown on RPMI medium, indicating that famesol 
(or possibly other, similar quorum sensing molecules) is produced in situ in
'I#biofilms (Ramage et a l,  2002a). A recent report demonstrated the effect of 
famesol on biofilm formation by non-C. albicans species. Famesol inhibited 
biofilm formation by C  parapsilosis with a crepe, concentric or crater phenotype, 
but did not inhibit biofilm formation by C  parapsilosis with a smooth phenotype 
(Laffey and Butler, 2005).
Another interesting observation comes from studies on the effect of farnesol 
on a C  albicans mutant lacking Chklp which was found to be avimlent in a 
murine model of haematogenously disseminated candidosis (Calera et a l,  1999).
Genn-tube formation and biofilm formation by the null mutant (chkl/chkl) were 
not responsive to farnesol, unlike the wild-type strain (Kruppa et a l, 2004). The
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CHKl gene encodes a histidine kinase signal transduction protein, but the specific 
function of Chklp has not been established (Kruppa et a l, 2003).
Analysis o f gene expression by C. albicans biofilms exposed to famesol 
using cDNA micro array analysis indicated that several genes were differentially 
expressed in the presence or absence of famesol, including genes involved in 
hyphal formation, cell surface hydrophobicity, and dmg resistance. For example, 
genes involved in hyphal formation such as TUPl were up-regulated, while 
PDE2 (a nucleotide phosphodiesterase gene), along with the cell surface 
hydrophobicity gene CSHl and dmg resistance genes CDRl, CDR2 and MDRl, 
were down-regulated (Cao et a l,  2005).
5.1.2 Quorum sensing in fungal-bacterial biofilms
Fungal-bacterial interaetions are common among microbial communities. 
Recently, interactions between two opportunistic pathogens, C. albicans and P. 
aeruginosa, were investigated in detail. Upon mixing cultures of P. aeruginosa 
and C  albicans it was observed that P. aeruginosa was able to attach to filaments 
o f C. albicans, but almost never adhered to yeast-fomi C. albicans cells, even 
after prolonged incubation. Moreover, it was found that more bacteria attached to 
filaments after a short period of coincubation when P. aeruginosa cells were taken 
from stationary-phase rather than from exponential-phase cultures. After 
incubation of the mixed culture for 24h, P. aeruginosa formed biofilms on C  
albicans filaments and killed the fungus. On other hand, P. aeruginosa did not 
bind or kill the yeast foim of C. albicans (Hogan and Kolter, 2002).
a
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Subsequent studies showed that this interaction between C  albicans and P. 
aeruginosa is dependent on P. aeruginosa quorum sensing molecules. It was 
demonstrated that 3-oxo-Ci2 homoserine lactone secreted by P. aeruginosa 
inliibits C  albicans filamentation without affecting C. albicans growth rates at 
levels similar those of famesol. Moreover, structurally related compounds with a 
12-carbon chain length such as Ciz-acyl homoserine lactone and dodecanol also 
affected C. albicans filamentation. On other hand, other acylated homoserine 
lactones of different chain lengths did not affect C. albicans morphology (Hogan 
et al,, 2004).
Other studies suggested that famesol might be useful as a new safe method 
for the treatment of atopic dermatitis infection caused by S, aureus, because 
famesol showed an inhibitory effect on biofilm formation by S. aureus (Masako et 
a l,  2005a; Masako et a l, 2005b). Farnesol also shows modest antibacterial 
activity against biofilms of Streptococcus sobrinus (Koo et a l, 2002). However 
the mechanism of famesol action remains unclear, since few studies of famesol 
antibacterial activity have been undeif aken so far.
Recently, famesol has been tested for anticancer activity in vitro and in vivo 
in a number of animal models. The results of these investigations demonstrate 
significant chemotherapeutic properties (Burke et a l,  2002; Duncan and Archer, 
2006). Famesol is found in fruits and vegetables (Tatman and Mo, 2002) but 
famesol-related toxicity has yet to be investigated in detail.
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5.2 Quorum sensing in Candida by tyrosol
Tyrosol, a derivative of tyrosine, (Fig. 2B), has also been identified as a 
quorum sensing molecule in C. albicans. Chen et al. (2004) detected a signalling
The possible role of tyrosol as a virulence factor for C. albicans and its 
interaction with host immune defences remain unknown. However, human 
neutrophil activity can be impaired by tyi'osol produced by Candida species 
including C. albicans (Cremer et a l,  1999). Moreover, substantially higher 
concentrations of tyrosol are produced by C. albicans and C. tropicalis than by C.
a
molecule in the culture medium of planktonically grown C. albicans, then showed
that tyrosol was the active component, and was released into the medium 
continuously during giowth. In addition, it was observed that accumulation of 
tyrosol in the medium increased along with increasing cell density. For example, 
tyi'osol was detected after lOh of incubation, but accumulated to a concentration 
of 3 pM when the eell density was 1 x 1 0 ^  cells /ml. The authors also found that 
exogenous tyrosol added to the growth medium shortened the lag phase, and 
accelerated the conversion of yeast to filaments in germ-tube fonnation (Chen et 
al., 2004).
Earlier, tyrosol had been isolated from the culture medium of Candida
species (Narayanan and Rao, 1976), and subsequent studies confirmed that tyrosol
production by C. albicans and C. tropicalis was greater than that of other Candida
species (Cremer et a l ,  1999). Other investigations showed that different fungi,
such as S. cerevisiae (Sentheshanmuganathan and Blsden, 1958; Batrakov et a l,
1993) and Rhodiola species (Xu et a l, 1998), as well as bacteria such as
,Enterobacter cloacae, can also produce tyrosol (Slininger et a l,  2004).
:___
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parapsilosis and C  glabrata, suggesting a potential role in pathogenicity ranking . /I
(Cremer et a l, 1999).
6. Hormones and Candida
6.1 Prostaglandins
of inflammation (Dannliardt and Kiefer, 2001). Prostaglandin synthases 
subsequently convert PGH2 into a series of prostaglandins, including PGI2, PGF2, 
PGD2 and PGE2 (HaiTis et a l, 2002). A PGE series lipid, possibly PGE2, was
formation by C  albicans and was also biologically active on mammalian cells 
(Noverr et a l, 2001).
5':
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!îProstaglandins are small lipid molecules that have diverse biological ;;1activities, including the modulation of host immune responses (Harris et a l, 4
2002). They are now known to be produced by pathogenic fungi as well as by
4.Ïmammalian cells (Noverr et a l,  2001; Noverr et a l,  2002; Noverr et a l, 2003).
4Both C  albicans and Cryptococcus neoformans secrete prostaglandins de novo or KIvia conversion of exogenous arachidonic acid (Noverr et a l, 2001). F
In mammalian systems, arachidonic acid, fonned by cleavage of 
phospholipids, is converted to prostaglandin H2 (PGH2) by the cyclooxygenase
isoenzymes, COX-1 and COX-2 (Fig. 3). It is thought that COX-1 is expressed
constitutively in most tissues of the body and is responsible for a basic level of IIPGH2, whereas COX-2 is mainly an inducible enzyme involved in the regulation
Ï
purified from both C. albicans and C  neoformans. It enhanced germ-tube I:,4
Figure 3
Synthesis of prostaglandins
The production of prostaglandins begins with the liberation of arachidonic acid from 
membrane phospholipids by phospholipase A2. Arachidonic acid is converted to 
PGH2 by the cyclooxygenase enzymes COX-1 and COX-2. Different synthase 
enzymes then convert PGH2 to the whole family of prostaglandins.
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The role of prostaglandins in fhngal biology is unknown. They may function 
as regulators of gene expression, as in animal cells. However, prostaglandin 
production could also represent an important virulence factor by promoting fungal 
colonization and chronic infection. Despite the fact that fungal pathogens produce 
prostaglandins, live C. albicans cells can cause significant endothelial release of 
eicosanoids, mainly prostaglandins. In addition, the ability o f different Candida 
species to induce endothelial prostaglandin release is closely related to their 
capacity to injure the endothelium. C. albicans was the only Candida species that 
either stimulated prostaglandin release or damaged endothelial cells (Filler et a l , 
1991). Subsequent studies demonstrated that endothelial cell invasion by C. 
albicans appeared to stimulate the conversion of arachidonic acid into 
prostaglandins by upregulating the synthesis of endothelial cell cyclooxygenase 
and increasing the activity of the endothelial cell phospholipase (Filler et a l,
1994).
6.2 COX inhibitors
Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most widely 
used therapeutics, primarily for the treatment of pain and inflammation, especially 
arthritis. These drugs specifically block the biosynthesis of mammalian 
prostaglandins by inhibiting one or both of the cyclooxygenase isoenzymes, 
COX-1 and COX-2; therefore NSAIDs can be classified COX 1 and COX 2 
inhibitors (Dannhardt and Kiefer, 2001; Fig. 4).
Figure 4
Structures of COX iuhibitors
* COX-1 inhibitors 
** COX-2 inhibitors
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6.2.1 COX inhibitors and antibacterial drugs
Although the nomial usage of COX inhibitors is as anti-inflammatory drugs, 
several investigations have evaluated possible improvements in antibiotic therapy 
by co-administration of COX inhibitors such as sodium salicylate. For example, 
salicylate can have both beneficial and detrimental effects on the giowth of 
bacteria, including the induction o f multiple antibiotic resistance with some 
organisms and a reduction in drug resistance with others (Price et a l, 2000). 
Serratia marcescens resistance to ciprofloxacin and nalidixic acid was enhanced 
in the presence of salicylate (Berlanga and Vinas, 2000), whereas treatment of an 
invasive experimental S. aureus infection (endocarditis) with intravenous aspirin 
caused a significant reduction in bacterial densities within target tissues 
(vegetations and kidneys) (Kupfei'wasser et a l, 1999).
Subsequent studies suggested that aspirin may exert a direct effect on 
bacterial adhesins that are necessary for S. aureus colonization and propagation in 
host tissues (Kupferwasser et a l, 2003). Additionally, Nicolau et a l (1995) 
demonstrated a combined effect of aspirin and vancomycin using a rabbit 
endocarditis model; they found a significant reduction in S. aureus densities 
within target tissues when aspirin was given prior to and during vancomycin 
therapy (Nicolau et a l, 1995). These results indicate that a combination of 
vancomycin and aspirin could be useful for treatment of S, aureus infections in 
vivo. Another interesting investigation showed that aspirin alone inhibits the 
growth of Helicobacter pylori and enhances the activity of some widely used 
antibiotics, such as amoxicillin, metronidazole and clarithromycin (Wang et a l, 
2003).
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6.2.2 COX inhibitors and antifungal drugs
The viabilities of C. albicans and C  neoformans were reduced significantly 
in the presence of some COX inhibitors suggesting that an essential 
cyclooxygenase enzyme might be responsible for fungal prostaglandin synthesis 
(Noverr et a l, 2001). Moreover, other fungi similar to dematophytes were 
remarkably susceptible to flurbiprofen which is a NSAÏD (Chowdhury et a l,
2003), Additionally it has been suggested that aspirin inhibits C. albicans by 
inhibition of Candida oxylipins, which are similar to prostaglandins (Deva et a l, 
2001).
Fluconazole is widely used in the treatment of Candida infections. However, 
fluconazole-resistant strains frequently appear, and therefore antifungal agents 
particularly fluconazole, have been investigated in combination with other drugs 
as a possible new therapeutic strategy. In the last few years several in vitro studies 
have evaluated the effect o f fluconazole in combination with ibuprofen against C. 
albicans. For example, Scott et a l  (1995) demonstrated the synergistic effect of 
fluconazole in combination with ibuprofen. Moreover, the MICs of fluconazole 
for some fluconazole-resistant strains decreased 2 to 128-fold when the drug was 
associated with ibuprofen (Pina-Vaz et a l,  2000). Another report showed that 
there was no synergistic effect of fluconazole combined with ibuprofen against 
fluconazole-susceptible strains, but a remarkable effect was seen against 
fluconazole-resistant strains (Arai et a l, 2005). Subsequent studies showed that 
resistance related to efflux pumps which export drugs in fluconazole-resistant C. 
albicans strains could be reversed by pre-treating the cells with ibuprofen (Pina- 
Vaz et a l,  2005).
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6.3 Steroid hormones
Hormones are biochemical signalling molecules that regulate physiological 
events in multicellular organisms. However, similar compounds have been 
described in unicellular organisms. For instance, flingi have similar systems of 
chemical communication including fungal hormones or pheromones (Gooday and 
Adams, 1993). These include sirenin hormones, which have precise functions and 
control sexual reproduction in Allomyces macrogynus. Similarly, a and a mating 
factors are the sole primary signals for inducing mating in S. cerevisiae (Gooday 
and Adams, 1993). Furthennore, fungi appear to interact with mammalian 
hormones at a level closely analogous to the interaction of mammalian cells with 
these chemical molecules.
Loose et al (1981) described a cytosolic protein from yeast cells of C. 
albicans that bound [^H] corticosterone and [^H] progesterone with high affinity 
and selectivity. They also demonstrated that a crude ethanolic extract of yeast 
cells of C  albicans contained a factor which competed reversibly with [^H] 
corticosterone for the fungal binding site. This material was released into the 
growth medium. Loose et al (1981) concluded that the ethanolic extract of C. 
albicans contained an endogenous ligand for the cytosol binder and proposed that 
C. albicans possesses both components of a hormone receptor system, namely a 
ligand and a binding protein. (Loose et a l, 1981).
Subsequently Wliite and Larsen (1997) investigated the role of the 
mammalian hormone, estrogen, in initiating the transfomiation o f C. albicans 
from yeast to mycelial gi'owth, which they believed to be associated with the 
organism’s vimlence. They found that the percentage of yeast cells germinating
i'.' î '- f i
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was profoundly reduced in stripped serum (without estrogen) compared to 
unstripped semm (White and Larsen, 1997).
Deslauriers et a l  (1995) observed that topical application of corticosteroids 
to the oral mucosa of 75 mice increased the residual Candida population. For 
example, topical application of a corticosteroid increased the Candida population 
on day 4 by up to 40-fold, and by day 21 the population was 400-fold greater. In 
contrast, on cessation of treatment, normal levels of Candida were quickly 
restored. Their results suggest that topical application of corticosteroids may 
dramatically shift the host-parasite relationship in favour of Candida (Deslauriers 
et a l, 1995).
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Aims and Objectives of Research
Bacterial biofilms have been studied extensively over the past 25 years, and 
much is known about their development, including cell signalling and regulation 
within the biofilm via quorum sensing. In 2001, farnesol, a specific signalling 
molecule was detected in culture supernatants of planktonically grown C. albicans 
and shown to prevent the formation of mycelia. A subsequent brief report showed 
that farnesol has an inliibitory effect on C. albicans biofilms but the role of 
farnesol in biofilm development was not fully investigated. More recently, tyrosol 
was also identified as quorum sensing molecule which could stimulate mycelial 
development in C  albicans’, however, tyrosol synthesis in C. albicans biofilms 
was not investigated. Prostaglandins, which are potent regulators of host immune 
responses, are now known to be produced by pathogenic yeasts, including C. 
albicans, but the possible role of prostaglandins in biofilm development and 
morphogenesis is still unknown.
The aim of this project was to explore the roles of farnesol, tyi'osol and 
prostaglandin(s) in genu-tube foimation and biofilm development by different 
strains and mutants of C  albicans.
Specific objectives included the following:
1) Evaluation o f germ-tube production and biofilm formation by a variety of 
genetically engineered mutants of C  albicans.
2) Deteimination of the effect of farnesol and/or tyrosol on gemi-tube 
formation and biofilm development.
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3) Investigation of the structure of biofilms foraied in the presence or 
absence of farnesol, tyi'osol and prostaglandin.
4) Measurement of tyrosol production by HPLC during planktonic growth 
and biofilm formation by C  albicans, including strains defective in germ- 
tube formation.
5) Investigation of the effects of COX inhibitors, prostaglandins and a 
combination of COX inliibitors with antifungal agents on biofilm 
development.
6) Measurement of prostaglandin production during planktonic growth and 
biofilm formation in the presence or absence of COX inhibitors using an 
ELISA assay.
7) Determination o f the effect of hormones and steroids on the development 
o f Candida biofilms and on germ-tube formation.
MATERIALS AND METHODS
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1. Organisms
Twentyfour C  albicans strains were used in this study, together with one 
strain of C  glabrata (Table 1).
2. Growth Media
Full details o f all media are given in Appendix 1.
2.1 Yeast nitrogen base
Unless otherwise stated, yeast nitrogen base (YNB; Difco) supplemented 
with 50 mM glucose was used as the standard liquid medium for growth of 
planktonic cells and biofllms of C. albicans. One litre of this medium contained 
6.7g of yeast nitrogen base and 9g of glucose (50 mM), with a final pH of 5.4 ± 
0.1; it was autoclaved at 10 p.s.i for 10 min.
2.2 Yeast nitrogen base plus uridine
YNB medium, prepared as described earlier, was supplemented with filter- 
sterilized uridine solution, (40 mg / litre, final concentration; Sigma) for giowth of 
the Nebraska strains as planktonic cells or biofilms.
2.3 Yeast nitrogen base plus 17 niM acetic acid
YNB medium, prepared as described earlier, was supplemented with acetic 
acid (1 g / litre), adjusted to pH 4.2 and filter-sterilized. This medium was used to
evaluate the combined effects of aspirin and fluconazole against mature biofilms 
of C. albicans.
I
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Table 1. Organisms used in this study
Strain Description
C. albicans GDH 2346 Isolated at Glasgow Dental Hospital from a patient with 
denture stomatitis
C albicans CAI-4 Wild-type strain
C  albicans H48 Hairy colony morphology
C  albicans H51 Hairy
C  albicans H I47 Hairy - wrinkled
C. albicans H I21 Hairy - wrinkled
C  albicans HI Mountain-like
C. albicans H253 Hairy - wrinkled
Strains from University of Nebraska (Jacob Hornby) 
including six mutants with altered colony morphology and 
response to farnesol (Jensen et al., 2006 ). All strains were 
ura".
C. albicans SC5314 Wild-type strain
C. albicans JKC19 Moiphological mutant blocked in signalling pathway 
(cphl/cphl)
C. albicans HLC52 Moiphological mutant blocked in signalling pathway (efgl/efgl)
C. albicans HLC54 Moi-phological mutant blocked in two signalling pathways 
{cphl/cphl efgl/efgl)
Strains from University of Aberdeen (Neil Gow) including 
three morphological mutants.
C  albicans DAY185 Wild-type strain
C  albicans DAY25 Mutant blocked in signalling pathways {rim 101/rim 101)
C  albicans VIC25 Mutant blocked in signalling pathways {mds3/mds3)
C. albicans VIC28 Mutant blocked two signalling pathways {rim 101/rim 101 
mds3/mds3)
Strains from Columbia University (Aaron Mitchell) 
including three mutants in pH-response or virulence.
C  glabrata AAHB 12 Isolated from patient with line infection at Crosshouse 
Hospital, Kilmarnock.
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Table 1 (Continued)
C. albicans CAF2-1 
C  albicans N 
C  albicans Ssk21 
C. albicans Chk21 
C. albicans Chk23 
C  albicans N2 
C  albicans RI 5 
C. albicans SN
Wild-type strain
Mutant blocked in signalling pathway (nikl/nikl)
Mutant blocked in signalling pathway {sskl/sskl)
Mutant blocked in signalling pathway (chkl/chkl)
Mutant blocked in signalling pathway {chkllCHKl)
Mutant blocked in signalling pathway {slm7/skn7)
Mutant blocked in signalling pathway (slm  7/SK N 7)
Mutant blocked in signalling pathway {slnl/slnl nikl/NIKl) 
Strains from Georgetown University (Bastiaan Ki'om) 
(Yamada-Okabe et at., 1999; Kruppa et a i, 2003).
All strains were maintained on slopes of Sabouraud dextrose agar (Difco) and 
subcultured monthly. Every 2 months, cultures were replaced by new ones freshly 
grown from fi'eeze-dried stocks. Freeze-dried yeasts were maintained in a dried 
state in small evacuated glass ampoules kept at -20 °C.
.
s
I
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2.4 Sabouraud dextrose agar
Sabouraud dextrose agar (Oxoid; 65g/litre) was autoclaved at 121 “C for 15 
min. The final pH was 5.6 ± 0.2. After autoclaving, the medium was cooled to 50 
and then dispensed in petri dishes or universals for plate and slope cultures, 
respectively. This medium was used to maintain all C  albicans strains as well as
C. glabrata AAHB 12.
2.5 Sabouraud dextrose broth
Sabouraud dextrose broth was prepared using 40g/litre dextrose (Difco) and 
lOg peptone (Duchefa). The medium was autoclaved at 121 ”C for 15 min. This 
medium was used to examine prostaglandin production by planktonic cells of C. 
albicans and to evaluate the combined effect of some COX inhibitors and 
antifungal agents.
2.6 RPMI 1640 buffered with MOPS
RPMI 1640 (with L-glutamine) liquid medium (Cambrex) was buffered with 
MOPS [3-(N-morpholino) propanesulfonic acid; 34.53g /litre] to a final pH of 7.0 
at 25°C (NCCLS, 1995). The medium was then filter sterilized (filter pore size, 
0.2 pm; Sartorius Minisart) and stored at 4 °C. This medium was used to evaluate 
the combined effect of COX inhibitors and some antifungal agents.
2.7 RPMI 1640 buffered with HEPES
RPMI 1640 (with L-glutamine) liquid medium (Cambrex) was buffered 
with HEPS [4-(2-Hydroxyethyl)piperazine-l-ethanesulfonic acid sodium salt; 
16.4 g/litre] to a final pH of 7.0 at 25®C (NCCLS, 1995). The medium was then 
filter sterilized (filter pore size, 0.2 pm; Sartorius Minisart) and stored at 4 °C.
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c) 10 mM proline + 2.5 niM N-acetylglucosamine
This medium was used to evaluate the combined effect of COX inhibitors and 
some antifimgal agents against Candida biofllms.
2.8 Yeast peptone dextrose
Yeast peptone dextrose (YPD) medium consisted of yeast extract (lOg/litre), 
peptone (20^1itre) and dextrose (20g/litre), adjusted to pH 6. This medium was 
used to grow inocula (overnight cultures) for biofilm formation in RPMI 1640 in 
96-well mierotitre plates (Ramage et a i, 2002a).
2.9 Vagina-simulative medium
Vagina-simulative medium, pH 4.2, was used to determine the combined
effect o f aspirin and fluconazole on C  albicans bio films. This medium was 
originally developed to imitate human vaginal fluid (Owen and Katz, 1999). It 
was sterilized by filtration (0.2 pm pore size).
i
2.10 Hornby medium
Hornby medium was prepared and sterilized by filtration (0.2 pm pore 
size). This medium was used to stimulate germ-tube formation by C  albicans as 
described by Hornby et al. (2001).
I2.11 Germ-tube inducers
Different inducers were used to examine germ-tube formation by C.
albicans. They were dissolved in 50 mM potassium phosphate buffer (pH 6.5). IThe inducers were:
a) 10 mM proline (Sigma)
b) 2.5 mM N-acetylglucosamine (Sigma)
i
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d) 5% foetal bovine serum (Gibco)
3. Chemicals
3.1 COX inhibitors and PGE2
Stock solutions (100 mM) of diclofenac, ibuprofen, indomethacin,
meloxicam, piroxicam, etodolac, celecoxib and nimesulide (Sigma) were prepared 
in dimethyl sulfoxide (DMSO). Stock solutions (100 mM) of aspirin 
(acetylsalicylic acid; Sigma) and salicylic acid (Sigma) were prepared in ethanol. 
Stock solutions (100 pM) of sodium salicylate (Sigma) were prepared in water. 
All stock solutions were filter-sterilized. In biofilm experiments, COX inhibitors 
were used at final concentrations ranging from 10 pM to 1 mM. PGE2 (Cayman 
Chemicals, Ann Arbor, Michigan) was dissolved in ethanol and used at final 
concentrations of 10 nM, 100 iiM and 1 pM.
3.2 Steroids
Stock solutions (100 mM) of progesterone, corticosterone, 
dexamethasone, prednisolone, hydrocortisone and P-estradiol (Sigma) were 
prepared in ethanol. Steroids were used at final concentrations ranging from 0.01 
pM to 1 mM.
3.3 Quorum sensing molecules
3.3.1 Farnesol
Stock solutions of farnesol (100 mM; trans, trans-famesol; Sigma) were 
prepared in methanol and filter-sterilized. For biofilm experiments, farnesol was 
added at the beginning of the adhesion period, or thi'oughout adhesion and again 
at time zero of biofilm formation.
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3.3.2 Tyrosol
3.7 Antifungal agents
3.7.1 Amphotericin B
Stock solutions of amphotericin B (1600 pg/ml) were prepared DMSO, 
filter-sterilized and stored at -20 ”C. Amphotericin B is light sensitive and 
therefore vials were covered in foil for protection fi'om the light.
3.7.2 Fluconazole
Stock solutions of fluconazole (1600 pg/ml) were prepared in water, 
filter-sterilized, and stored at -20 °C.
Stock solutions (100 mM) of tyrosol [2-(4-hydroxyphenyl) ethanol; Aldrich, 
Germany] were prepared in water, filter-sterilized, and stored at 4”C.
3.4 Propranolol
Stock solutions (100 mM) of propranolol (Sigma) were prepared in 
water, filter-sterilized, and stored at 4°C.
3.5 l-01eoyl-2-acetyl“Sn-glycerol (OAG)
Stock solutions (100 mM) of l-oleoyl-2-acetyl-sn-glycerol (OAG)
(Sigma) were prepared in dimethyl sulfoxide (DMSO), filter-sterilized, and stored 
at 4°C.
3.6 Dlbutyryl cyclic-AMP
Stock solutions (100 mM) of N^,2'-0-dibutyryladenosine 3',5'-cyclic
monophosphate (dibutyryl cAMP) (Sigma) were prepared in water, filter- 
sterilized, and stored at 4°C.
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4. Biofilm formation on catheter disks
4.1 Preparation of catheter disks
Biofilms were grown on small disks (surface area, 0.5 cm^; Fig. 5 A) cut by 
a metal punch (Fig. 5 B) from polyvinyl chloride (PVC) Faucher tubes (French 
gauge 36; Vygon, Cirencester, UK), or from polystyrene 75 cm^ tissue culture 
flasks (Costar; Corning Incorporated, USA). Disks were placed in petri dishes and 
sterilized by exposure to ultraviolet radiation for 20-30 min on each side.
4.2 Preparation of microorganisms
All organisms were grown in YNB medium containing 50 mM glucose 
unless stated otherwise. For the Nebraska strains only, uridine (40mg/litre) was 
added. Batehes of medium (25 mi, in 100-ml Erlenmeyer flasks) were inoculated 
from fresh culture slopes and incubated at 37 °C in an orbital shaker at 60 rpm. 
Under these conditions all the strains grew exclusively in the budding-yeast phase. 
Cells were harvested after 24 h and washed twice in 0.15 M phosphate-buffered 
saline (PBS; pH 7.2; Sigma). Washed cell suspensions were adjusted to an optical 
density of 0.8 at 520 nm before use in biofilm experiments.
Figure 5
Biofilm disks and metal punch
A) On the left, a polyvinyl chloride (PVC) disk cut from catheter tubing (French 
gauge 36; Vygon, Cirencester, UK). On the right, a polystyrene disk cut from 
75 cm^ tissue culture flask.
B) A metal punch used to cut PVC disks from catheter tubing.
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4.3 Biofilm formation
Biofilms were grown on small disks (surface area, 0.5 cm^) as described
■
previously in Section 4.1. The disks were placed in the wells of 24-well Nunclon 
tissue culture plates, and a standardized cell suspension (80 pi) was applied to the 
surface of each one. Initially, incubation lasted for 1 h at 37 °C (adhesion period). 
Non-adherent organisms were removed by washing with PBS, and the disks were 
then incubated for a further 48 h at 37 °C, submerged in 1 ml o f gi'owth medium 
(biofilm formation). At the end of the incubation period, disks were washed gently 
twice with PBS and transfeiTed to fresh 24-well plates for quantitative 
measurement of bio film formation.
4.4 Quantitative measurement of biofilm formation
Biofilm growth was quantified colorimetrically by a 2,3-bis (2-tnethoxy-4~ 
nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) reduction assay. XTT 
solution (250 pg / ml; Sigma) was prepared in PBS containing 1 % (wt/vol) 
glucose, and 1 ml was added to each well of fresh plates containing the biofilm 
disks. Menadione solution (Sigma; 1 mM in acetone; 4 pi) was also added to the 
wells and the plates were incubated for 5 h at 37 °C in the dark. After incubation, 
the liquid was removed fr'om each well and transferred to a microftige tube, 
clarified by centrifugation at 13,000 rpm, and XTT formazan production was 
measured at 492 mn. Control disks were used to check for interference with XTT 
reduction by any inhibitors or agents used in the experiment.
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5. Biofilm formation in wells of mierotitre plates
This assay was used to evaluate the effect of farnesol on biofilm fomiation 
on the surfaces o f wells o f mierotitre plates. Batches o f YPD medium (20 ml) in 
100 ml flasks were inoculated with one loopful of C. albicans, fi'om a slope 
culture. Inoculated flasks were incubated on an orbital shaker at 37 and 60 rpm 
overnight when the cells had reached the stationary phase of gi'owth. Cells were 
harvested and washed twice in sterile PBS at 3000 ipm for 5 min. The cells were 
then resuspended in RPMI 1640 buffered with MOPS and adjusted to a density of 
l.Ox 10  ^ cells/ml in RPMI 1640 by counting in a haemocytometer. Standardized 
cell suspensions (100 pi) were added to wells o f flat-bottomed 96-well plates 
(Iwaki Microplate, Japan); these suspensions were added with and without 1 mM 
farnesol. Plates were ineubated at 37 °C for 48h. After biofilms were formed, the 
medium was aspirated and nonadherent cells were removed by thoroughly 
washing the biofilm thi'ee times in sterile PBS. XTT stock solution (0.5 mg/ml in 
PBS+1% glucose) was prepared and menadione (10 mM prepared in acetone) was 
added to a final concentration of 1 pM. A 100-pl aliquot o f this XTT-menadione 
stock solution was added to each well containing a prewashed biofilm, and to 
control wells (to measure background XTT levels). Plates were incubated in the 
dark for 2 h at 37 °C, and the colorimetric change was measured in a mierotitre 
plate reader at 490 nm.
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6. Measurement of tyrosol in culture supernatants
6.1 Supernatant preparation
6.1.1 Growth of planktonic cells and biofilms
For planktonic cultures, standardized cell suspension (100 pi) was used 
to inoculate YNB medium (50 ml, in 250-ml Erlenmeyer flasks) giving a cell 
density of 4x10"  ^ cells/ml by counting in a haemocytometer. Cultures were 
incubated at 37 °C in an orbital shaker at 60 ipm for time periods of up to 48 h 
and then centrifuged at 3000 rpm. The supernatants were decanted and filter- 
sterilized through a 0.2 pm filter. Biofilms were grown on the surface of 75-cm^ 
flat-bottom tissue culture flasks (Costar; Coming Incorporated, USA) with vented 
cap. Standardized cell suspensions of C  albicans strains were prepared as 
described previously (Section 4.2). Cell suspension (10 ml) was added to the 
surface of each tissue culture flask, and the cells were allowed to adhere for 1 h at 
37 "C. The remaining cell suspension was decanted and non-adherent cells were 
removed by washing with 10 ml of PBS. Fresh YNB (110 ml) was added and 
biofllms were formed over 48h at 37 °C under static conditions. The biofilm 
supernatant was then decanted, centrifuged at 3000 ipm and filter-sterilized using 
a 0 . 2  pm filter.
6.1.2 Dry weight determinations
At the end of the incubation period, 3 ml of planktonic cells or bio film 
cells were collected on preweighed cellulose nitrate filters (Wliatman; 0.45-pm 
pore size; 25-mm diameter) and cell dry weights determined as described in 
Section 11.
60 Materials and Methods
6.2 Tyrosol extraction and quantification using HPLC
A method for the extraction and quantification of tyrosol (2-(4- 
hydroxyphenyl) ethanol) from C  albicans culture supernatant was developed in 
collaboration with Mohammed Oteef (PhD student) and Dr. Hugh Flowers 
(Department of Chemistry, University of Glasgow). The method is based on the 
extraction of tyrosol using solid phase extraction (SPE). Tyrosol in the extract was 
quantified by a reverse phase (RP) HPLC method.
6.2.1 Chemicals
Tyrosol (2-(4-hydroxyphenyl) ethanol); 98% pure; Aldrich, Gemiany) was 
used to prepare a 1000 pM stock solution in acetonitrile which was then diluted to 
give working standards. Acetonitrile and methanol were HPLC Grade solvents 
(Fisher Scientific, UK). Sulphuric acid was AnalaR Grade (BDH, UK).
6.2.2 Solid phase extraction (SPE) method
Culture supernatant (50 ml) was acidified by the addition of 0.2 ml of 0.1 M 
sulphuric acid. A C-18 Waters Sep-Pak Plus (820 mg; Fig. 6 A) cartridge was 
conditioned with 10 ml of methanol followed by 10 ml of 1.0 mM sulphuric acid. 
The acidified supernatant was then loaded on to the cartridge. Tyrosol was eluted 
with 10 ml of 7.5% acetonitrile in 1.0 mM sulphuric acid. The loading and eluting 
flow rates were controlled to be 2-4 ml/min in a SPE vacuum manifold (Fig. 6  B). 
No washing step was carried out as it caused a reduction in the recovery of 
tyrosol.
I
: |
Figure 6
Sep-Pak cartridge and vacuum manifold
A) Waters Sep-Pak ® Plus Environmental C l8  cartridge. The long body cartridge 
is packed with 820 Sep-Pak silica-based C l8  bonded phase with sorbent 
particle size ranging from 55-105 pm and a pore size of 125Â. The carbon 
loading is 12% and the suitable pH range is 2-8.
B) The vacuum manifold used to control the flow rates during the solid phase 
extraction. The vacuum is generated by a water pump and controlled by a 
pressure valve to give the desired flow rate. The loading and eluting flow rates 
were conti'olled to be 2-4 ml/min.
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6.2.3 HPLC equipment
progi'amnied to record data from 200-400 nm. The purity of tyrosol peaks was 
checked and the peaks were identified by comparing their spectra with those of a 
pure standard. The amount of tyrosol present was quantified by external 
calibration.
The HPLC system used consisted of a Merck-Hitachi L-7100 pump (Fig.
...
7A), a L7200 autosampler and L4500 Diode Array Detector (Fig. 7B). The signal g-
Îand UV spectra were processed by Merck-Hitachi Chromatography Data Station
.software.
Î
"'S6.2.4 Chromatographic conditions 7?IHPLC analyses were carried out using a C-18 Waters Spherisorb 0DS2 m
f
analytical column (4.6 x 250 mm). The elution profile consisted o f three mobile g
phase compositions over 30 min of run-time. For the first 10 min, the mobile
Iphase consisted of acetonitrile: 1.0 mM H2SO4 (10:90, v/v) for eluting tyrosol.
The mobile phase composition for the second 10 min was acetonitrile: water 
(50:50 v/v) to clean up the column after some late eluted compounds. The column 
was then re-conditioned using acetonitrile: 1.0 mM H2SO4 (10:90, v/v) for 10 min
to be ready for the next injection. The flow rate was set at 1.5 ml/min and the
'analysis was carried out at room temperature. An aliquot of 10 pi from the 
purified extract was injected into the HPLC system. The photodiode array was
I 
I 
I
I
: 
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Figure 7
The HPLC system used for the separation and quantification of tyrosol
A) Merck-Hitachi L-7100 4 channels gradient pump (bottom left). It was
programmed to deliver the mobile phase as follows: t= 0  to 1 0  min, 1 0 %
acetonitrile: 90% 1.0 mM H2SO4; t—10.1 to 20 min, 50% acetonitrile: 50% 
H2O; t=20.1 to 30 min, 10% acetonitrile: 90% 1.0 mM H2SO4. The flow rate 
was set at 1.5 ml/min. A L-7200 autosampler (top left) was used to inject 10 
pi of sample via the injection port which is connected to a 100 pi loop. A L- 
4500 Diode Array Detector (bottom right) was programmed to record data 
from 200-400 nm for peak identification and purity checks.
B) The computer containing Merck-Hitachi Chromatography Data Station
software which was used for signal and UV spectra processing.
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6.2.5 Method validation
The linearity of the detector response was assessed by analysing tyi’osol 
standards in the range 20-100 pM (Fig.8). The system precision was examined by 
analysing replicate injections (n =7) at the targeted limit of quantification (1 pM) 
and at the usual working level (50 pM). The recovery of the SPE method was 
assessed by spiking replicate samples with 6 pM tyi'osol (Fig. 9A). The growth 
medium was analysed for possible interference, and was shown to have no 
interfering substances eluting at or near the retention time of tyrosol (Fig. 9B).
7. Germ-tube formation
7.1 Measurement of germ-tube formation
This assay was used to evaluate the activity of different genu-tube inducers 
on germ-tube fonuation. Initially, a 100-ml Erlenmeyer flask containing 25 ml 
YNB was inoculated from a slope culture and incubated at 37 ”C in an orbital 
shaker operating at 60 rpm. After 24 h, cells were harvested and washed twice in 
50 mM potassium phosphate buffer, pH 6.5. The washed cell suspension was 
adjusted to 2 xlO^ cells/ml in the same buffer. A portion (25 pi) o f the adjusted 
inoculum was added to 5 ml of different genu-tube inducers as described in 
Section 2.11 to give a final cell density of 1 x 10  ^cells/ml. Flasks were incubated 
with gentle shaking at 37 °C for up to 5h. The suspensions were examined for the 
percentage of germ tubes present using a light microscope; 200 cells were counted 
each time.
Figure 8
Tyrosol calibration curve
The range examined was 0-100 pM. The detector response showed good linearity (R  ^
=99.99 %) against the nominal tyrosol concentrations.
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Figure 9
Typical HPLC chromatograms
A) A supernatant extract containing 35 pM tyrosol (extracted by the developed 
SPE method). Chromatographic conditions: C-18 analytical column (Waters 
Spherisorb ODS2 5 p, 4.6 x 250 mm). Mobile phase composition: t=0 to 10 
min, 10% acetonitrile: 90% 1.0 mM H2SO4 ; t=10.1 to 20 min, 50% 
acetonitrile: 50% H2O; t=20.1 to 30 min, 10% acetonitrile: 90% 1.0 mM 
H2SO4. The flow rate was 1.5 ml/min and the analysis was carried out at room 
temperature.
B) The growth medium (cleaned up by the developed SPE method) showing no 
interfering peaks at or around the tyrosol retention time (~ 7.7 min).
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7.2 Effect of biofilm supernatant or farnesol on planktonic cell morphology
Initially, tissue culture flasks (75-cm^ flat-bottom flasks) were used to 
prepare biofilm supernatant on a large scale to determine whether this culture 
supernatant could affect the morphology of planktonic cells grown in RPMI 1640
medium. A standardized cell suspension (1.0 x 10  ^ cells/ml in RPMI 1640) was
'prepared as described previously (Section 5), and 30 ml of this suspension was 
added to 75-cm^ tissue culture flasks. The cells were allowed to adhere for 1 h at 
37 °C, the cell suspension was decanted to remove non-adherent cells and then 
fi'esh RPMI 1640 (40 ml) was added. Biofilms were allowed to fomi over 48h.
The bio film supernatant was then decanted, clarified by centrifugation at 3000 
rpm, filter-sterilized through a 0.2 pm filter, and diluted 1:1 with a two-fold 
concentrate of RPMI 1640. Planktonic cells from an overnight culture were 
washed, resuspended and added to a flask containing 20 ml of this diluted
supernatant to a density of 1.0 x 10*^  cells/ml. Flasks were incubated for 24h at 37 
in an orbital shaker operating at 60 rpm. A negative control flask (RPMI 1640 
only) and positive control flask (RPMI 1640 with 100 pM farnesol) were also 
included. Cell morphology was evaluated under a light microscope.
7.3 Effect of planktonic cell and biofilm supernatant on germ-tube formation
In this assay, germ-tube formation was used as an indicator to estimate the 
concentration of farnesol (and possibly other similar-quorum sensing molecules) 
produced during planktonic cell growth and biofrlm fonnation. Cultures of C. 
albicans grown overnight in YNB-glucose medium were harvested and the cells 
were washed twice in 50 mM potassium phosphate buffer, pH 6.5. The cells were 
then resuspended at 1 x 10  ^ cells/ml in 2.5 ml of a two-fold concentrate of the
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same buffer containing 10 mM proline and 2.5 mM N-acetylglucosamine. This 
suspension was added to 2.5 ml of filter-sterilized supernatant from biofilms or 
planktonic cultures grown as described in Section 6.1.1. For a standard response 
curve, cells were resuspended at Ix 10  ^ cells/ml in 5 ml of the same buffer 
containing 10 mM proline and 2.5 mM N-acetylglucosamine with farnesol at final 
concentrations ranging from 5 to 100 pM. Cell suspensions were incubated with 
gentle shaking at 37 °C for 3 h. At 0 min and 3 h, the suspensions were examined 
for the percentage of genn tubes present using a light microscope; 200 cells were 
counted each as described in Section 7.1.
7.4 Germ-tube formation in the presence of COX inhibitors
Cultures of C. albicans grown overnight in YNB-glucose medium were 
haiwested and the cells were washed twice in 50 mM potassium phosphate buffer, 
pH 6.5. The cells were then resuspended at 10  ^ cells / ml in the same buffer 
containing either 10 mM proline and /or 2.5 mM N - acetyl glucosamine, or 5 % 
foetal bovine serum. Where indicated, at time zero, COX inhibitors were added to 
a final concentration of 100 pM, and PGE2 was added to a final concentration of 1 
nM, 100 iiM or 1 pM. Cell suspensions were incubated with gentle shaking at 37 
°C for 2 h. At 0 min and 2 h, the suspensions were examined for the percentage of 
germ tubes present using a light microscope; 200 cells were counted each time.
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8, Scanning electron microscopy
8.1 Air-drying method
After bio film formation, catheter disks were transferred to new 24-well 
plates and biofilms fixed with 2.5% (v/v) glutaraldehyde in 0.1 M phosphate 
buffer for Ih at room temperature. The biofilms were then rinsed twice for 5 min 
with 0.1 M phosphate buffer, treated with 1% (w/v) osmium tetroxide (Sigma) for 
Ih, washed three times with distilled water for 10 min, dehydrated in a series of 
ethanol solutions (30, 70, 90 and 100 %) for 10 min for each time, and finally 
treated with dried absolute ethanol for 10 min. The samples were left to air dry in 
a desiccator overnight, coated with gold using a Polaron coater and viewed under 
a Philips 500 scanning electron microscope or Joel 6400 scanning electron 
microscope.
8.2 Freeze-drying method
Biofdms were fixed with 2.5% (v/v) glutaradehyde in 0.1 M cacodylate 
buffer (pH 7.0) for Ih. Samples were then transferred to a new 24-well plate, 
washed gently tlii'ee times in distilled water, and plunged into a liquid propane- 
isopentane mixture (2:1; v/v) at -  196 ”C before freeze-drying under vacuum. A 
Polaron coater was used to coat the samples with gold before they were viewed 
under a Philips 500 scanning electron microscope or Joel 6400 scanning electron 
microscope.
I
__
70 Materials and Methods
9. Antifungal susceptibility testing by the NCCLS M27 method
9.1 Inoculum preparation
Five colonies of > 1 mm in diameter from 24-h culture plates (SDA) were 
resuspended in 5 ml saline (8.5 g/litre NaCl), and the resulting suspension was 
vortexed for 15 sec. The cell density was then adjusted to a reading of 0.5 at 530 
nm using a spectrophotometer. This procedure yielded a yeast suspension of 1 x 
10  ^ to 5 X 10  ^ cells/ml. A working suspension was made by a 1:100 dilution 
followed by 1:20 dilution of the stock suspension with RPMI 1640 medium 
buffered with 0.165 M MOPS (or another medium according to the experiment), 
which resulted in a yeast suspension of 0.5 x 10  ^to 2.5 x 10  ^cells/ml.
9.2 Microdilution method
Aspirin and/or amphotericin B solutions were prepared at twice the final 
concentration in RPMI 1640 medium buffered with 0.165 M MOPS (pH 7). The 
C. albicans inoculum was prepared as described previously (Section 9.1) except 
that the second dilution was 1:10 instead of 1:20. 100 pi o f each agent or 
combined agent was placed in the wells of a micro titre plate. The final inoculum 
(100 pi) was added to each well of microtitre plate. This results in a 1:2 dilution of 
the agent or combined agent and also 1:2 of the inoculum. Control wells contained 
medium only, and inoculum with solvent but without any agent. The microtitre 
plates were incubated at 37 “C and observed for the presence or absence of visible 
growth. The plates were then read using a microplate reader at 490 nm.
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9.3 Macrodilution method
This method was used to study the effect of COX inhibitors on the viability 
and optical density of planktonic cells of C  albicans. Stock solutions (100 mM; 
10 pi) of aspirin, diclofenac, etodolac, salicylic acid and sodium salicylate were 
placed in 12 X 75 mm tubes. The control received 10 pi of dimethyl sulfoxide or 
ethanol without COX inhibitor. After the inoculum had been standardized 
(Section 10.1), 1 ml was added to each tube containing 10 pi of COX inhibitor 
and mixed. This resulted in a 1:100 dilution of each COX inhibitor to a final 
concentration of 1 mM.
10. Prostaglandin detection by ELISA
10.1 Preparation of samples
Prostaglandin production was determined in culture supernatants of 
planktonic cells and biofilms after concentrating the supernatant 10-fold by freeze 
drying. At the end of the incubation period, planktonic cells were centrifuged at 
3000 rpm for 3 min. The supernatants were filtered through non-pyrogenic filters 
(pore size, 0.2 pm) and portions (5 ml) were freeze dried. For biofilms, after 
removal of disks with their adherent cells, the remaining medium fi*om 12 wells 
was similarly filtered through non-pyrogenic filters (pore size, 0.2 pm) and 
portions (5 ml) were freeze dried. All freeze-dried samples were reconstituted by 
the addition of 0.5 ml of distilled water and analysed for prostaglandins using a 
prostaglandin screening enzyme immunoassay kit (Cayman Chemicals). All kit 
reagents (ElA buffer, wash buffer, prostaglandin acetylcholinesterase conjugate, 
prostaglandin antiserum and Ellman’s reagent) were prepared according to the
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manufacturer’s instructions and only ultrapure water (Cayman Chemicals) was 
used. For standard cui-ves, PGE2 was diluted in a ten-fold concentrate of yeast 
nitrogen base medium.
10.2 ELISA plate assay
Controls, standards and samples were assayed in special 96-well plates pre­
coated with mouse anit- rabbit IgG, included with the kit. For every experiment, 
each plate or set o f strips contained two wells of blanks, two non-specific binding 
wells, two maximum binding wells, one total activity well and an eight-point 
standard curve mn in duplicate. Each sample was assayed at a minimum of two 
dilutions (Table 2). To check for possible interference by COX inliibitors, 
additional controls were included that contained a 10-fold concentrate of medium 
plus inliibitors. Each plate or set of strips was covered with plastic film supplied 
with the kit, and incubated for 18 h at 23 “C.
10.3 ELISA plate development and reading
To develop tbe plate, wells were emptied and rinsed five times with wash 
buffer. Ellman’s reagent (200 pi) was added to each well and 5 pi of tracer was 
added to the total activity well. The wells were covered with plastic film, and the 
plate was placed in an orbital shaker, and allowed to develop in the dark. The 
plate was read in a microtitre plate reader at a wavelength of 405 nm after 60-90 
min when the absorbance of the maximum binding wells was in the range of 0.3- I
0 .8 .
I
I
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Table 2. ELISA plate pipetting summary
Well EIA Buffer Standard/Sample Tracer Antibody
Blank ---
Total activity --- 5 pi *
Non specific-binding 100 nl --- 50 pi
Maximum binding 50 Hi --- 50 pi 50 Hi
S tandard/S ample --- 50 111 50 pi 50 nl
Added at development of the plate.
;i1
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11. Determination of cell dry weight
Growth of planktonic cells and biofilms was measured by determination of 
cell diy weiglit. At the end of the iiieubation period, portions of planktonic cell 
cultures (3 ml) were collected on preweighed cellulose nitrate filters (0.45 pm 
pore size; 25 mm diameter) and given three washes with water (5 ml). The filters 
were dried to constant weight at 37 °C, and the dry weights of cells per filter were 
calculated. Diy weights were deteimined in triplicate. After biofilm formation, 12 
disks with their adherent eells were transferred to 12 ml of 0.15 M phosphate- 
buffered saline, pH 7.2, and vortexed vigorously. Portions (3 ml) of the resulting 
cell suspensions were then collected on preweighed cellulose nitrate filters and 
processed as described above.
12. Statistical analysis of data
Standard errors of the mean are quotes for all quantitative assays of biofilm 
formation. Student's t-test was used to detect significant differences between mean 
values and the results are presented as P  values. All statistical tests were canied 
out using Microsoft Excel 2003.
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1. Preliminary studies on biofilms and germ-tube development in 
C. albicans
1.1 Quantitative measurement of biofilm formation using the XTT assay
Initial experiments on bio film formation were earned out using an XTT 
assay procedure in which the tétrazolium salt was dissolved in YNB medium. A 
yellow colour was produced and the A492 readings were quite low, ranging from 
0.100 to 0.300, with average value of 0.230 ± 0.082 (Fig. 10). When XTT was 
dissolved in PBS containing 1% glucose instead of YNB medium, a dark orange 
color was produced in the assay and A492 readings ranged from 1.220 to 1.600, 
with an average reading of 1.450 ± 0.066 (Fig. 10). For this reason, in all 
subsequent experiments XTT was dissolved in PBS containing glucose to enhance 
the metabolic activity of biofilm cells and so produce a higher level of XTT 
reduction.
1.2 Determination of optimal glucose concentration for the XTT assay
To determine the optimal concentration of glucose for the XTT reduction 
assay, PBS solutions containing different glucose concentrations (0, 0.2, 0,4, 0.6, 
0.8 and 1%) were tested (Fig. 11). There was a steady increase in A492 reading 
with increasing glucose concentration, and a maximal A492 value (1.845) was 
reached at 1% glucose (Fig. 11). fi
#
Figure 10
Quantitative measurement of biofilm formation by C. albicans GDH 2346 using 
the XTT assay
Biofilms were grown on PVC catheter disks for 48h at 37°C. Quantitative 
measurements of biofilm metabolic activity were made using the XTT assay with 
XTT dissolved in YNB or PBS +1% glucose. The results are means ± SEM from two 
independent experiments done in triplicate.
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Figure 11
Effect of different glucose concentrations in the XTT assay for measurement of 
biolllm formation by C. albicans GDH 2346
Biofilms were grown on PVC catheter disks for 48h at 37°C. Quantitative 
measurements of biofilm metabolic activity were made using the XTT assay with 
XTT dissolved in PBS supplemented with different glucose concentrations. The 
results are means ± SEM from two independent experiments done in triplicate.
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1.3 Standard curve of planktonic cell count against OD 520 reading
were related to the optical density at 520mn (Fig. 12). There was a linear
A haemocytometer slide was used to count planktonic cells of C. albicans in 
order to standardize cell suspensions. In this experiment, C  albicans cell numbers
relationship between cell number (log 10 cells/ml) and OD520 for optical density
-
readings between 0.600 and 1.600 (Fig. 12).
1.4 Biofilm formation by C. albicans strains obtained from the University of 
Nebraska.
The C. albicans strains used in these experiments were provided by Jacob 
M. Hornby (School of Biological Sciences, University of Nebraska). They include 
C. albicans CAI-4 (wild-type strain) and six mutants with altered colony 
moiphology and farnesol-mediated quorum sensing. Biofilm formation by these 
strains was evaluated by the catheter disk method; biofilms were allowed to grow 
for 48h and biofilm metabolic activity was measured by XTT reduction. Biofilm 
formation (XTT reduction) by the mutants was calculated as a percentage of that 
of the wild type strain CAI-4 (Fig. 13). The results showed no significant 
difference in biofilm fonnation between the wild type and mutants. Biofilm 
fonnation by the mutants was 88 to 108 % of that of C. albicans CAI-4 (Fig. 13).
1.5 Biofilm formation by C. albicans strains obtained from Columbia 
University, New York
Biofilm formation by C. albicans mutants defective in the MDS3 gene 
which is necessaiy for alkaline pH-induced responses (Davis et al., 2002), or the 
RJMlOl pathway which is required for in vivo pathogenesis (Davis et a l, 2000)
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were investigated. The strains were: C  albicans DAY185 (wild type), C. albicans 
VIC25 imds3/mds3), DAY25 (rimlOl/rimlOl) and VIC28 {rimlOl/rimlOl 
mds3/mds3). The results (Fig. 14) demonstrate that biofilm formation by C. 
albicans VIC25 and VIC28 was significantly less than that of the wild type by 27 
and 11%,  respectively {P< 0.01 and P  <0.05). However, biofilm formation by C. 
albicans DAY25 was 10% greater than that of the wild type (P<0.05).
1.6 Biofilm formation by C. albicans SC 5314 and its morphological mutants
Germ-tube fonnation is important in the expression of C  albicans 
pathogenicity. In these experiments, biofilm formation by morphological mutants 
blocked in one of two signalling pathways {cphl/cphl or efgl/efgl) or in both i
pathways {cphl/cphl efgl/efgl), was investigated. The results (Fig 15), showed 
that biofilm formation by the morphological mutants was similar to that of the 
wild-type strain, as detennined by the XTT assay. This indicates that the 
blockages in these signalling pathways did not affect biofilm fonnation by any of 
the mutants. The stmcture and cell morphology of these biofilms is described later 
(Section 2.12).
#
__
Figure 12
Standard curve of planktonic cell count against O.D 520 reading for C. albicans 
GDH 2346
The results are the means of two independent experiments done in duplicate. C, 
albicans cells were counted in a haemocytometer.
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Figure 13
Biofilm formation by C. albicans strains obtained from tbe University of 
Nebraska
B iofilm  formation (as measured by XTT reduction) is expressed as a percentage o f  
that o f  the wild-type strain C. albicans CAI-4. The results are means ±  SEM  o f  four 
independent experim ents carried out with at least three replicates. The mean (±  SEM ) 
A492 value for C. albicans CAI-4 was 2.685 ±  0.142.
■  CAI-4 (wild type)
■  H48 hairy
I I H I47 hairy-wrinkled 
0  H121 hairy-wrinkled 
H  H51 hairy 
B  HI mountain-like 
H  H253 hairy-wrinkled
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Figure 14
Biofilm formation by C. albicans strains obtained from the Columbia University, 
New York
B iofilm  formation (as measured by XTT reduction) is expressed as a percentage o f  
that o f  the wild-type strain C. albicans D A Y  185. The results are means ±  SEM  o f  
three independent experim ents carried out in triplicate. The mean (±  SEM ) A 492 value 
for C. albicans D A Y  185 was 2 .732±  0 .082.
■ D A Y  185
■ VIC 25
□ D A Y  25
□ VIC 28
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Figure 15
Biofilm formation by C. albicans SC 5314 and its morphological mutants
Biofilm formation (as measured by XTT reduction) is expressed as a percentage of 
that of the wild-type strain C. albicans SC5314. The results are means ± SEM of two 
independent experiments done in triplicate. The mean (± SEM) A492 value for C. 
albicans SC5314 was 2.402+ 0.321.
H  C. albicans SC5314 
I C. albicans iYSl \9 {cphl/cphl)
I  C. albicana HLC 52 {efgl/efgl)
CH C. albicans HLC 54 {cphl/cphl efgl/efgl)
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1.7 Germ-tube formation with different inducers
The ability of C  albicans to form germ tubes varies aeeording to the growth 
conditions and the germ-tube inducers used. In preliminaiy experiments on germ- 
tube formation, 5% serum caused problems in counting because the cells clumped 
together. For this reason, two other inducers were used: 10 mM proline (Pro) and 
2.5mM N-acetylglucosamine (GlcNAc). These inducers were used individually or 
as a mixture. Germ-tube formation was evaluated with and without gentle shaking 
to establish the optimal condition for counting the cells. The results show that 
both inducers activate budding yeast cells to form germ tubes (Fig. 16). Maximal 
germ-tube formation was achieved using a mixture of proline and N- 
acetylglucosamine with gentle shaking; figures of 55 % and 86% germ-tube 
foiTnation were obtained at 2h and 5h, respectively. In contrast, at the same time 
periods only 14% and 28% of cells formed germ tubes in the presence of proline 
alone without shaking. Therefore treatment with a mixture of 10 mM proline and
2,5 mM N-acetylglucosamine, with gentle shaking, was used as the standard 
method for germ-tube fonnation.
1.8 Germ-tube formation in the presence of farnesol
Famesol is a quorum-sensing molecule which inliibits gemi-tube fonnation 
(Hornby et a l, 2001). Before evaluating the effect of farnesol on biofilm 
fonnation, it was o f interest to study its effect on C  albicans genn-tube 
formation. All of the C. albicans strains used here were incubated in the presence 
of the proline-N-acetylglucosamine inducer. The results show that most strains 
were able to form genn tubes and the majority gave over 40% germ-tube
_________________________________ 85___________________________Results
fonnation within 3h (Fig. 17). Two strains defective in signalling pathways (HLC 
52 and HLC 54) were the exception and failed to produce any genn tubes. With 
all the other strains famesol (100 pM) completely blocked germ-tube formation
'
(data not shown).
1.9 Effect of propranolol and l-oleoyl-2-acetyl-sn-glycerol (OAG) on germ- 
tube formation by C. albicans GDH 2346
Propranolol (Prop) was reported in previous studies to inhibit genn-tube 
formation in C. albicans by binding with phosphatidic acid which is involved in 
switching on filamentous growth (Baker et a l, 2002). In S, cerevisiae growth is 
inhibited in medium containing famesol; this inhibition can be abolished by 
coaddition o f diacylglycerol analogues such as OAG (Machida et al., 1999).
Consequently, it was of interest to investigate the effect o f these compounds on 
germ-tube formation by some of the C. albicans strains used in this study. Initially 
C. albicans GDH 2346 was selected as a model strain in these experiments 
because it has been well studied for its ability to form genn tubes and biofilms.
The results (Fig. 18) show that 100 pM famesol completely inhibited germ-tube i
formation, while 100 pM and 1 mM propranolol inhibited germ-tube formation by
■31 % and 88 %, respectively (P<0.05 and P<0.01). In further experiments, similar 
results were found for C. albicans SC5314 and JKC19. Farnesol at 0.1 mM and 1 
mM blocked genn-tube formation completely while 1 inM propranolol inhibited 
the process by more than 78% (P< 0.001; Table 3).The effect of OAG was studied 
only with C. albicans GDH 2346. This compound on its own did not increase 
genn-tube formation by C. albicans GDH 2346 as compared with the control (Fig.
18). However, OAG decreased the ability of farnesol to block germ-tube
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formation; 38% of the cells were able to form germ tubes in the present of both 
100 pM famesol and 1 mM OAG (Fig. 18).
Figure 16
Germ-tube formation by C. albicans GDH 2346 in the presence of different 
inducers
Yeast cells were suspended in 50 inM potassium phosphate buffer (pH 6.5), 
containing 10 mM proline (Pro) and / or 2.5 mM N-acetylglucosamine (GlcNAc) and 
incubated for 5h at 37°C with and without gentle shaking. Results are means ± SEM 
of two detemiinations, with 200 cells counted.
♦  Pro
■  Pro with gentle shaking 
A Pro + GlcNAc
□  Pro + GlcNAc with gentle shaking 
A GlcNAc
O  GlcNAc with gentle shaking

Figure 17
Germ-tube by formation of different C. albicans strains
Yeast cells were suspended in 50 mM potassium phosphate buffer (pH 6.5), 
containing 10 mM proline (Pro) and 2.5 mM N-acetylglucosamine (GlcNAc), and 
incubated for 5h at 37°C with gentle shaking. Results are means ± SEM of two 
detenninations, with 200 cells counted.
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Figure 18
Effects of farnesol, propranolol and OAG on germ-tube formation by C. albicans 
GDH 2346
Genn-tube formation is expressed as a percentage of that of control cells incubated in 
the absence of any agents. Results are means ± SEM of triplicate determinations. The 
mean (± SEM) control value was 170 ± 10 germ tube-forming cells / 200 cells 
counted.
Far = Farnesol
Prop = Propranolol
OAG = l-oieoyl-2-acetyl-sn-glycerol
89  Results
120
100
o 60
I  40O
20
É
100 pM Far 100 pM Pro 1 m M Pro 1 nnMOAG 1mM Control
OAG+IOOpM Far
Inhibitor
90 Results
Table 3, Germ-tube formation by C. albicans SC5314 and its morphological 
mutants
C. albicans
Germ tube (%) in the presence of :
strain
Control 100 pM Farnesol 1 mM Farnesol 1 mM Propranolol
SC5314 100 0 0 22 + 3"
JKC 19 100 0 0 21 + 3"
HLC 52 0 0 0 0
HLC 54 0 0 0 0
Germ-tube fomiation is expressed as a percentage of that of control cells 
incubated in the absence of farnesol or propranolol. Results are means ± SEM of 
two independent experiments done in duplicate. The mean (± SEM) control value 
for C. albicans SC5314 was 170 + 8 and for C. albicans JKC 19 was 168 ± 6 
germ tube-forming cells /200 cells counted.
 ^Value significantly different at P < 0.001 from that of control.
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2. Role of farnesol as a quorum sensing molecule in C. albicans 
biofilms
Farnesol is known to inhibit both the dimorphic transition and biofilm 
formation in C. albicans (Hornby et a l, 2001; Oh et a l,  2001; Ramage et a l, 
2002a). Recently, tyrosol was identified as another quorum sensing molecule 
which promotes hyphal formation (Chen et a l, 2004). However, the mechanisms 
by which the two molecules interact to regulate C. albicans biofilm development 
are unknown. In this section the effect o f farnesol on C. albicans biofilms was 
investigated.
2.1 Biofilm formation by C. albicans GDH 2346 in the presence of farnesol
Farnesol at tliree different concentrations (50 pM, 100 pM and IM) was 
added at different stages of biofilm development in YNB medium. Only the early 
stages of biofilm fonnation were sensitive to the effect of farnesol (Fig. 19), i.e. 
when farnesol was added during the adhesion period and again at time zero, so 
that it was present throughout biofilm formation. For example, 50 and 100 pM 
farnesol inliibited biofilm formation by 14 and 19%, respectively (P<0.05), when 
added at this stage. Maximal inhibition of 33% (P<0.001) was observed with 1 
mM farnesol, again when added during the adhesion period and maintained 
tlnoughout biofilm fonnation (Fig. 19).
Figure 19
Effect of farnesol concentration on biofîlm formation of C. albicans GDH 2346 
grown in YNB medium
Different farnesol concentrations (50 pM , 100 pM , and 1 mM ) were added at 
different stages o f  biofilm  developm ent. B iofilm  formation (XTT reduction) is 
expressed as a percentage o f  that o f  control biofilm s incubated in the absence o f  
farnesol. Results are means ±  SEM  from at least tw o independent experim ents carried 
out in triplicate. Mean (±  SEM ) control values ( A 4 9 2 )  ranged from 1.999 ±  0 .399  to 
2 .3 1 1 + 0 .1 4 2 .
Farnesol was added at:
I  Adhesion
I  Adhesion and time zero 
D Tim e zero
D  2 h o f biofilm  formation 
I 4h o f  biofilm  formation 
9  24h o f  biofilm  formation 
9 Control biofilm  (no farnesol added)
* P < 0 .05 compared with control 
* * p  < 0.(X)1 compared with control
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2.2 Effect of 1 mM farnesol on biofilm formation by C. albicans GDH2346 
and C. albicans CAI-4 grown on Hornby medium or RPM I1640
The previous experiment showed that 1 mM farnesol inliihited hiofilm 
fonnation by C  albicans GDH 2346 by up to 33% when the organism was grown 
in YNB. In order to detennine whether gi'owth medium composition could affect 
farnesol activity against C. albicans biofilms, YNB medium was replaced by two 
different media which enhance germ-tuhe formation: Homhy medium and RPMI 
1640. Farnesol was added for the Ih adhesion period only or for the adhesion 
period and throughout biofilm formation. The results showed that farnesol did not 
significantly affect biofilm fonnation by C. albicans CAI-4 when added at either 
stage in either growth medium (Fig. 20). Similar results were found for C. 
albicans GDH 2346 grown in Hornby medium. In contrast, 1 mM farnesol 
inliibited biofilms of strain GDH 2346 grown in RPMI 1640 medium by 17% {P< 
0.01) when added for the adhesion period and maintained throughout biofilm 
fonnation (Fig. 20).
Figure 20
Effect of farnesol on C. albicans biofllms grown in Hornby medium or RPMI 
1640 medium
Biofilm formation by C. albicans GDH 2346 and C. albicans CAI-4 (as measured by 
XTT reduction) is expressed as a percentage of that of control biofilms incubated in 
the absence of 1 mM farnesol. Results are means ± SEM from two independent 
experiments with a total of six replicates. Mean (± SEM) control values (A492) in 
Hornby medium were 0.964 ±0.105 and 2.577 ±0.182 for C. albicans GDH 2346 
and C. albicans CAI-4 respectively, while in RPMI 1640 they were 2.927 ± 0.262 
and 3.226 ± 0.075. Farnesol (1 mM) was added at the start of the adhesion period 
(Ad, 0 )  or at adhesion and again at time zero of biofilm formation (Ad + Oh, ■  ). A, 
Hornby medium; B, RPMI 1640 medium.
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2.3 Biofilm formation by C. albicans GDH 2346 in the presence of farnesol 
and l-oleoyl-2-acetyl-sn-glycerol (OAG)
Previous results showed that OAG partially prevented farnesol from 
blocking germ-tuhe formation. In this experiment, 1 mM OAG was added 
together with farnesol during biofilm formation by C  albicans GDH 2346 to 
determine whether OAG could affect the inhibitory activity of farnesol on biofilm 
fonnation. Initially, 1 mM farnesol and 1 mM OAG were added individually or 
together at adhesion and time zero for biofllms grown in YNB. The results (Fig. 
21) showed that 1 mM farnesol inhibited biofilm formation by 24 % (P<0.01). 
However, the inhibitory effect of farnesol was abolished when biofllms were 
grown in the presence of both 1 mM farnesol and 1 mM OAG (Fig. 21).
2.4 Scanning electron microscopy of the effects of farnesol, propranolol and 
OAG on C. albicans GDH 2346 biofilms grown in YNB, RPMI 1640 and 
Hornby medium
It is known that C. albicans biofilms gi'own on catheter disks in YNB 
medium normally contain two layers: a thin, basal region of densely packed yeast 
cells and an overlying, mostly hyphal layer (Baillie and Douglas, 1999b). 
Therefore in this investigation the effects of farnesol, propranolol and OAG on the 
stmcture of C. albicans GDH 2346 biofllms grown in YNB, RPMI 1640 and 
Hornby medium were studied. As can be seen fi.*om the scanning electron 
micrographs in Fig. 22, control hiofilms grown in YNB medium consisted of a 
mixture of yeasts and hyphae (A-1), whereas control biofllms grown in Homhy 
medium and RPMI 1640 consisted mainly of hyphae ( A-2 and A-3). Biofllms 
treated with 1 mM farnesol or 1 mM propranolol in all gi'owth media consisted of
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yeast cells only (Fig. 22, B-1,2,3 and C-1,2,3). Flowever, OAG did not change the 
stmcture of biofllms grown in the tluee media; they retained the morphology of 
control biofilms (Fig. 22, D-1, 2, 3). When farnesol was added together with OAG 
mainly yeast-only biofilms were formed, apart fi’om biofilms grown in RPMI 
1640 which contained a small number of hyphae (Fig. 22, E-1, 2 and 3). Similar 
results were obtained with biofilms gi'own in the presence of 1 mM OAG and 
propranolol, although biofilms grown in Hornby medium contained a few hyphae 
(Fig. 22, F- 1,2 and 3).
i
;
Figure 21
Effect of farnesol and /or OAG on biofilm formation by C. albicans GDH 2346
Biofilm  formation by C. albicans GDH 2346 (as measured by X TT reduction) is 
expressed as a percentage o f  that o f  control biofilm s incubated in the absence o f  1 
mM farnesol or 1 mM OAG. Farnesol and O AG  were added at adhesion and time 
zero o f  biofilm  formation. Results are means ±  SEM  from three independent 
determinations. Mean (±  SEM ) control value (A492) was 1.971 ±  0.095.
Additions;
I  1 mM OAG
I  1 mM O A G + 1 mM farnesol 
D  1 mM farnesol
D  Control (addition o f  equal volum e o f  methanol)
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Figure 22
Scanning electron micrographs of the effects of farnesol, propranolol and OAG 
on biofilms of C. albicans GDH 2346 grown in three different media
C  albicans GDH 2346 biofilms were grown on PVC disks for 48h in (1) YNB 
medium; (2) RPMI 1640; (3) Hornby medium. A, control biofilms; B, with 1 mM 
farnesol; C, with 1 mM propranolol; D, with ImM OAG; E, with 1 mM farnesol and 
OAG; (F) with 1 mM propranolol and 1 mM OAG. All agents were added at 
adhesion and time zero of biofilm formation. Bar, 8 pm.
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2.5 Effect of farnesol on planktoiiic inocula for biofilm formation by different 
C albicans strains
Hornby medium is known to induce germ-tube fomiation in C. albicans. 
This experiment was designed to investigate biofilm formation by C. albicans 
prepared from ovemight cultures grown on Homby medium in the presence of 1 
mM farnesol. Thus, ovemight planktonic cultures were exposed to the effect of 
germ-tube enliancement by the growth medium and the effect of germ-tuhe 
inhibition by farnesol. Subsequently biofilm formation was determined in both the 
presence and absence of famesol.
The effects of famesol in this experiment were evaluated in C. albicans 
strains GDH 2346, CAI-4, H I21 and HI. For biofilm fomiation, famesol was 
added at adhesion only, or adhesion and time zero of biofilm formation. The 
results (Fig. 23) show that biofilm fomiation by C. albicans GDH 2346 was 
inhibited when famesol was added at adhesion or adhesion and time zero by 29
and 33%, respectively (P< 0.05). In contrast, farnesol did not inhibit biofilm 
fomiation of the tliree other C. albicans strains (Fig. 23). Moreover, in flirther
investigations famesol showed similar activity when Homhy medium was 
replaced by YNB (Fig. 24); famesol inliibited biofilm fomiation by 29 % and 33 
% when added at adhesion, and at adhesion plus time zero of biofilm formation,
%
respectively (P<0.01).
Figure 23
Effects of 1 mM famesol on overnight cultures and biofîlm formation by 
different C. albicans strains grown in Hornby medium
Biofilm  inocula were prepared from ovem ight cultures grown in H om by medium in 
the presence o f  1 mM fam esol. Fam esol was added at adhesion, and at adhesion plus 
time zero o f biofilm  formation. Results are means ±  SEM  from tw o independent 
experiments carried out in triplicate. Mean (± SEM ) control values (A492) for different
C. albicans strains ranged from 1.139 ± 0 .058  to 2 .065 ± 0 .065.
Fam esol was added:
I  at adhesionI at adhesion plus time zero o f  biofilm  formation 
D  Control
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Figure 24
Effect of 1 mM farnesol on overnight cultures and biofîlm formation of C. 
albicans GDH 2346 grown in YNB medium
Biofilm inocula were prepared from overnight cultures grown in YNB in the presence 
of 1 mM fainesol. Biofilms were grown in YNB, with 1 mM farnesol added at 
adhesion (Ad, H) or at adhesion plus time zero of biofilm formation (Ad+Oh, ■  ). 
Results are means ± SEM from two independent experiments carried out in triplicate. 
Mean (± SEM) control value (A492) for C. albicans GDH 2346 was 1.822 ± 0.093.
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2.6 Biofilm formation in microtitre plates in the presence of farnesol
The results described above showed less inhibition by farnesol than those in 
an earlier study by Ramage et al. (2002) who demonstrated by a microtitre plate 
method that 300 pM farnesol inhibited biofilm formation by 85 % when added at 
time zero o f biofilm fonnation (Ramage et al., 2002a). In this experiment, the 
effect of farnesol on C. albicans biofilms was evaluated by the microtitre plate 
method i.e. biofilms were formed on the polystyrene surfaces of the plate wells. 
Biofilms were grown for 24 h in the presence or absence of 1 mM farnesol. 
Before biofilm metabolic activity was measured using the XTT assay, biofilms 
were washed in PBS tlnee times, once or not at all (Fig. 25, A and B).
The results showed that farnesol inhibited bio film formation by both C. 
albicans GDH 2346 and C. albicans CAI-4. For example, C. albicans GDH 2346 
biofilm formation was inhibited by 13, 15 and 21% at no wash, one wash and 
tliree washes respectively (P< 0.01 to P< 0.05; Fig. 25 A). For biofilm formation 
by C. albicans CAI-4, the gi'eatest inhibitory effect of farnesol was seen when 
biofilms were washed three times (38 %; P<0.001; Fig. 25 B). Overall the results 
show that there is a correlation between the XTT reduction obseiwed and the 
number of washes. This suggests that bio films grown in the presence of farnesol 
are more easily dislodged from the polystyrene surface.
Figure 25
Effect of farnesol on biofîlm formation in wells of microtitre plates
B iofilm s were grown on the surfaces o f  w ells o f  96-w ell microtitre plates, in the 
presence or absence o f  1 mM farnesol. B iofilm  formation by C. albicans strain GDH  
2346 (A ) and strain CAI-4 (B) was measured using the XTT assay. Results are means 
±  SEM from two independent experim ents with 16 replicates each time.
I  B iofilm  grown in the presence o f  1 mM farnesol 
I Control biofilm
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2.7 Effect of different farnesol concentrations on biofilm formation by C. 
albicans strains obtained from the University of Nebraska
Previous results showed that 1 mM farnesol inhibited biofilm formation by 
C  albicans GDH 2346 when added for the adhesion period and at time zero of 
biofilm formation. In this experiment, the effects of farnesol were further 
investigated in another seven C. albicans strains obtained from the University of 
Nebraska. These strains are mutants with different colony morphologies and 
different responses to farnesol. Tliree farnesol concentrations (50 pM, 100 pM or 
1 mM) were added for the adhesion period only, or for adhesion and at time zero 
of biofilm fonnation. The effects of farnesol were determined by subsequent 
measurement of biofilm metabolic activity. The results (Fig. 26) appeared to show 
some inhibition by farnesol with some C  albicans strains, but none of these 
results were statistically significant (P>0.05).
Figure 26
Effect of three different farnesol concentrations on biofilm formation by C. 
albicans mutants obtained from the University of Nebraska
Biofilm  formation by the C. albicans strains (as measured by X TT reduction) is 
expressed as a percentage o f  that o f  control biofilm s incubated in the absence o f  
farnesol. Farnesol (50  pM , 100 pM  or 1 mM ) was added at adhesion (Ad) or 
adhesion and time zero (Ad + Oh) o f  biofilm  formation. Results are means ±  SEM  
from two independent experiments with at least five replicates each time. Mean (±  
SEM ) control values ( A 4 9 2 )  for all the strains ranged from 2.479  ±  0.405 to 3.113 ±  
0.260.
■  50 pM  (Ad)
I 50 pM  (Ad + Oh)
0  100 pM  (Ad)
□  100 pM  (Ad + Oh)
1  1 mM (Ad)
O  1 mM (Ad + Oh)
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2.8 Scanning electron microscopy of biofilm formation by C. albicans 
Nebraska strains in the presence of 1 niM farnesol
Scanning electron microscopy was used in this investigation to determine 
whether 1 mM farnesol could affect the biofilm stmcture of these C. albicans 
strains, since the previous results showed that farnesol did not affect biofilm 
metabolic activity. Initially, scanning electron microscopy showed that control 
biofilms o f most o f the strains consisted almost exclusively of hyphae (Fig.27), 
apart from biofilms of C. albicans CAI-4 and H I21 which consisted of a mixture 
of yeasts and hyphae (Fig. 27 A-1 and D-1). In the presence of farnesol, C  
albicans CAI4, H121 and H253 formed yeast-only biofilms (Fig. 27 A-2, D-2 and 
G-2), while biofilms of strains HI and H I47 consisted mostly of yeasts with only 
occasional hyphae (Fig. 27, C-2 and F-2). On the other hand, biofilms of C. 
albicans H48 and H51 retained their mainly hyphal structure (Fig. 27 B-2 and E- 
2).
Figure 27
Scanning electron micrographs of biofilm formation by C albicans mutants 
obtained from the University of Nebraska
Biofilms were grown on PVC catheter disks for 48h in the absence of farnesol (1), or 
in 1 mM farnesol added for the adhesion period and at time zero of biofilm formation 
(2). Bars, 8 pm (1) and 16 pm (2).
A. C  albicans CAI-4
B. C, albicans H48
C. C. albicans YilAl
D. C. albicans'B ill
E. C. albicans VL5\
F. C. albicans B \
G. C  albicans H253
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2.9 Effect of biofilm culture supernatants on the morphology of planktonic 
cells
A previous report by Hornby et u/.(2001) showed that quorum-sensing 
molecules could be isolated from culture supernatants of planktonic cells of C. 
albicans (Hornby et a l,  2001). Another report confrnned that this quorum-sensing 
activity was also present in supernatants obtained from C. albicans biofilms 
(Ramage et a l, 2002a). It was therefore o f interest to investigate quorum-sensing 
activity in biofilm supernatants of some of the C. albicans strains used in this 
study. Initially, planktonic cells were grown in RPMI 1640 medium in the 
presence of 100 pM farnesol. Biofilm supernatants were prepared from biofilms 
of the same strain grown in RPMI 1640 medium in 75-cm^ tissue culture flasks as 
described by Ramage et al (2002a). Control planktonic cells were grown in RPMI 
1640 without farnesol. The results (Fig. 28) showed that hypha fonnation was 
inhibited by 51 to 88% for most C. albicans strains when planktonic cells were 
treated with biofilm supernatant; this inliibition was statistically significant 
(T*<0.05 to P<0.01). Farnesol (100 pM) added to cultures of planktonic cells 
inhibited hypha formation more than did homologous biofilm supernatant; 88 to 
97% of hypha formation was inlribited for all C. albicans strains (P<0.01 to 
H<0.001) (Fig. 28). In a further experiment, planktonic cells o f C. albicans CAI-4 
were gi'own with biofilm supernatant obtained from different C. albicans strains. 
The results showed that most biofilm supernatants inhibited hypha fonnation by
C. albicans CAI-4 by more than 70% (P<0.001 ; Fig. 29).
Figure 28
Effect of biofilm supernatant on hypha formation by planktonic cells using 
different C. albicans strains
Planktonic cells were grown for 24h at 37 °C in: (i) 20 ml RPMI 1640 as a control; 
(ii) 20 ml filter-sterilized biofilm  supernatant diluted 1:1 with a tw o fold concentrate 
o f  RPMI 1640 ( I); and (iii) 20 ml RPMI 1640 with farnesol at a final concentration  
o f  100 pM  ( H ). Hypha formation is expressed as percentage o f  that o f  control 
planktonic cells incubated in RPMI 1640 in the absence o f  farnesol. Results are 
means ±  SEM  o f  tw o independent experim ents. Mean (±  SEM ) control values ranged 
from 50  ±  5 to 85 ±  4 hyphae /  100 cells counted. Planktonic cells were incubated for 
24h at 37 °C, and then the numbers o f  yeast ce lls and hyphae were determined by 
light microscopy.
110 Results
in
c
£
COI
u
o i n o i n o m o i n o m o i n oc o m m T t T j - c o c o c \ J c \ j f - T -
(jonuoo aiff 10 %) uojieLUJOi eydÀH
Figure 29
Effect of different biofilm supernatants on planktonic cells of C albicans CAI-4
Hypha fonnation is expressed as a percentage of that of control planktonic cells of C. 
albicans CAI-4 incubated in RPMI 1640 in the absence of biofilm supernatant. 
Results are means ± SEM of two independent experiments. The mean (± SEM) 
control value was 84 ± 5 hyphae /100 cells counted.
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2.10 Effect of planktonic and biofilm culture supernatants on germ-tube 
formation by C albicans
To investigate the concentration of farnesol (and possibly other, similar 
quorum-sensing molecules) produced during planktonic cell growth and biofilm 
fonnation, culture supernatants of C  albicans SC5314 were collected at 24, 48 
and 72h and tested for their ability to inhibit germ-tube fonnation by the same C  
albicans strain. This was accomplished by measuring cell diy weights at the times 
that supernatant samples were collected, and by determining the percentage 
inhibition of genn-tube formation produced by the supernatants. The results 
showed that supernatants from planktonic cells after growth for 24, 48 and 72h 
inhibited germ-tube fonnation by 7, 17 and 20 %, respectively (Fig. 30 A). 
However, supernatants from biofilms haiwested at the same time points inhibited 
genn-tube fonnation by 10, 28 and 42% (Fig, 30 B).
When the percentage inhibition was calculated as a function of cell dry 
weight, it became apparent that biofilm cells produce significantly more farnesol 
(and possibly other, similar quorum-sensing molecules) than planktonic cells. For 
example, supernatant equivalent to ling dry wt of biofilms formed at 24, 48 and 
72h inhibited genn-tube formation by 11, 28 and 47 %, respectively. In contrast, 
supernatant fimn Img dry wt of planktonic cells inhibited genn-tube formation by
only 5, 8 and 11% (Fig. 30 C). This suggests that the production of farnesol (and 
possibly other, similar quorum-sensing molecules) increases more during the later 
stages of biofilm formation than it does during planktonic cell growth.
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Figure 30
Effects of planktonic and biofilm culture supernatants on germ-tube formation 
by C. albicans SC5314
The inhibitory effect o f  culture supernatants on germ-tube formation ( O  ) is shown  
together with cell dry weight over 72h ( ■  ) for planktonic cells (A) and biofilm s (B). 
This percentage inhibition o f  germ-tube formation is also show n as a function o f  cell 
dry weight (C) for planktonic cultures ( H  ) and biofilm s ( I  ). Germ-tube formation 
was determined as a percentage o f  that for control cells incubated in the absence o f  
culture supernatants. Results are means ±  SEM  o f  two independent experim ents 
carried out in triplicate. Mean (±  SEM ) values for the controls ranged from 158 ±  7 to 
180 ± 12 ce lls/200  cells counted.
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albicans strains blocked in signalling pathways was unaffected in the presence of
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2.11 Biofilm formation by morphological mutants in the presence of 1 mM 
farnesol or propranolol
In order to further investigate the activity of farnesol as a quorum-sensing 
molecule, other C  albicans strains were evaluated, including C. albicans SC5314 
and its morphological mutants described earlier. Moreover, in these experiments 
the effect of propranolol was studied to determine whether biofilm formation by 
the morphological mutants which are blocked in signalling pathways {efgl/efgl or 
cphl/cphl or efgl/efg l cphl/cphl) could be inhibited by 1 mM propranolol or 1 
mM farnesol when these compounds were added at the beginning of adhesion 
period and again at time zero of biofilm formation. As can be seen from Table 4, 
neither farnesol nor propranolol affected biofilm fonnation by these strains as 
compared with control biofilms grown in the absence of farnesol or propranolol.
2.12 Scanning electron microscopy of biofilm formation by C. albicans 
SC5314 and its morphological mutants in the presence of farnesol or 
propranolol
The results in section 2.11 showed that biofilm metabolic activity of C.
I
1 mM farnesol or 1 mM propranolol. Here, biofilm fonnation by these strains was
.examined by Scanning electron microscopy. This was important since other 
investigators reported that such mutants fail to produce any biofihns (Lewis et a i,
2002; Ramage et a l,  2002b). The results (Fig. 31) show that control biofihns of 
strains SC5314 and JKC19 consisted of a mixture of yeasts and hyphae (Fig. 31,
A-1 and B-1), whereas in the presence of farnesol or propranolol biofilms of
#
these two strains contained a high proportion of yeast cells (Fig. 31, A-2,3 and B-
■I
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2,3). On the other hand, strains HLC52 and HLC54 formed yeast-only biofilms in 
the presence or absence of farnesol or propranolol (Fig. 31, C -l,2,3 and D-1,2,3). 
However, the biofilms produced by these strains were extensive and contained 
densely packed yeast cells, in the contrast to the earlier reports.
2.13 Biofilm formation by C. albicans CAF2-1 and its quorum sensing mutant 
strains lacldng CHKl
It has been shown that a C. albicans Clik21 mutant, lacking the Chklp 
histidine kinase, is refi'actory to the inhibitoiy effect o f farnesol. For example, in 
the presence o f farnesol, biofilm formation by the wild type, C. albicans CAF2-1, 
was reduced, whereas biofilm formation by the Chk21 strain was not affected 
(Ki'uppa et a l, 2004). Since these results were obtained using a microtitre plate 
assay, it was important to monitor biofilm formation by these strains at different 
time periods using the more reliable catheter disk assay to detennine any 
differences between the mutant and wild-type strains. No significant differences 
were obseiwed between biofilms formed by C. albicans CAF2-1 and the two 
mutant strains up to 24h of incubation (Fig. 32). However, hom  48 to 72h C. 
albicans Clik21 (chkl/chkl) showed significantly increased biofilm formation 
compared with C. albicans CAF2-1 and Chk23 (Chkl/CHKl) ( f <0.001 to 
P<0.01, respectively; Fig. 32). For example, XTT reduction (A492) at 48h for 
strain Chk21 was 3.039 ± 0.048, whereas for strains CAF2-1 and Chk23 A492 
values were nearly similar at 2.670 ± 0.046 and 2.678 ± 0.032, respectively (Fig. 
32).
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Table 4. Biofilm formation of C. albicans SC5314 and its morphological 
mutants with farnesol and propranolol
XTT reduction (%) " with 1 mM
C. albicans
strain
Farnesol Propranolol
SC5314 93 ±4.5 102 ± 1.0
JKC 19 {cphl) 93 ± 2.6 101 ±0.3
HLC 52 {efgl) 102 ± 1.2 98 ± 0.9
HLC 54 {cphl/efgl) 97 ±4.1 97 ±0 .7
 ^Biofilm fonnation is expressed as a percentage of that control biofilms incubated 
in the absence of farnesol or propranolol. The results are means ± SEM fr om one 
experiment with tliree replicates. Farnesol and propranolol were added at adhesion 
and time zero of biofilm formation, Mean (± SEM) control values (A492) for all 
the strains ranged from 2.932 ± 0.033 to 3.298 ± 0.024.
Figure 31
Scanning electron micrographs of biofilm formation by C. albicans SC5314 and 
its morphological mutants in the presence of farnesol and propranolol
Biofilms were grown on PVC catheter disks for 48h. The figure shows control 
biofilms (1) and biofilms grown in the presence of 1 mM farnesol (2) or 1 mM 
propranolol (3) for the strains listed below. Bar, 10 pm.
A. C  albicans SC5314
B. C. albicans JKC 19 (cphl/cphi)
C. C. albicans HLC 52 (ephl/ephl)
D. C. albicans HLC 54 (cphl/cphl efgl/efgl)
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Figure 32
Biofilm formation by C. albicans CAF2-1 and its quorum sensing mutant strains 
lacking Chklp
Biofilms of C. albicans CAF2-1 (A), Chk21 ( A  ) and Chk23 (■ )  were grown on 
PVC catheter disks for 72h at 37°C. At 0, 8, 16, 24, 48 and 72h, biofilm formation 
was measured as cell metabolic activity (XTT reduction at A492). The results are 
means ± SEM from two independent experiments done in quadruplicate.
* P  < 0.01 for biofilms of strain Chk21 compared with those of strain CAF2-1 or 
Chk23
* * P  < 0.001 for biofilms of strain Chk21 compared with those of strain CAF2-1 or 
Clik23
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3. Role of tyrosol as a quorum-sensing molecule in C albicans 
biofilms
Tyi'osol was recently identified in planktonic cultures of C. albicans as
3.1 Biofilm formation in the presence of tyrosol
Here, the effect o f tyrosol on biofilm formation by C, albicans GDH 2346 was 
investigated. Tyrosol at 20 pM or 50 pM was added at different stages (0, 3 , 6 , 
24 and 48 b) of biofilm formation, and biofilm metabolic activity was detennined 
after 48b. The results (Fig. 33) show bio film fonnation of C. albicans GDH 2346 
was not affected by either tyrosol concentration added at an early or late stage. For 
example, 20 or 50 pM tyrosol added at time zero or at 24b produced biofilms with 
a metabolic activity similar to that of untreated biofilms (Fig 33). In a separate 
experiment the effect o f higher tyrosol concentrations (100 pM, 500 pM and 1000 
pM) added at an early stage was investigated with biofilms grown on YNB or 
RPMI 1640 medium, The results showed that tyrosol did not significantly affect 
biofilms gi'own in either medium at any of these concentration (Fig. 34A and B).
another type of quorum-sensing molecule which promotes hyphal formation and 
reduces the lag phase before exponential growth is initiated (Chen et a l, 2004). 
However, the role o f tyiosol in regulating C. albicans biofilm fonnation is 
unknown. In this section, the effects of tyrosol on biofilm development, and 
tyrosol production by planktonic and biofilm cells are described.
Figure 33
Effect of tyrosol on biofilm formation by C. albicans GDH 2346
B iofilm  formation o f  C. albicans (as measured by XTT reduction) is expressed as a
percentage o f  that o f  control biofilm s incubated for 48h in the absence o f  tyrosol.
Tyrosol at 50  pM  or 100 pM  was added at 0 , 3, 6, 24 and 48h o f  the incubation.
Results are means ±  SEM  from tw o independent experim ents done in triplicate. The
mean (±  SEM ) control value (A492) was 2 .271+  0 .061.
g  20 pM  Tyrosol 
■  50 pM  Tyrosol
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Figure 34
Effect of different tyrosol concentrations on biofilm formation by C albicans 
GDH 2346 grown in YNB or RPMI 1640 medium
Biofilms were grown in YNB (A) or RPMI 1640 medium (B). Tyrosol was added at 
time zero of biofilm formation. Biofilm formation after 48b is expressed as a 
percentage of that of control biofilms incubated in the absence of tyrosol. Results are 
means ± SEM from two independent experiments done in triplicate. Mean (± SEM) 
control values (A492) for biofilms grown in YNB and RPMI 1640 were 0.871 ± 0.032 
and 1.967 ±0160 respectively. XTT reduction in this experiment was measured after 
3h rather than 5h, so that the A492 values for biofilms grown in RPMI 1640 medium 
were less than 3.500.
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3.2 Scanning electron microscopy of the effect of tyrosol on biofilm formation 
by C. albicans GDH 2346
To determine the effect of tyrosol on C. albicans biofilm stmcture, tyrosol at 
tln*ee concentrations (50, 500 and 1000 pM) was added at time zero of biofilm 
formation. Scanning electron microscopy demonstrated that that tyrosol-treated 
biofilms at all tyrosol concentrations (Fig 35 B, C and D) had a structure similar 
to that of control biofilms i.e. a mixture of yeasts and hyphae (Fig. 35 A). Thus, 
tyi'osol addition did not affect biofilm structure when examined after 48h of 
incubation.
3.3 Scanning electron microscopy of the effect of tyrosol on biofilm formation 
by C albicans SC5314 and its morphological mutants
The effect of tyi'osol on biofilm stmcture was fiirther investigated using C. 
albicans SC5314 and its moi-phological mutants, to deteimine whether tyrosol 
could stimulate hyphal fonnation in C. albicans strains defective in the signalling 
pathways containing efgl or cphl. Strains JKC 19 (cphl), HLC 52 (efgl) and 
HLC 54 (cphl/efgl) were used together with the wild-type strain C. albicans 
SC5314 in these experiments. Biofilm fonnation was carried out in the presence 
of 20 and 50 pM tyrosol. Scanning electron micrographs (Fig. 36 C-1,2,3 and D- 
1,2,3) showed that control biofilms and tyrosol-treated biofilms of strains HLC 
52 (efgl) and HLC 54{cphl/efgl) contained yeast cells exclusively, indicating that 
tyrosol was not able to stimulate hyphal fonnation in C. albicans defective in the 
efgl pathway. Biofilm stmcture in C. albicans SC5314 and JKC 19 was similar, 
and consisted of a mixture of yeasts and hyphae in the presence or absence of 
tyrosol (Fig. 36, A-1, 2, 3 and B-1, 2, 3).
Figure 35
Scanning electron micrographs showing the effect of tyrosol on C. albicans GDH 
2346 biofilms grown in YNB
Tyrosol was added at time zero of biofilm formation. C. albicans GDH 2346 biofilms 
were grown on PVC disks for 48h. (A) Control biofilm; (B) with 50 pM tyrosol; (C) 
with 500 pM; (D) with 1 mM tyrosol. Bar, 10 pm.
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Figure 36
Effect of tyrosol on biofilm structure of C. albicans SC5314 and its 
morphological mutants
Biofilms were formed on catheter disks incubated for 48h in the presence of 20 pM
(2) or 50 pM tyrosol (3). Control biofilms were formed in the absence of tyrosol (1).
Bar, 8 pm.
A. C. albicans SC5314
B. C. albicans JKC 19 {cphl/cphl)
C. C. albicans HLC 52 {efgl/efgl)
D. C. albicans HLC 54 {cphl/cphl efgl/efgl)
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3.4 Tyrosol production by planktonic cells of C albicans
Tyrosol production was investigated by an HPLC method using planktonic 
cells of four C  albicans strains: C  albicans SC5314 (wild type) and the 
morphological mutants JKC 19 (cphl/cphl), HLC52 (efgl/efgl) and HLC54 
(cphl/cphl efgl/efgl). Tyrosol production was determined over 48h. Tyrosol was 
not detectable at 5h but it was present at 1 Oh in culture supernatants of all four C. 
albicans strains at concentrations ranging from of 0.09 to 1.28 pM (Fig. 37). After 
lOh, however, tyrosol production increased rapidly in all strains and reached 
concentrations o f more than 11.6 ±1.3 pM at 48h (mean ± SEM).
3.5 Tyrosol production by biofilms of C albicans
Biofilms in this experiment were grown in 75-cm^ polystyrene tissue culture 
flasks to produce a sufficient volume of supernatant (> 100ml) for the HPLC 
assay. The results (Fig. 38) show that tyrosol was detectable at 5h (0.07, 0.1 and 
0.1 pM for C. albicans SC5314, HLC52 and HLC54, respectively). At lOh of 
incubation, tyrosol production was 1.15 to 1.35 pM for biofilms of all strains. 
From 10 to 48h, tyrosol production increased rapidly and reached concentrations 
of 9.3 ± 0.7 to 13.6 ± 3.5 pM (Fig. 38). Moreover, there was good correlation 
between tyrosol production and cell dry weight in nearly all C. albicans strains 
gi'own planktonically (Fig. 37) or as biofilms (Fig 38). These results support the 
notion that tyrosol acts as a quorum sensing molecule in C. albicans.
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3.6 Comparison of tyrosol production by planktonic cells and biofilms on the
basis of cell dry weight
To compare tyrosol production in biofilms and planktonic cells of these
strains, tyrosol production was calculated in relation to cell dry weiglit (Fig. 39). It
became clear that biofilm cells produce significantly more tyrosol than do
.planktonic cells. For example, tyi'osol production at 48h by biofilms of C. 
albicans SC5314 and JKC 19 was 9.6 ± 0.5 and 9.7 ± 0,3 nmol/mg dry wt, 
respectively, while for planktonic cells it was 5.7 ± 1,1 and 6.3 ±1.5 nmol/mg dry 
wt (f<0.05; Fig. 39 A, B). With biofilms of C. albicans HLC52 and HLC54, 
tyrosol production was also significantly greater than that of planktonic cells (Fig. 
39C and D). For example, at 24 and 48h tyrosol production by biofilms of C. 
albicans HLC52 was 10.1 ± 1.8 and 16.4 ± 3 . 2  nmol/mg dry wt, respectively, 
which is significantly more than that for planktonic cells (3.9 ± 0.6 and 6.0 ± 0.3 
nmol/mg dry wt) at the same time points ( P<0.05; Fig. 39 C).
I
Î
Figure 37
Relationship between tyrosol production and planktonic cell dry weight of C.
albicans
Planktonic cells of C. albicans SC5314 (A), JKC 19 (B), HLC52 (C) and HLC54 (D) 
were grown in YNB at 37 ”C for 48h. At 0, 5, 10, 24 and 48h, 50ml of culture 
supernatant was used for measurement of tyrosol production ( □  ) by the HPLC 
assay. Meanwhile, at identical time points culture samples were assayed in triplicate 
for cell dry weight ( ■). Results are means ± SEM of three independent experiments.
127 Results
( l^ r l)  lO SO jA i
<0 CM
(lAirl) i o s o j Ai
CD
o
(|U1/6UJ) tl |6 l9 M  Aj q ( | u j/ 6 lu) jL iB iaM  Aj q
(lAjrl) I0S0JÂ 1 ( l/\|r i)  i o s o j Aj .
O O
o
CO8 oCO o
F
(3 in c) LO o 
CÔ CO CM CM
(]lu/6 lu) }l|6 !9 m  A j q
o  q  q  q  q  q  qTf cn cn CM CM r  F
(1LU/6lu) m B î0M  Aj q
Figure 38
Relationship between tyrosol production and biofilm cell dry weight
Biofilms of C. albicans SC5314 (A), JKC 19 (B), HLC52 (C) and HLC54 (D) were 
grown in YNB in 75-cm^ polystyrene tissue culture flasks at 37 “C for 48h. At 0, 5, 
10, 24 and 48h, 50ml of culture supernatant was used for measurement of tyrosol 
production ( □  ) by the HPLC assay. Meanwhile, at identical time points culture 
samples were assayed in triplicate for cell dry weight ( ■  ). Results are means ± 
SEM of thi'ce independent experiments.
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Figure 39
Tyrosol production expressed as a function of cell dry weight for planktonic cells 
and biofilms
Tyi’osol production is expressed as a function of cell dry weight of C  albicans 
SC5314 (A),JKC 19 (B), HLC52 (C) and HLC54 (D) grown as planktonic cells ( O  ) 
or biofilms ( # ) .  The results are means ± SEM of three independent experiments 
carried out in triplicate.
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3.7 Effect of simultaneous addition of farnesol and tyrosol on biofilm 
formation
To determine whether the effect of farnesol as a negative quomm-seiising 
molecule could be abolished by the effect of tyrosol as a positive quorum-sensing 
molecule, tyrosol at different concentrations (100, 500 and 1000 pM) was added 
together with farnesol at different concentrations for the adhesion period, and 
tliroughout the 48-h incubation. All tyrosol concentrations abolished the effect of 
50 pM farnesol, as can be seen by comparing the results with those for 50 pM 
farnesol alone which inhibited biofilm formation by 15% (jP<0.05; Fig. 40). The 
effect of 100 pM farnesol was abolished only by 1 mM tyiosol. Farnesol at 1 mM 
inhibited biofilm formation by 29 %, and none of the three tyi'osol concentrations 
was able to abolish this inliibitory effect (Fig. 40).
3.8 Scanning electron microscopy of biofilm formation in the presence of 
farnesol and/or tyrosol
Previous studies have shown that farnesol prevents hyphal formation and 
biofilm development in C. albicans (Ramage et a l, 2002a), whereas conversely 
tyrosol promotes hyphal foimation. In this study, the development o f C. albicans 
biofilms in the presence of these two quomm-sensing molecules was investigated 
by scaiming electron microscopy. Biofilms of C. albicans SC5314 were foimed 
on polystyrene disks cut from 75-cm^ tissue culture flasks (to match the procedure 
used for tyrosol detection by HPLC) over 48h in the presence of 1 mM farnesol 
and/or 500 pM tyi'osol. Scanning electron microscopy showed that farnesol-
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treated biofilms consisted of yeast cells only (Fig. 41 B), while control biofilms or 
tyi'osol-treated biofilms contained a mixture of yeasts and hyphae (Fig 41, A and 
D). Biofilms fomied in the presence o f both farnesol and tyiosol on the other 
hand, consisted almost exclusively of yeasts (Fig. 41 C). This indicates that 
tyrosol did not reverse the effect of farnesol in preventing hyphal formation at 
these concentrations. It also demonstrates the complexity of interactions between 
these two quomm-sensing molecules in regulating C. albicans biofilm formation.
3.9 Scanning electron microscopy of the effect of tyrosol on the early stages of 
biofilm formation by C. albicans
Previous work demonstrated that tyiosol accelerates the morphological 
conversion (yeast cells to filaments) in C, albicans (Chen et a l ,  2004). To 
investigate this phenomenon with biofilms, scanning electron microscopy was 
carried out at 1, 2, 3 and 6h of biofilm formation by C. albicans SC5314 in the 
presence or absence o f 50 pM tyrosol. Tyrosol was added at time zero of biofilm 
formation. The results (Fig. 42 B) showed that tyi'osol increases hyphal formation 
between at 2h and 6h of biofilm development, as compared with control biofilms 
incubated in the absence of tyrosol (Fig. 42 A).
Figure 40
Effect of simultaneous addition of farnesol and tyrosol on biofilm formation by
C. albicans GDH 2346
Farnesol and tyrosol were present during the adhesion period and throughout the 48-h 
incubation. Biofilm formation (XTT reduction) is expressed as a percentage of that of 
control biofilms incubated in the absence of farnesol or tyrosol. Results are means ± 
SEM from two independent experiments done in duplicate. The mean (± SEM) 
control value for biofilm fonnation in the absence of farnesol (A492) was 2.477 ± 
0.099.
* Values significantly different from the control values at P < 0.05 
* * Values significantly different from the control values at P < 0.001
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Figure 41
Scanning electron micrographs of C albicans SC5314 biofilms grown on 
polystyrene disks in the presence of farnesol and tyrosol
Biofilms were gi'own for 48h in the presence of 1 mM farnesol and/or 500 pM 
tyrosol. (A) Control biofilm; (B) famesol-treated biofilm; (C) famesol+ tyrosol- 
treated biofilm; (D) tyrosol-treated biofilm. Bar, 10 pm.
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Figure 42
Scanning electron micrographs showing the effect of 50 pM tyrosol on the early 
stages of biofilm formation by C. albicans
Biofilms of C. albicans SC 5314 were grown on PVC catheter disks in the presence 
or absence of 50 pM tyrosol. (A) Control biofilms incubated for 1 ,2 ,3  and 6 h; (B) 
tyrosol-treated biofilms incubated for 1 ,2 ,3  and 6 h. Bar, 10 pm.
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4. Effects of aspirin and other nonsteroidal anti-inflammatory 
drugs on biofilm and planktonic cells of C albicans
Prostaglandins are now known to be produced by C  albicans and may play 
an important role in fungal colonization. Their synthesis in mammalian cells is 
decreased by inhibitors of the cyclooxygenase (COX) isoenzymes required for 
prostaglandin formation. In this study, a catheter disk model system was used to
investigate the effect o f nonsteroidal anti-inflammatory drugs, which are COX 
inhibitors, on biofilm formation.
4.1 Effect of PGE2 on biofilm formation by C albicans
Earlier work showed that purified fungal prostaglandin, isolated from C. 
albicans, enhanced germ-tube formation by this organism when added to 
incubation mixtures (Noverr et a l, 2001). Commercially available PGE2 also 
enhanced germ-tube foimation, although to a lesser extent (Kalo-Klein and 
Witkin, 1990; Noven* et a l, 2001). This finding was confirmed in the present 
investigation. Germ-tube formation by C. albicans GDH 2346 and C. albicans
[M.
SC5314 was increased by more than 80 % over 2 h in the presence of PGE2 (10 
nM, 100 nM or 1 pM) and two different germ tube inducers (lOmM proline+ 
2.5mM N - acetyl gluco samine or 5% serum) (Table 5). Moreover, biofilm 
fonnation by C. albicans GDH 2346 was increased slightly when PGE2 was 
added. For example, in the presence of 100 nM PGE2, biofilm formation was
114.8 % ± 2.4 % (mean + SEM; P < 0.05) of that of control biofilms incubated 
in the absence of PGE2 (Table 6 ).
I
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4.2 Effect of COX inhibitors on biofilm formation
A variety of COX inhibitors were tested in biofilm assays with three strains 
of C, albicans. The compounds were all used at a final concentration of 1 mM, 
and were present during the adhesion period of the assay and throughout the 
subsequent 48-h incubation. Aspirin, etodolac (a COX-2 inhibitor) and diclofenac 
produced the gi'eatest effects, with aspirin inhibiting biofilm formation by up to 95 
% (Table 7), Celecoxib, nimesulide, ibuprofen and meloxicam all inhibited 
biofilm fonnation to a lesser, but still significant, extent. Indomethacin and 
piroxicam failed to produce significant inhibition with any of the strains tested 
(Table 7). Similar results for aspirin were obtained with a number of other C. 
albicans strains; 1 mM aspirin again inhibited biofilm fonnation by more than 
8 8 % (Fig 43). Salicylic acid which, like aspirin, has been a known NSAID for 
over a century, also significantly inhibited biofilm fonnation by more than 75 % 
(F'<0.001) at concentrations of 0.1 to 1 inM (Table 8 ). Salicylate has virtually no 
activity against purified COX-1 or COX-2, and until recently its mechanism of 
action was not understood. It is now thought to inhibit prostaglandin synthesis in 
intact cells by suppressing COX-2 gene transcription (Xu et a l ,  1999).
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Table 5. Effect of PGE2 on germ-tube formation by two C. albicans strains
Germ-tube foimation (%)
PGE2
C. albicans GDH 2346 C. albicans SC5314
concentration
Pro+GlcNAc 5% serum Pro+GlcNAc 5% serum
IpM 46.3±3.2* 31.7 ±3.8" 36.0 ±7.1" 29.0 ±5.3"
lOOnM 45.0 ±2.9^ 32.7± 4.8" 38.7± 2.2" 34.3 ±3.2*
InM 48.7± 4.7* 35.7±2.0^ 38.3 ±8.4" 32.0 ±3.1*
Control 24.7 ±3 .0 17.3 ± 1.2 18.3 ±1.8 16.0 ± 1.7
Germ-tube formation for 2h at 37 ”C was assayed in the presence of two different 
indueers: (a) 10 mM proline+2.5mM N-acetylglucosamine and (b) 5% semm, 
both in 50mM potassium phosphate. Geiin-tube formation is expressed as the 
number of germ tubes counted / 100 cells. Control cells were incubated for 2 h in 
the absence of PGE^. Results are means ± SEM of two independent experiments 
done in triplicate.
 ^Value significantly different at P  < 0.001 from that of control.
 ^Value significantly different at P  < 0.01 from that of control.
 ^Value significantly different at P  < 0.05 for that of control.
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Table 6. Biofilm formation by C albicans GDH 2346 in the presence of PGE2
Prostaglandin
concentration
XTT reduction (%) by biofilms after 48 h
lOnM 112.9 ±2.4
lOOnM 114.8 ±2.4"
1 pM 115.3 ±2.5"
PGE2 was present during the adhesion period and throughout the 48-h growth 
period. XTT reduction is expressed as a percentage of that of control biofilms of 
the same strain incubated in the absence of PGE2 . Results are means ± SEM h'om 
two independent experiments carried out in triplicate. The mean (± SEM) control 
value (A492) was 2.498 ± 0 .1 0 0 .
" Value significantly different at P  < 0.05 for that of control.
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Table 7. Effects of COX inhibitors on biofilm formation by three strains of C. 
albicans
Inhibitor XTT reduction (%) by biofilms after 48 h
Strain GDH 2346 Strain SC5314 Strain CAI4
Aspirin 20.6 + 2.8* 12.3+2.2* 4 .6  ±  0.8  ''
Diclofenac 57.6 + 3.6* 31.2 + 1.1 * 59 .7  +  2 .6 ' '
Ibuprofen 82.7 + 3.9" 81.7 + 6.3" 8 8 .4  + 6 . 3 “'
Indomethacin 92.7 + 2.8 95.8 + 4.2 85 .7  +  13.8
Piroxicam 93.7+2.9 84.4 + 6.0 80 .6  ±  7 .4
Celecoxib " 77 .3+2.7* 79.5 + 7.4" 9 4 .0  + 3.9
Etodolac " 62.9 ± 1.5* 4 9 . 4 1 3 . 8 ' ' 7 3 .4  +  3 .6 *
Meloxicam " 88.4 + 7.0^ 84.5  ±  3 .0  ’’ 8 1 . 3 1 2 . 4 ' '
Nimesulide " 84.8 + 3.5" 86.7  ±  7.8 9 4 . 4 1 6 . 3
" Inhibitors were present during the adhesion period and tliroughout the 48-h 
growth period. XTT reduction is expressed as a percentage o f that of control 
biofilms of the same strain incubated in the absence of inhibitor. Results are 
means ± SEM from at least two independent experiments carried out in triplicate. 
Mean (± SEM) eontrol values (A4 9 2) were 2.413 ± 0.069, 2.676 ± 0.066 and 2.833. 
± 0.072 for strains GDH 2346, SC5314 and CAI4, respectively.
* Value significantly different at P  < 0.001 from that of control.
"Value significantly different at P  < 0.01 from that of control.
^ Value significantly different at P  < 0.05 for that of control.
" COX-2 inhibitor.
Figure 43
Effect of 1 mM aspirin on biofilm formation by different C. albicans strains
1 mM aspirin was present during the adhesion period and throughout the 48-h growth 
period. Biofilm fonnation (XTT reduction) is expressed as a percentage of that of 
control biofilms of the same strain incubated in the absence of aspirin. Results are 
means ± SEM from at least two independent experiments carried out in triplicate. 
Mean (± SEM) control values (A4 9 2) ranged from 2.048+ 0.219 to 2.809+ 0.320 for 
all C. albicans strains.
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Table 8. Effect of salicylic acid on biofilm formation by three strains of C
albicans
Salicylic acid
XTT reduction (%)  ^ by biofilms after 48 h
concentration
Strain GDH 2346 Strain SC5314 Strain CAI4
100 pM 
500 pM 
1 mM
26.1 ±5 .4  11.0 ±1.5 
16.5 ±1 .6  7.3 ±0.4 
11.2±1.8 2.8 ±0.8
21.7 ±2.0 
4.0 ± 0.4 
4.2 ±1.3
" Salicylic acid was present during the adhesion period and throughout the 48-h 
growth period, XTT reduction is expressed as a percentage of that of control 
biofilms of the same strain incubated in the absence of inhibitor. Results are 
means ± SEM from two independent experiments carried out in quadruplicate. 
Mean (± SEM) control values (A492) were 2.481 ± 0.126, 2.754 ± 0.011 and 2.655 
±0.312 for strains GDH 2346, SC5314 and CAI4, respectively.
All results were significantly different at f  < 0.001 from that of the control.
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4.3 Inhibition of biofilm formation by different concentrations of aspirin
Although aspirin has been reported to have antifungal aetivity (Deva et al., 
2001), its dramatic inhibition of biofilm fonnation was unexpected, and was 
therefore investigated further at drug concentrations lower than 1 mM. The 
inhibitoiy effect on biofilms appeared to be dose related. Over 70 % inhibition 
was obseiwed at aspirin eoneentrations between 100 pM and 1 mM (Fig. 44). 
Lower eoneentrations (50-75 pM) produced only around 20 % inliibition, while 
10 pM aspirin had no effect on biofilm formation. Aspirin concentrations of 50- 
200 pM can be aehieved by therapeutic doses of the drug in humans (Xu et a l, 
1999; Wu, 2000), suggesting that the antibiofilm effect observed in vitro might 
also be relevant in vivo.
4.4 Aspirin addition during different stages of biofilm growth
The results presented in Table 7, Fig. 43 and Fig. 44 eould eonceivably be 
explained by the antifungal activity of aspirin on planktonic (fiee-fioating) cells 
used as the inoculum for biofilm foimation. To discount this possibility, the effect 
of adding aspirin at different times during biofilm giowth was investigated. After 
the 1-h adhesion period, all remaining planktonic cells were removed fi’om the 
disks by washing. Disks with firmly attached cells were then submerged in fiesh 
gi'owth medium and aspirin was added at 0, 2, 4, 24 or 48 h o f the incubation 
period, at a final concentration of 1 mM. Biofilm formation, as determined by the 
metabolic activity of biofilm cells in the XTT reduction assay, was measured after 
48 h (Table 9). In one experiment (Expt B), aspirin was also present during the 1- 
h adhesion period. Biofilm gi’owth was severely inhibited by aspirin addition at
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any time up to 24 h. For example, addition of aspirin to relatively mature, 24-h 
biofilms reduced their metabolic activity at 48 h by over 80% (Table 9). Drug 
addition at 48 h produeed little or no effect because at this stage in the experiment, 
the biofilms were immediately harvested, washed and tested in the XTT assay. 
However, the 48-h result (Table 9, Expt B) does indicate that the presence of 
aspirin during the adhesion period had only a minimal effect on biofilm 
formation. Overall, these findings demonstrate that the antibiofilm effect of 
aspirin is not simply due to an antifungal effect on the biofilm inoculum.
:
4.5 Aspirin addition to mature biofilms
In a further series o f experiments, mature, 48-h biofilms grown in the 
absence of aspirin were transferred to fi'esh growth medium containing different 
concentrations of the drug, and incubated for further periods of 5 - 48 h. Most of 
the aspirin eoneentrations tested (75 pM to 1 mM) significantly inhibited biofilm 
metabolie activity and viability after 16 h (Tables 10 and 11). After 48 h of 
additional incubation, biofilm activity and viability was reduced by 17-87 %. 
Moreover, physiological concentrations of the drug (75-200 pM) reduced activity 
by 17-87%, suggesting that aspirin could have a significant inhibitory effect on 
mature biofilms in vivo.
Figure 44
Inhibition of biofilm formation by C albicans GDH 2346 by different 
concentrations of aspirin
Biofilm formation (as measured by XTT reduction) is expressed as a percentage of 
that of control biofilms incubated in the absence of aspirin. Most results are means ± 
SEM from at least two independent experiments with a total of seven or more 
replicates. Results for 250 pM and 500 pM aspirin are means ± SEM of triplicate 
detenninations. The mean (± SEM) control value (A492) was 2.212 ± 0.084.
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Table 9. Effect of aspirin addition at different times during biofilm formation 
by C albicans SC5314
Time of aspirin (1 mM) 
addition (h)
XTT reduction (%) " by biofilms at 48 h
Expt A Expt B
0 10.8 ± 0 .8 '’ 8.0 ±1 .8*
2 13.4 + 1 .2 '’ 7.6 ±0 .6*
4 18.7 ±2 .4* 8.3 ±0 .7*
24 18.8 ± 4 .7* 12.1 + 1.5*
48 103.6 ±4.0 94.3 ±3 .4
-
1" XTT reduction is expressed as a percentage of that of control biofilms incubated 
for 48 h in the absence of aspirin. Results are means ± SEM of four replicate 
determinations. In Expt B, aspirin was initially present at a concentration of 1 mM 
during the 1-h adhesion period of all assays, after which it was removed along 
with unattached yeasts during washing. The drug was then added at the times 
indicated during the subsequent incubation period. In Expt A, no aspirin was 
present during the adhesion period. Mean (± SEM) control values (A492) were
2.532 ± 0.081 (Expt A) and 2.979 + 0.122 (Expt B).
, Value significantly different at P  < 0.001 from that of control. S
I:
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Table 10. Effect of aspirin on XTT reduction by mature (48-h) biofilms of C. 
albicans GDH 2346
Period of flirther 
incubation (h)
XTT reduction (%) “ after ftirther incubation in 
medium containing aspirin at a concentration of
75 pM 100 pM 200 pM 1 mM
5 100.8 ±2.7 99.8 ±2.7 7 9 . 3  ± 3 .3 * 6 6 . 0  ± 2 .6 *
16 89.7 ±4.1^ 87.8 ± 3 .2 '' 80.1 ±4 .0* 58.2 ± 3 .0 *
24 94.4 ± 5.2 85.6 ±4.1 " 78.3 ±2 .6* 41.8 ±2 .0*
48 80.8 ± 6.5 44.4 ± 2.7 ^ 20.2 + 1.6* 10.3 ±1.1 *
" Different concentrations of aspirin were added to mature (48-h) biofilms grown 
in the absence of the drug, and incubation was continued for a further 5 - 4 8  h. 
XTT reduction is expressed as a percentage of that o f control 48-h biofilms 
incubated for the same time period without aspirin. Results are means ± SEM for 
two independent experiments canied out in quadruplicate. Mean (± SEM) control 
values (A492) for different incubation periods ranged from 2.556 ± 0.033 to 2.807 
±0.080.
 ^Value significantly different at P  < 0.001 fiom that of control.
 ^Value significantly different at P  < 0.01 from that of control.
 ^Value significantly different at P  < 0.05 for that of control.
147 Results
Table 11. Effect of aspirin on viability of mature (48-h) biofilms of C. albicans 
GDH 2346
Period of further 
incubation (h)
Viability (%) after further incubation in 
medium containing aspirin at a concentration of
75 pM 100 pM 200 pM 1 mM
5 97.6 ± 6.4 89.4 ±2.3 87.6 ± 6.0 81.9 + 3.3 ''
16 90.0 ±8.8 84.9 ± 3 .0 " 77.2 ± 6.6 65.7 ± 2 .2 '
24 87.5 ±15.9 69.3 ± 3 .5 " 70.2 ±2.5* 50.6 ±4.1 *
48 83.3 ±11.4 30.3 ± 2 .5* 13.0 ± 0 .4* 4.7+  0.2*
 ^Different concentrations of aspirin were added to mature (48-h) biofilms grown 
in the absence of the dmg, and incubation was continued for a further 5 - 4 8  h. 
Viability is expressed as a percentage of that of control cells incubated under 
identical conditions in the absence of aspirin. Results are means ± SEM of at least 
four replicate determinations. Controls counts gave mean values of 4.03 x 10  ^±
2.8 X 10  ^ to 6.00 X 10  ^± 2.3 x 10  ^ cells / biofilm disk. Viable counts were carried 
out by the standard procedure of serial dilution followed by plating. Cells from 
triplicate disks were resuspended in 3 ml of PBS and were then diluted and plated. 
* Value significantly different at P  < 0.001 from that of control.
''Value significantly different at P  < 0.01 from that of control.
^ Value significantly different at P  < 0.05 for that of control.
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4.6 Effect of simultaneous addition of aspirin and PGE2 on biofilm formation
To investigate whether the antibiofilm effect of aspirin might be related to 
an inhibition of fungal prostaglandin production, PGE2 was added simultaneously 
with aspirin at the beginning of the 1-h adhesion period, and again at time zero of 
the subsequent 48-h incubation. Aspirin alone, at a concentration of either 25 pM 
or 50 pM, significantly inhibited biofilm fonnation (Table 12). However, 1 nM 
orlOO nM PGE2 completely abolished the iifhibition due to aspirin at these 
relatively low concentrations, indicating a possible role for prostaglandin(s) in the 
regulation of biofilm formation.
4.7 Viability of biofilms after treatment with COX inhibitors
Viable counts were carried out on both biofilm and planktonic cells of C.
albicans GDH 2346 after growth for 24 h in the presence of 1 mM aspirin,
etodolac, indomethacin or piroxicam. Aspirin, whose antifungal properties have
been reported previously (Deva et al^ 2000), drastically reduced the viability of
planktonic cells to 1.0 % of that of untreated control cells (Table 13).
Suiprisingly, however, it also reduced the viability of normally recalcitrant 1
biofilm cells to 1.9 % of that of untreated controls. A longer incubation period
with aspirin (48 h) decreased viability still further to 0.1 % of that of controls for
both cell types (data not shown). With the other COX inhibitors, viability in most
cases was reduced to around 40% after 24 h although, interestingly, biofilm cells
.were completely resistant to indomethacin.
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T a b l e  1 2 .  E f f e c t  o f  s i m u l t a n e o u s  a d d i t i o n  o f  a s p i r i n  a n d  P G E 2 o n  b i o f i l m  
f o r m a t i o n  b y  C. albicans G D H  2 3 4 6
Addition XTT reduction (%)  ^by biofilms at 48 h
Aspirin (25 pM) 87.7 ± 9 .5 "
+ PGE2 (1 nM) 106.1 ± 6 .0
+ PG E2(100nM ) 101.3 ± 8 .9
Aspirin (50 pM) 79.0 ± 7 .6 ^
+ PGE2 (1 nM) 101.2± 11.3
+ PGE2 (100 nM) 102.9 ± 7 .8
 ^ XTT reduction is expressed as a percentage o f  that o f control 48-h biofilms 
incubated in the absence o f aspirin and PGE2 . Results are means ± SEM from two 
independent experiments earned out with a total o f seven replicates. The mean (± 
SEM) control value (A4 9 2) was 2.500 ± 0.112,
 ^Value significantly different at P  < 0.001 from that o f  control.
"Value significantly different at P  <0.01 h'om that o f control.
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Table 13. Viability of planktonic and biofilm cells of C albicans GDH 2346 
after growth for 24 h in the presence of different COX inhibitors "
Inhibitor Viability (%)
Planktonic cells Biofilm cells
Etodolac 39.2 ±1.7 38.7 ±2.3
Indomethacin 41.6 ±0.7 98.7 ±1.0
Piroxicam 40.6 ±3.1 37.9 ±2.6
Aspirin 1.0 ±0.1 . 1.9±0.1
Salicylic acid 4.9 ±0.1 0.8 ± 0.1
Viability is expressed as a percentage o f that o f control cells incubated under 
identical conditions in the absence of inliibitor. Results are means ± SEM of at 
least four replicate detenninations. Control counts gave mean values of 14.7 x 10  ^
± 1 . 5 x 1 0 ^  cells / ml for planktonic cells and 1.9 x 10  ^± 0.1 x 1O*' to 10.4 x 10  ^+ 
0.6 X 10  ^ cells / disk for biofilms. Viable counts were canied out by the standard 
procedure of serial dilution followed by plating. For biofilm counts, cells from 
triplicate disks were resuspended in 3 ml of PBS and were then diluted and plated.
I
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4.8 Scanning electron microscopy of biofilms exposed to COX inhibitors
Morphogenesis appears to be an important feature of the development of C. 
albicans biofilms under many environmental conditions (Douglas, 2003). 
Biofilms grown on catheter disks normally consist of two distinct layers: a thin, 
basal region of densely packed yeast cells and an overlying, mainly hyphal layer 
(Baillie and Douglas, 1999b). In this study, the moiphological appearance of 
biofilms of C  albicans GDH 2346 was examined by scanning electron 
microscopy after growth in the presence of various COX inhibitors. Aspirin 
reduced biofilm formation substantially as determined by quantitative 
measurements (Table 7 and Fig 43), but in areas of the catheter disks where 
biofilm could be observed, large numbers of yeasts and hyphae were present, just 
as in untreated controls (Fig. 45A, B). However, examination of the cells at higher 
magnification revealed that aspirin-treated fungi had very wrinkled surfaces (Fig. 
45C, D). Piroxicam affected the appearance of biofilms veiy little (Fig. 45B), 
whereas treatment with either indomethacin or etodolac resulted in biofilms that 
consisted almost entirely of yeast cells (Fig. 45C, D). The change in morphology 
due to indomethacin is particularly noteworthy, since this dmg affected neither 
cell viability (Table 13) nor the extent o f biofilm formation, as detennined by 
XTT assays (Table 7 and Fig. 43),
4.9 Effect of COX inhibitors on germ-tube formation
Germ-tube formation by planktonic C  albicans GDH 2346 in the presence 
o f COX inhibitors (100 pM) was detemiined in proline/N-acetylglucosamine 
buffer over 2 h. Indomethacin had the greatest effect, inliibiting germ-tube
________________________________ 152__________________________ Results
formation by almost 80% (Fig. 47). This is consistent with the absence of hyphae 
in developing biofilms exposed to the drug (Fig. 46C). Treatment with celecoxib 
or ibuprofen also resulted in significant inhibition (>70%; Fig. 47). The 
compound that inhibited germ-tube fonnation least was aspirin, a finding that 
coiTelated with the presence o f both yeasts and hyphae in biofilms exposed to this 
drug (Fig. 45B).
4.10 Effect of simultaneous addition of aspirin and cAMP on biofilm 
formation by C. albicans GDH 2346
It has been reported that a cyclic adenosine monophosphate (cAMP) 
signalling pathway can regulate morphological changes between yeast and 
filamentous forms in many fungi, including C, albicans (Lengeler et a l , 2000). In 
this experiment, cAMP was added together with aspirin to determine whether the 
antibiofilm activity of aspirin could be influenced by the presence of cAMP. 
Table 14 shows that cAMP alone did not affect C. albicans biofilm formation; in 
contrast, 100 pM aspirin inliibited C, albicans biofilm formation by more than 
78% in the presence or absence of cAMP (P<0.001). This result demonstrates that 
aspirin activity against biofilm formation by C. albicans is unlikely to involve the 
cAMP signalling pathway, which may explain why aspirin-treated biofilms 
consist o f both yeast cells and hyphae (Fig. 45).
Figure 45
Scanning electron micrographs of C. albicans GDH 2346 bioülms grown in the 
presence of aspirin
Biofilms were grown on PVC catheter disks for 48 h in the presence of 1 mM aspirin. 
(A) Control biofilm; (B) aspirin-treated biofilm; (C) enlargement of marked square in 
A; (D) enlargement of marked square in B. An'ows indicate smooth surface of control 
cells (C) and wrinkled surface of aspirin-treated cells (D). Bars, 8pm (A, B) and 1pm 
(C, D).
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Figure 46
Scanning electron micrographs of C albicans GDH 2346 biofilms grown in the 
presence of different COX inhibitors
Biofilms were grown on PVC catheter disks for 48 h in the presence of no inhibitor 
(A), 1 mM piroxicam (B), 1 mM indomethacin (C), or 1 mM etodolac (D). Bar, 8pm.
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Figure 47
Effects of COX inhibitors (final concentration 100 pM) on germ-tube formation 
by C. albicans GDH 2346
Gei-m-tube formation is expressed as a percentage of that for control cells incubated 
in the absence of inhibitors. Results are means ± SEM of triplicate determinations. 
The mean (± SEM) control value was 72.6 ± 12  germ tube-forming cells / 200 cells 
counted.
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T a b l e  1 4 .  E f f e c t  o f  s i m u l t a n e o u s  a d d i t i o n  o f  a s p i r i n  a n d  c A M P  o n  b i o f i l m  
f o r m a t i o n  b y  C .  albicans G D H  2 3 4 6
Addition XTT reduction (%)  ^by biofilms at 48 h
cAMP (10 pM) 95.3 ±3.0
cAMP (100 pM) 9 8 . 8  ± 3 . 9
Aspirin (100 pM) 21.3±1.0*
+ cAMP (10 pM) 18.6 ±4.4*
+ cAMP (lOOpM ) 2 0 . 9  ± 2 . 2 *
a reduction is expressed as a percentage of that of control 48-h biofilms 
incubated in the absence of aspirin and cAMP. Results are means ± SEM from at 
least four replicates. The mean (± SEM) control value ( A 49 2 )  was 2.417 ± 0.304.
* Value significantly different at P  < 0.001 from that of control.
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5. Combined effects of COX inhibitors and antifungal agents on 
Candida biofilms
5.1 MICs of aspirin and / or amphotericin B for planktonic C albicans GDH 
2346
Previous v^ork showed that a combination o f fluconazole with either sodium 
salicylate or ibuprofen results in synergistic activity against C  albicans (Scott et 
a l, 1995; Pina-Vaz et a l ,  2000). Therefore it was of interest to investigate the 
combined activity of COX inliibitors and antifungal agents on planktonic cell 
growth and biofilm fonnation. In these experiments, the effect of aspirin and / or 
amphotericin B on planktonic gi'owth of C. albicans GDH 2346 was evaluated by 
a broth microdilution method (M27) in accordance with the recommendations of 
the National Committee of Clinical Laboratory Standards (NCCLS). This method 
was used to investigate the effects of aspirin (50pM, 75pM, lOOpM and 1 mM), 
amphotericin B (0.0313, 0.0625, 0.125, 0.25, 0.5, 1, 2 and 4 pg/ ml) and 
combinations of the two dmgs. Preliminaiy results showed that aspirin did not 
affect C. albicans cell density. On the other hand, the minimum inhibitory 
concentration (MIC) of amphotericin B was 0.5 pg/ml i.e. the lowest drug 
concentration that prevents discernible growth (data not shown). Similar results 
were obtained for both drugs (ie., aspirin did not affect C. albicans cell density 
and MICs of amphotericin B were 0.5 to 1.0 pg/ml) when RPMI 1640 medium 
was replaced in the NCCLS protocol by other media such as YNB buffered by 
PBS, YNB buffered by MOPS at pH 7, and unbuffered YNB (data not shown).
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5.2 Effect of aspirin and amphotericin B on biofilm formation by C albicans 
GDH 2346
Aspirin and /or amphotericin B activity against C  albicans biofilms grown
in buffered or unbuffered YNB was evaluated. Both agents were added during the
.adhesion period and again at time zero of bio film formation by C. albicans GDH
Î
2346 grown for 48h in MOPS-buffered YNB (pH 7) or unbuffered YNB. The 
drugs were added individually or in combination and bio film metabolic activity 
(XTT reduction) was measured. In unbuffered YNB, aspirin at 75 or 100 pM and 
amphotericin B at 0.5, 0.25 or 0.125 pg/ml significantly inhibited biofilm 
formation when added individually or in combination (P <0.01 to P  <0.001 ;Table 
15). In contrast, biofilm formation in buffered YNB was unaffected by the 
presence of aspirin or amphotericin B (Table 15).
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Table 15. Effect of aspirin and amphotericin B on biofilm formation by G 
albicans GDH 2346 in YNB (with and without MOPS)
Drug(s) added;
Biofilm formation (%) “
YNB+ MOPS YNB
lOOpM aspirin 100.0+1.3 34.5 + 1,4*
75 pM aspirin 100.4 + 2.8 74.5 + 1.2"
50pM aspirin 101.6 + 2.9 86.9 + 8.4
0.5pg/ml AmB 100.3 + 1.4 2 .1 + 1 .0 *
0.25 pg/ml AmB 104.1 + 1.4 52.0+1.3*
0.125pg/ml AmB 102.5+1.6 51.3 + 5.5"
lOOpM aspirin +0.5 pg/ml AmB 92.9 + 5.0 1.4+ 0 .6 *
lOOpM aspiiin + 0.25 pg/ml AmB 94.1 + 3.2 1 0 .6  + 0 .8 *
lOOpM aspirin + 0.125 pg/ml AmB 106.0+1.0 15.0 + 4.6*
75pM aspirin + 0.5 pg/ml AmB 98.3 + 1.6 3.9+  0.2*
75pM aspirin + 0.25 pg/ml AmB 101.7+1.5 12.7+1.7*
75pM aspirin + 0.125 pg/ml AmB 100.9 + 0.8 12.4+1.7*
50pM aspirin + 0.5 pg/ml AmB 96.6+1.4 1.4+ 1.2*
50pM aspirin + 0.25 pg/ml AmB 103.8 + 0.4 20.5 + 1.3*
50pM aspirin + 0.125 pg/ml AmB 102.9+1.0 21.5 + 3.0*
“ Aspirin and amphotericin B were present during the adhesion period and 
throughout the 48-h gi’owth period. XTT reduction is expressed as a percentage of 
that of control biofilms incubated in the absence of aspirin or AmB. Results are 
means ± SEM from at least two independent experiments earned out in triplicate. 
Mean (± SEM) control values (A492) were 3.135 + 0.129 and 2.548 ±0.121 for C  
albicans GDH 2346 gi'own in YNB+MOPS and YNB respectively 
* Value significantly different at P  < 0.001 from that of control.
 ^Value significantly different at P  < 0.01 from that of control.
160 Results
5.3 Effect of aspirin, salicylic acid and amphotericin B on biofilm formation 
by C. albicans GDH 2346 in different media
Aspirin, as shown in the previous section, had no significant effect on C. 
albicans biofilms grown in YNB buffered with MOPS. To determine whether the 
buffer could influence COX inliibitor activity, aspirin, salicylic acid and 
amphotericin B were tested against biofilms of C. albicans grown in YNB, YNB 
buffered with PBS or MOPS, and RPMI 1640 buffered with HEPES (Table 16). 
The pH values of the media were measured before and after incubation (Table 16, 
footnote). The results show that there was a significant decrease in biofilm 
fonnation in YNB with 1 mM aspirin or 1 mM salicylic acid; inhibition was 79 % 
and 84 %, respectively (P<0.001). These inhibition effects were decreased but still 
significant when biofilms were grown in YNB+PBS. For example, aspirin and 
salicylic acid inliibited biofilm formation by 38 % and 22 %, respectively (P<0.01 
and P< 0.05; Table 16). However, aspirin and salicylic acid did not inhibit biofilm 
formation in YNB+MOPS or RPMI 1640+HEPES. In contrast, amphotericin B at 
2 or 10 pg/ml inliibited biofilm formation by more than 99% in all four media 
(Table 16).
5.4 Effect of COX inhibitors other than aspirin on biofilm formation by 
three C. albicans strains grown in two different media
The effect of COX inhibitors other than aspirin (etodolac, indomethacin and 
piroxicam) was further investigated to detennine whether the pKg (ionization 
constant) of these COX inhibitors could affect their activity, since the pH value of
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the gi'owth medium was higher than the pK^ value o f the inhibitors. It is known 
that aspirin has a pKa value of 3.5, which could explain why aspirin did not inhibit 
Candida biofilms gi'own in media buffered to pH 7.0. Therefore, other COX 
inhibitors (etodolac, pKa 4.7; indomethacin, pKa 4.5; and piroxicam, pKa 6.3) 
were tested with two different media and three C. albicans strains. Biofilms of 
these strains were grown in RPMI 1640 or Sabouraud dextrose broth (SDB) in the 
presence of the COX inhibitors. The results (Table 17) showed that none of these 
compounds inhibited biofilm fonnation (XTT activity) in RPMI 1640 or SDB, 
which indicates that the pKa of COX inhibitors is not a factor in their activity 
against Candida biofilms.
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Table 16. Effect of aspirin, salicylic acid and amphotericin B (AmB) on 
biofilm formation by C albicans GDH 2346 in different media
Medium
Biofilm formation (XTT reduction %) *
Aspirin 
(1 mM)
Salicylic acid 
(1 mM)
AmB 
( 2  pg/ml)
AmB 
( 1 0  pg/ml)
YNB'' 21.1 +4.2" 15.7±3.0" 0.8± 0.3" 0 .1  ± 0 .1 "
YNB+PBS" 62.1 ±5.5* 77.9 ± 2.9" 0.3 ±0.1" 0 . 2  ± 0 .2 "
YNB+MOPS^ 1 0 1 .0 ± 2 . 2 1 0 2 .2  ± 1 .2 0 .1  ± 0 .0 " 0 . 2  ± 0 .1"
RPMI+HEPES^' 97.8 ±3.9 95.0 ±2.2 0.3 ± 0.2 " 0 .1± 0 .1  "
* Aspirin, salicylic acid and amphotericin B were present during the adhesion 
period and throughout the 48-h growth period. XTT reduction is expressed as a 
percentage of that of control biofilms incubated in the absence of any agent. 
Results are means ± SEM from at least two independent experiments carried out 
in triplicate. Mean (± SEM) control values (A492) were: YNB, 2.548 ± 0.121; 
YNB+PBS, 2.873 ± 0.243; YNB+MOPS, 3.007 ± 0.101; RPMI+HEPS, 3.408 ± 
0.073.
 ^Value significantly different at P  < 0.001 from that of control.
* Value significantly different a tP  < 0.01 from that of control.
" Value significantly different at P  < 0.05 for that of control.
^ pH value of YNB started at 5.4 and ended at 3.4; with aspirin, pH value started 
at 4.6 and ended at 3.2.
" pH value of YNB+PBS started at 5.8 and ended at 5.3; with aspirin, pH value 
started at 5.7 and ended at 5.0.
^pH value of YNB+MOPS started at 7.1 and ended at 6.9.
 ^pH value of RPMI+HEPES started at 6.7 and ended at 6.4.
163 Results
Table 17. Biofilm formation by three strains of C. albicans with COX 
inhibitors in two different media
XTT reduction (%) " after 48 h
Inliibitor 
(1 mM) Strain GDH 2346
RPMI SDB
Strain SC5314
RPMI SDB
Strain CAI4
RPMI SDB
Etodolac 94 .0+ 8 .0  80.7 + 2.0 104.3 + 4.2 ND 111.1+0.4 ND
Indomethacin 108.6 + 2.3 102.6 + 2.7 103.3 + 7.2 ND 111.5 + 0.1 ND
Piroxicam 107.9 + 4.9 107.5 + 8.0 108.5+ 1.1 ND 108.1 + 1.8 ND
" Inhibitors were present during the adhesion period and throughout the 48-h
growth period. XTT reduction is expressed as a percentage of that of control 
biofilms incubated in the absence o f any agent. Results are means ± SEM ft om at 
least two independent experiments carried out in triplicate. Mean (± SEM) control 
values (A492) in RPMI+MOPS ranged from 2.969 + 0.286 to 3.043 + 0.384 for all 
strains, and for strain GDH 2346 in SDB was 2.391+ 0.258.
ND, not determined.
I
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5.5 Relationship between optical density and viability of planktonic cells of 
C albicans GDH 2346 grown in buffered and unbuffered YNB in the 
presence of COX inhibitors
The NCCLS M27 macrodilution procedure is generally used to determine 
the MIC of an antifungal agent. However, here a similar protocol was used to 
determine the relationship between optical density and viability for planktonic 
cells grown in unbuffered YNB (Fig. 48), or YNB buffered with MOPS (Fig. 49), 
in the presence of COX inliibitors. All COX inliibitors significantly reduced the 
viability of planktonic cells grown in YNB (Fig. 48) but aspirin had the greatest 
effect, followed by salicylic acid and sodium salicylate (inhibition of 98 ± 0.6 %, 
95.9 ± 0.5 % and 93 ± 0.4 %, respectively; P<0.001). Moreover, all COX 
inhibitors reduced the optical density of the culture by 23 ± 3 .8  % to 47 ± 5.7 % 
(P < 0.05 to P  < 0.001 ; Fig. 48).
In contrast, COX inhibitors did not significantly reduce the optical density 
or viability of planktonic cells gi'own in buffered YNB (Fig. 49), except for 
sodium salicylate and diclofenac which decreased cell viability by 38.2 ± 6.2 % 
and 11.9 ± 1.8 %, respectively (P< 0.001 and P< 0.01; Fig. 49). In these 
experiments, the pH value of the growth medium was measured in the presence of 
COX inhibitors before and after the 48-h incubation period, to determine whether 
the activity of COX inhibitors depended on pH. The results show that the initial 
pH of unbuffered YNB in the control (in the absence of COX inhibitors) was 5.3 
and the final pH was 3.0 (Table 18), In the presence of COX inhibitors, the initial 
pH value was lower; for example, the pH values in the presence of salicylic acid 
and aspirin were 3.8 and 4.0, respectively. However, all the final pH values were
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similar in the test cultures and the controls (gi'own with and without COX 
inhibitors) with range of pH values from 3.0 to 3.4 (Table 18). In contrast, there 
was no difference in the initial and final pH values when biofilms were gi'own in 
buffered YNB in the presence or absence of COX inhibitors. These results, taken 
together with the previous results (Figs. 48 and 49), confirm that the activities of 
COX inhibitors on C. albicans biofilms are pH dependent.
Figure 48
Relationship between optical density and viability of planktonic cells of C. 
albicans GDH 2346 grown in unbuffered YNB with different COX inhibitors 
present at 1 mM
The effect of different COX inhibitors (1 mM) on planktonic cells was evaluated by 
measuring viability (■  ) and optical density ( B  ).Viability is expressed as a 
percentage of that of control cells incubated under identical conditions in the absence 
of inhibitor. Viability results are means ± SEM of at least two experiments done in 
duplicate. Control counts gave mean values ranging from 2.5 x 10* ± 3.8 x 10^  to 2.8 
X 10* ± 3.8 X 10'^  cells /ml. Viable counts were carried out by the standard procedure 
of serial dilution followed by plating. Optical density of control cultures ranged from 
1.401 to 1.427 at 520nm.
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Figure 49
Relationship between optical density and viability of planktonic cells of C. 
albicans GDH 2346 grown in YNB+MOPS (pH 7) with different COX inhibitors 
present at 1 mM
The effect o f  different COX inhibitors (1 mM ) on planktonic cells was evaluated by 
measuring viability ( B  ) and optical density ( H ). V iability is expressed as a 
percentage o f  that o f  control cells incubated under identical conditions in the absence 
o f  inhibitor. V iability results are means ±  SEM  o f at least tw o experim ents done in 
duplicate. Control counts gave mean values ranging from 1.4 x 10* ±  5.5 x 10^ to 1.6 
X 10*± 5.5 X  10  ^ cells /m l. V iable counts were carried out by the standard procedure 
o f serial dilution follow ed by plating. Optical density o f  control cultures ranged from  
1.239 to 1.306 at 520nm .
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Table 18. pH measurements during planktonic growth of C. albicans GDH
2346 for 24h in YNB, with or without MOPS, and 1 mM COX
inhibitor
Inhibitor pH before and after growth in
(1 mM)
YNB YNB+MOPS
Initial pH Final pH Initial pH Final pH
Aspirin 4.0 3.1 6.9 7.0
Diclofenac 5.5 3.2 6.9 7.0
Etodolac 4.4 3.0 6.9 7.0
Salicylic acid 3.8 3.0 6.9 7.0
Sodum salicylate 5.3 3.4 6.9 7.0
Results are means of two independent experiments. For controls grown in YNB 
the initial pH was 5.3 and the final pH was 3.0. For controls grown in YNB + 
MOPS both initial and final pH values were 7.0.
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5.6 Effect of aspirin on the optical density and viability of planktonic cells of 
C. albicans GDH 2346 grown in different buffered media
As shown in the previous sections, COX inhibitors significantly affect 
planktonic cell viability during growth in unbuffered YNB. On other hand, aspirin 
had no effect when planktonic cells were grown in YNB buffered with MOPS at 
pH 7. In these experiments, further different types of buffer were used to 
determine whether the inliibitoiy activity of aspirin on optical density and 
viability could be influenced by the type of buffer used. Planktonic cells of C. 
albicans GDH 2346 were grown in YNB, YNB buffered with PBS or MOPS (pH 
7) and RPMI buffered with MOPS (pH 7) in the presence or absence of 1 mM 
aspirin. After 24h the optical density and viability were determined. The results 
(Fig 50) confirm that the activity of COX inhibitors is not related to the type of 
buffer used in the medium, because 1 mM aspirin failed to affect cell viability in 
any buffered medium (Fig 50). However, it decreased cell viability in unbuffered 
YNB by 98 % as compared with controls gi'own in the absence of 1 mM aspirin 
(P< 0.001).
:
:
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5.7 Relationship between the effect of 1 niM aspirin on optical density and 
the pH value of the growth medium for planktonic cells
It is clear from the previous results that most COX inhibitors had no 
significant effect on the viability and optical density of planktonic cells gi'own in 
buffered medium, inespective of the type of buffer used. To determine whether 
aspirin activity was based on the pH value of the growth medium, its effect was 
investigated with planktonic cells grown in YNB buffered to different pH values. 
Planktonic cells of C. albicans GDH 2346 were gi'own for 48h in YNB medium 
buffered to pH values of 3, 4, 5, 6 , 7 (O.IM citric acid- 0.2M disodium hydrogen 
phosphate buffer) and to pH 8  (0.2 M tris maleate-sodium hydroxide) buffer. The 
results showed that the final pH values of the growth medium with and without 1 
mM aspirin were similar (Fig. 51 A, B). At some pH values the optical density of 
aspirin-treated planktonic cells was lower than that of control cells gi'own in the 
absence of 1 mM aspirin (Fig. 51 A, B). When this decreased optical density was 
expressed as a percentage of the control optical density (Fig. 51 C) it was clear 
that aspirin had the greatest effects on cells grown in unbuffered YNB, or YNB 
buffered at pH 3, which showed an inhibition of 32.1 % and 24.2 %, respectively. 
The inhibitory effect of aspirin on optical density gradually decreased when 
planktonic cells were grown at pH values > 4. For example, at pH 5-7, aspirin had 
no effect on optical density (Fig 51, C).
f .
5.8 Viable counts of planktonic and biofilm cells of C. albicans GDH 2346 
grown at different pH values with 1 mM aspirin
To determine the effect of 1 mM aspirin on viability of planktonic cells and 
biofilms gi'own in YNB at different pH values, the growth medium was buffered
¥
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to pH 3, 4, 5, 6 , 7 and 8 . Aspirin was added at time zero for planktonic cells and 
during the adhesion period and again at time zero for biofilm formation. In both 
cases, incubation was for 48h. Figure 52 shows the correlation between aspirin 
activity and the pH value of the gi'owth medium. Aspirin had the greatest effect (> 
80%) on the viability of both planktonic and biofilm cells in unbuffered YNB, or 
YNB buffered to pH 3 (B<0.001) as compared with control cells grown at same 
pH value in the absence of aspirin. At pH 7, aspirin reduced biofilm cell viability 
by 35% (B<0.01; Fig. 52). These results confimi the previous findings with 
planktonic cells which showed that aspirin activity is pH dependent, and has the 
greatest effect on optical density at low pH values (Fig 51, C).
Figure 50
Effect of aspirin on the optical density and viability of planktonic cells of C. 
albicans GDH 2346 grown in different buffered media
The effect of 1 mM aspirin on planktonic cells grown in different buffered media was 
evaluated by measuring viability ( ■  ) and optical density ( B). Viability is expressed 
as a percentage of that of control cells incubated under identical conditions in the 
absence of aspirin. Viability results are means ± SEM of at least two replicate 
determinations. Control viable counts and O.D at 520nm gave mean values as 
follows: in YNB, 3.9x 10*± 1.5 x 10* with O.D 1.453; in YNB+PBS, 3.0x 10*+ 1.0 
X 10* with O.D 1.403; in YNB+MOPS, 3.2 x 10* ± 6.0 x 10^  with O.D 1.413; in 
RPMI+MOPS, 4.2 X 10*+ 1.2 x 10* with O.D 1.581.
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Figure 51
E f f e c t  o f  1  m M  a s p i r i n  o n  t h e  o p t i c a l  d e n s i t y  o f  C. albicans G D H  2 3 4 6  c u l t u r e s  
g r o w n  a t  d i f f e r e n t  p H  v a l u e s
Plaiiktonic cells of C. albicans GDH 2346 were grown for 48h in YNB medium 
buffered to different pH values ranging from 3 to 8  for 24h. The optical density ( □  ) 
and final pH (A) were measured in the absence (A) or presence (B) of 1 mM aspirin. 
The inhibitoiy effect of aspirin on optical density was calculated as percentage of 
control growth in unbuffered YNB (C, open bar) or at identical pH values (C, closed 
bar). Results are from at least two experiments. The OD520 of the control culture in 
unbuffered YNB without 1 mM aspirin was 1.717.
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Figure 52
Viable counts of planktonic and biofîlm cells of C. albicans grown at different 
pH values with 1 mM aspirin
Viability of planktonic ( 0  ) or biofilm ( B  ) cells is expressed as a percentage of 
that of control cells incubated at the same pH values in the absence of aspirin. Results 
are means ± SEM of at least two determinations. Control counts for planktonic cells 
ranged from 10.0 x 10^± 1.2 x 10  ^ to 17 x 10^  ± 4,7 x lO'^  cells / ml and for biofilms 
from 0.9 x 10^± 0.1 x 10^  to 14 x 10^  ± 0.3 x 10"^  cells / disk. Viable counts were 
carried out by the standard procedure of serial dilution followed by plating. For 
biofilm counts, cells from triplicate disks were resuspended in 3 ml of PBS then 
diluted and plated.
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5.9 Effects of COX inhibitors on metabolic activity of mature biofilms of C. 
albicans GDH 2346 grown in unbuffered YNB and YNB at pH 7
In YNB at pH 7, aspirin partially reduced biofilm viability (Section 5.8). In 
the light of this observation, a variety of different COX inhibitors were tested on 
mature biofilms grown in buffered YNB (pH 7). Mature (48-h) biofilms grown in 
the absence of COX inhibitors in YNB or YNB (pH 7) were transferred to 
identical, fi*esh medium containing different COX inhibitors at concentration of 1 
mM and then incubated for a further period o f 48h. Most o f the COX inliibitors, 
and especially aspirin, significantly inhibited biofilm activity in unbuffered YNB 
(Table 19). In buffered YNB, aspirin inhibited biofilm metabolic activity by 27% 
{P < 0.01). The effects o f diclofenac, ibuprofen and indomethacin were 
reasonably similar in buffered or unbuffered YNB, with inhibition of biofilm 
activity of 14 to 32% (P < 0.01 to P  < 0.05; Table 19).
1
a
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Table 19. Effect of COX inhibitors on XTT reduction by mature (48-h) 
biofilms of C. albicans GDH 2346
XTT reduction (%)^ ;after fiirther incubation for 48h in
Inhibitor
(1 mM)
Unbuffered YNB YNB buffered to pH 7
Aspirin 10.7 ±2.1 ^ 73.4 ± 4 .3 "
Diclofenac 67.7 ± 3.4 85.6 ± 4.8
Ibuprofen 78.5 ± 6.4 69.6 ± 2 .3 "
Indomethacin 83.9 ± 3.4 77.8 ± 4.9
Piroxicam 90.6 ± 4.7 74.9 ± 4.9 "
Celecoxib 68.8 ±3.7'' 87.9 ±4 .7
Etodolac 71.9 ± 2 .0 " 93.3 ± 4.6
Nimesulide 97.2 ±6.7 101.3 ±4 .0
 ^ Different COX inhibitors were added to mature (48-h) biofilms grown in the 
absence of the drug in buffered or unbuffered YNB, and then the incubation was 
continued for a further 48 h. Biofilm activity (XTT reduction) after treatment with 
COX inhibitors is expressed as a percentage of that of control biofilms incubated 
in the same medium without inhibitors. Most results are means + SEM of two 
independent experiments done in triplicate. The mean (± SEM) control value 
(A492) was 2.616 ± 0.169 for bio films grown in unbuffered YNB, and 2.630 ± 
0.160 for biofilms grown in YNB buffered to pH 7 with O.IM citric acid- 0.2M 
disodium hydrogen phosphate buffer.
* Value significantly different at P  < 0.001 from that of control.
 ^Value significantly different at P  <0.01 from that of control.
^ Value significantly different at P  < 0.05 for that of control.
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5.10 Effects of 1 mM aspirin on viability and metabolic activity of mature 
(48-h) C. albicans GDH 2346 biofilms grown in YNB buffered at different pH 
values
Metabolic activities of mature (48-h) biofilm were further evaluated at 
different pH values in the presence of 1 mM aspirin. The effect of aspirin on 
metabolic activity and viability of mature biofilms (Fig. 53) was pH dependent. 
For example, aspirin inhibited the metabolic activity o f mature biofilms by more 
than 80% in unbuffered YNB or YNB buffered to pH 3 ( P  < 0.001), while at pFI4 
to pH 7 inhibition was 22 % to 43% ( P  < 0.01). Similar results were found for 
viability; aspirin reduced the viability of mature biofilms at pH 3 and pH 7 by 91 
% and 14 % respectively (Fig. 53).
5.11 Effect of aspirin and fluconazole on metabolic activity of mature (48-h) 
C. albicans GDH 2346 biofilms grown at different pH values
Previous results confinned that the activity of aspirin against developing 
biofilms (Fig 52) or mature biofilms (Fig. 53) of C. albicans was pH dependent. 
In these experiments, the activities of aspirin, fluconazole, and mixtures of the 
two drugs were compared against mature biofilms grown at different pH values. 
Aspirin at pH 3 inhibited the metabolic activity of mature biofilms by 8 8  %, more 
than either fluconazole or a mixture of fluconazole and aspirin. At pH 4, the 
combination of 1 mM aspirin with fluconazole (at 64 or 16 pg/ml) reduced the 
activity of mature biofilms by 40%, which was more than with fluconazole alone 
(P <0.05; Fig. 54). However, as expected, at pH 7 fluconazole inhibited the 
metabolic activity of mature C. albicans biofilms more than did aspirin.
Figure 53
Effects of 1 mM aspirin on viability and metabolic activity of mature (48-h) 
biofilms of C. albicans GDH 2346 grown at different pH values
B iofilm s were grown for 48h without aspirin in Y N B  buffered at different pH values, 
transferred to fresh medium at the same pH value containing 1 mM aspirin (control 
biofilm s were incubated without aspirin), and incubated for a further period o f  48h. 
Results are means ±  SEM o f  at least three replicates. Mean (±  SEM ) control values 
for XTT reduction ( A 4 9 2 )  ranged from 2.213 ±  0 .179  to 2 .906  ±  0 .043  for pH 3 to pH 
7. Control viable counts gave mean values at pH 3 o f  1.8 x 10^ ±  0.7 x 10^, and at pH  
7 o f 1.6 X 10*±  0 .6  X 10^ cells /  disk. For viable counts, cells from triplicate disks 
were resuspended in 3 ml o f  PBS then diluted and plated.
□  XTT reduction
I Viability (done for pH 3 and pH 7 only)
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Figure 54
Effects of aspirin and fluconazole on metabolic activity of mature (48-h) bioRlms 
of C. albicans GDH 2346 grown at different pH values
Mature 48-h biofilm s were grown in the absence o f  any agent in Y N B  buffered to pH 
3 ( ■ ) ,  pH 4 ( B )  or pH 7 ( □ ) .  B iofilm s were then transferred to fresh medium at 
the same pH and incubated for a further period o f 48h in the presence or absence o f  
aspirin and/ or fluconazole. Results are means ±  SEM  from at least three replicates. 
The mean (±  SEM ) control values for XTT reduction ( A 4 9 2 )  were 2 .479  ± 0 .224, 
2.593 ±0.048 and 3.025 ± 0 .1 2 6  for pH 3, 4  and 7, respectively.
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5.12 Effects of aspirin and fluconazole on metabolic activity of mature (48-h) 
biofilms of C. albicans GDH 2346 grown in three different media
Since the pH value of the growth medium clearly plays an important role in
the antifungal activity of aspirin, it was of interest to determine the effects of
aspirin and fluconazole on mature biofilms grown in synthetic vagina-simulative
(VS) medium pH 4.2 which was developed as vaginal fluid simulant to investigate
therapeutic products (Owen and Katz, 1999). This medium was used to evaluate
.fluconazole fungicidal activity in a previous study (Moosa et a l,  2004), which
demonstrated that fluconazole was fungicidal for C. albicans in VS, but not in 
other media at pH 4.2.
5.13 Effects of aspirin and fluconazole on metabolic activity of mature (48-h) 
biofilms of C. glabrata AAHB 12 grown in three media
.In this study, the effects of aspirin and fluconazole were investigated on 
mature biofilms of C. albicans GDH 2346 gi'own in unbuffered YNB, YNB + 17 
mM acetic acid at pH 4.2, and vagina-simulative (VS) medium, pH 4.2. The 
results show that 1 iiiM aspirin inhibited mature biofilms grown in YNB medium 
by up to 90 % which is significantly more than the effect of aspirin in either YNB
+ 17 mM acetic acid or in synthetic vagina-simulative (VS) medium (P<0.001; 
Fig. 55). Moreover, mature biofilms grown in YNB + 17 mM acetic acid were 
inhibited by 1 mM aspirin by 63 % (P<0.01) which is more than the inliibition by 
64 or 16 jig fluconazole at 35 % and 45%, respectively (Fig 55).
It is known that C. glabrata is normally resistant to fluconazole (Pfaller et 
a l,  2001). In the view of this fact, mature biofilms of C. glabrata AAHB 12 were
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tested in the presence of aspirin and fluconazole individually, or in combination. 
The results show that 1 mM aspirin alone inhibited mature biofilms of C  glabrata 
grown in all three media by up to 75 % (P <0.001; Fig. 56). This effect was 
greater than that of 64 pg fluconazole which inliibited metabolic activity of 
mature biofilms grown in VS medium by 50 % (P<0.01; Fig. 56).
5.14 Viability of mature (48-h) biofilms of C. albicans GDH 2346 and C 
glabrata AAHB 12 after treatment with 200 pM or 1 mM aspirin
As described in Section 5.12, the effect of aspirin on C. albicans GDFI 2346 
was gieater in YNB medium (> 90 % inhibition) than in either YNB + 1 7  mM 
acetic acid or in synthetic vagina-simulative (VS) medium. Flowever, with mature 
biofilms of C. glabrata, aspirin inliibited metabolic activity by about 75-80 % in 
all three media (Fig. 56; Section 5.13). In these experiments the viabilities of 
biofilms of both species were investigated after aspirin treatment. Viable counts 
were caiTied out after further incubation of mature biofilms (48-h) of C  albicans 
GDH 2346 and C. glabrata AAHB 12 in the presence of 200pM or 1 mM aspirin. 
As expected, the effect of 1 mM aspirin on C. albicans biofilms was gi'eater in 
unbuffered YNB (90 % loss of viability; P  <0.001) than in YNB + 17 mM acetic 
acid and VS medium (58 % and 45% loss of viability, respectively; Table 20). 
For C  glabrata AAHB 12, 1 mM aspirin decreased the viability of mature 
biofilms by more than 60% in YNB + 17 mM acetic acid or in VS medium. 
Furtheimore, in unbuffered YNB there was a 90 % loss of viability following 
treatment with 1 mM aspirin (P < 0.001; Table 20).
Figure 55
Effects of aspirin and fluconazole on metabolic activity of mature (48-h) biofilms 
of C. albicans GDH 2346 grown in three different media
Mature 48-h biofilm s were grown in the absence o f  any agents in Y N B  ( H  ) ,  Y N B +  
acetic acid ( ■ )  and vagina-sim ulative (V S) m edium ( □  ). B iofilm s were then 
transferred to identical, fresh medium and incubated for a further period o f  48h in the 
presence or absence o f  aspirin and/or fluconazole. Results are means ±  SEM  o f  two  
experiments with at least three replicates each time. The mean (±  SEM ) control 
values for XTT reduction ( A 4 9 2 )  were 2 .552 ±  0 .069 , 2 .546  ± 0 .1 1 8  and 1.567 ±  0 .077  
for Y N B , Y N B + acetic acid, and vagina-sim ulative (V S) medium, respectively.
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Figure 56
Effects of aspirin and fluconazole on metabolic activity of mature (48-h) biofîlms 
of C. glabrata AAHB 12 grown in three media
Mature 48-h biofilm s were grown in the absence o f  any agent in Y N B  ( H  ) ,  Y N B +  
acetic acid ( I )  and vagina-sim ulative (V S) m edium ( □  ). B iofilm s were transferred 
to identical, fresh medium and then incubated for further period o f  48h in the 
presence or absence aspirin and/or fluconazole. Results are means ±  SEM  from two  
experiments with as least three replicates each time. The mean (±  SEM ) control 
values for XTT reduction ( A 4 9 2 )  were 1.661 ± 0 .1 0 8 , 1.569 ±  0 .116  and 0 .739  ±  0 .073  
for YNB , Y N B + acetic acid and vagina-sim ulative (V S) medium, respectively.
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Table 20. Viability of mature (48-h) biofilms of C. albicans GDH 2346 and C 
glabrata AAHB 12 after treatment with 200 pM or 1 mM aspirin
Viability (%)
Medium
C. albicans GDH 2346 C. glabrata AAHB 12
Aspirin 
(200 pM)
Aspirin 
(1 mM)
Aspirin 
(200 pM)
Aspirin 
(1 mM)
YNB 2 0 . 0  ± 1 .1  ^ 8 .6  ± 1.5^ 1 0 .2  ± 0 .4 " 6.7 ± 0 .5 "
YNB 5 1 .8 ± 8 .6 '' 41.9 ± 2 .7 ^ 67.3 ±6.1 27.3 ±2.1 "
VS medium 68.9 ± 2 .3 '' 54.7 ± 2 .7 ^ 55.8 ± 1.1 34.3 ± 1 .9"
YNB pH 7 ND ND 70.0 ± 1.7^ 64.0 ± 2 .0^
Mature, 48-h biofilms were grown in the absence of aspirin in different media and 
then transferred to fresh identical medium containing 200 pM or 1 mM aspirin 
and incubated for a further period of 48h. Viability is expressed as a percentage of 
that of control cells incubated under identical conditions in the absence of aspirin 
and fluconazole. Results are means ± SEM of at least two determinations. Control 
counts for C. albicans GDH 2346 gave mean values of 0.32 x 10  ^± 3.2 x 10  ^to 
1.22x 10  ^± 5 X 10  ^ cells / biofilm disk, and for C. glabrata 1.9 x 10  ^± 4.1 x 10"^  
to 4.3x 10  ^ ± 8.5 X 10"^ . For viable counts, cells fiom triplicate disks were 
resuspended in 3 ml of PBS, then diluted and plated.
 ^Value significantly different at P  < 0.001 from that of control.
 ^Value significantly different at P  <0.01 from that of control.
 ^Value significantly different at P  < 0.05 for that of control.
YNB YNB medium containing 17 mM acetic acid.
ND, not detenuined.
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6. Prostaglandin production during growth of C albicans biofilms
Prostaglandin synthesis and its sensitivity to COX inhibitors during growth 
of planktonic cells and biofilms were investigated using a prostaglandin-screening 
enzyme immunoassay kit (Cayman Chemicals). This ELISA detects PGE2, PGEi,
PGp2a, and PGFia, and to a lesser extent PGFsa, PGD2, PGE3, and thromboxane 
B2 . It does not detect the PGA class, PGBi, 15-keto PGE2, 13,14-dihydro-15-keto 
PGp2a, or misoprostol.
6.1 Development of prostaglandin standard curve using growth medium
A prostaglandin standard curve was prepared using YNB medium (Fig. 57 
A). The results showed that there was no interference between YNB medium and i
the ELISA assay. Moreover, as can be seen from Fig. 57 A, the ELISA kit can 
detect prostaglandins in the range of 15 to 2000 pg/ml. Preliminaiy experiments 
showed that low levels of prostaglandin were detected in the supernatant of 
planktonic cells of C. albicans GDH 2346 gi'own in YNB for 48h. YNB medium 
was therefore replaced by Sabouraud dextrose broth (SDB) in an attempt to 
increase prostaglandin secretion. The results showed that one or more components 
o f SDB medium interfered with the assay (Fig 57 B). Further experiments 
revealed that neopeptone (a component of SDB) from two different sources 
interfered with the assay (data not shown). In addition, 1 mM arachidonic acid, 
which has been used previously to promote prostaglandin secretion by C. albicans
%
I
(Noverr et a l, 2001), appeared to interfere with this assay. Routinely, therefore, 
culture supernatants fiom either biofilms or planktonic cells were concentrated 
1 0 -fold by fieeze-diying before the prostaglandin assay since preliminary
__
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experiments showed that a ten-fold concentrate is the maximum that can be used 
with this kit without interference (Fig. 57C).
6.2 Prostaglandin production by biofilms and planktonic cells of C. albicans 
GDH 2346
Prostaglandin synthesis was barely detectable after incubation for 10 h, at 
concentrations of 1.4 ± 0.8 pg/ml (mean + SEM) and 0.5 ± 0.5 pg/ml for 
planktonic and biofilm cells, respectively (Fig. 58 A, B). After 10 h, however, 
prostaglandin production increased rapidly to a maximum of 61.9 ± 2.7 pg/ml for |
planktonic cells and 49.1 ± 2.7 pg/ml for biofilm cells after 48 h. Throughout the i
entire growth period there was little correlation between prostaglandin 
concentration and cell density. When prostaglandin production was calculated as a 
function of cell dry weight, it became apparent that biofilm cells produce more 
prostaglandin than do planktonic cells. For example, at 24 and 48h biofilms 
produced 38.5 ± 11.3 and 95.5 ± 19.7 (pg/mg dry wt), respectively. This is 
significantly more (P<0.05) than the prostaglandin concentrations of 14.6 ± 0.4 
and 51.8 ± 2.3 (pg/mg diy wt) detected with planktonic cells at the same time 
periods (Fig. 58 C).
1
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Figure 57
Prostaglandin standard curve for the prostaglandin screening kit
Prostaglandin (PGE2) solutions were prepared according to the manufacturers 
instmctions in (A) YNB; (B) EÏA reagent ♦  , YNB A  or SDB □  ; and (C) a 10-fold 
concentrate of YNB.
EIA , Buffer supplied with ELISA kit.
B, Sample or standard absorbance reading at A4 0 5 .
Bo, Maximum absorbance reading at A405 from positive control.
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Figure 58
Prostaglandin production by biofîlms and planktonic cells of C. albicans GDH 
2346
Relationship between prostaglandin production ( □ ) and cell dry weight (■ ) of (A) 
planktonic cells and (B) biofilms of C. albicans GDH 2346 during growth over 48 h. 
The results are means ± SEM of three independent experiments carried out in 
duplicate. (C) Prostaglandin production expressed as a function of cell dry weight for 
planktonic cells (O ) and biofilms (#  ) of C. albicans GDH 2346. The results are 
means + SEM of three independent experiments carried out in duplicate.
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6 3  Effects of COX inhibitors on prostaglandin production by biofilms and 
planktonic cells of C albicans GDH 2346
.1Previous work showed that aspirin, diclofenac and etodolac had the greatest 
inhibitory effects on the growth of Candida biofilms (section 4.2). In this part of
the project, tliese inhibitors were used at a relatively low concentration of 50 juM. 
Aspirin at this concentration was shown by the earlier work to decrease biofilm
formation by about 20% after 48 h (section 4.3). Here, aspirin significantly 
reduced prostaglandin synthesis by both biofilms and planktonic cells (Table 21). 
For biofilms, prostaglandin production was only 48.6% of that of control cells 
after 24 h {P < 0.001), but had recovered to 77.4% after 48 h {P < 0.01). Both 
diclofenac and etodolac also significantly decreased prostaglandin synthesis by 
biofilms after 48 h (P < 0.05).
6.4 Prostaglandin production by C albicans SC5314 and its morphological 
mutant HLC54 {cphl/cphl efgl/efgl)
To investigate further a possible role for Candida prostaglandin in hyphal 
formation during biofilm development, prostaglandin production was determined 
in a mutant with defined defects in two filamentation pathways {cphl/cphl
efgl/efgl) and its wild-type strain C  albicans SC5314. The mutant is capable of 
gi'owth in the yeast form only, whereas the parent strain can grow in both yeast 
and hyphal forms. Prostaglandin levels were measured for biofilm and planktonic 
cells o f both strains after 24 and 48 h. As noted already with strain GDH 2346,
-,
biofilm cells of both wild type and mutant produced significantly more 
prostaglandin than did planktonic cells (P < 0.001 to P  < 0.05; Fig. 59). For 
example, biofilm cells of strain SC5314 secreted 234.2 ± 0.6 pg/mg dry wt (mean
________________________________ 190__________________________ Results
± SEM)  after 48 h whereas planktonic cells of the same strain produced only 53.8 
± 3 .9  pg/mg. However, there was no significant difference between prostaglandin 
production by biofilm cells of the mutant and parent strains after 48 h (Fig. 59).
6.5 Scanning electron microscopy of C. albicans SC5314 and its 
morphological mutant HLC54 {cphl/cphl efgl/efgl)
Scanning electron microscopy demonstrated that biofilms of the parent 
strain possessed a morphology typical of C. albicans biofilms on PVC catheter 
disks ie., a basal region of densely packed yeast cells with an overlying, mostly 
hyphal layer (Fig 60A; BailHe & Douglas, 1999b). The mutant also produced 
substantial biofilms, but in this case the structures consisted o f yeast cells only 
(Fig. 60B). Overall, our experiments with the morphological mutant demonstrate 
that the genetic defects of this strain did not affect its ability to secrete 
prostaglandin. Moreover, biofilms of this strain, consisting entirely of yeast cells, 
produced significantly more prostaglandin than did planktonic cells.
I
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Table 21. Effects of COX inhibitors on prostaglandin production by biofilms 
and planktonic cells of C. albicans GDH 2346
Growth condition
Prostaglandin production (%)
Planktonic cells Biofilm
24h with Aspirin 76.2 ± 6.2" 48.6 ±3.7"
24h with Diclofenac 86.9 ±3.4" 100.0 ±8.5
24h with Etodolac 84.1 ±6.2^ 93.7±11.1
48h with Aspirin 75.3 ± 8.9" 77.4 ± 26.4^
48h with Diclofenac 81.5 ±9.2 88.4 ± 17.7"
48h with Etodolac 89.9 ± 1.4" 82.2 ± 10.8"
Inliibitors were present at a concentration of 50 pM throughout the incubation 
period (24h or 48h). Prostaglandin production in the presence of inhibitor, 
determined as pg/mg cell dry weight, is expressed as the percentage of that 
produced by control cells incubated in the absence of inhibitor. Results are means 
± SEM of at least two independent experiments carried out in duplicate. Mean ± 
SEM values for controls were 14.6 ± 0.4 pg/mg and 51.8 ± 2.76 pg/mg for 
planktonic cells at 24h and 48h, respectively; and 38.5 ±11.1 pg/mg and 95.5 ± 
19.7 pg/mg for biofilm cells at 24h and 48h, respectively.
“ Value significantly different at P  < 0.001 from that for the control.
 ^Value significantly different at P  < 0.01 from that for the control.
 ^Value significantly different at P  < 0.05 fr om that for the control.
Figure 59
Prostaglandin production by C. albicans SC5314 and its morphological mutant 
HLC54 {cphl/cphl efgl/efgl)
Prostaglandin production after 24 h (white bars) and 48 h (black bars) by planktonic 
cells and biofilms of C. albicans SC5314 and its morphological mutant HLC54 
{cphl/cphl efglefgl)/IhQ  results are means ± SEM of two independent experiments 
carried out in duplicate.
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Figure 60
Scanning electron microscopy of C albicans SC5314 and its morphological 
mutant HLC54 {cphl/cphl efgl/efgl)
SEM of 48-h biofilms of C, albicans SC5314 (A) and its morphological mutant 
HLC54 {cphl/cphl efgl/efgl) (B). Bars, 10 pm.
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7. Effects of steroids on biofilm development and germ-tube 
formation by C albicans
Hormones or pheromones have been described in unicellular organisms. For 
example, fungal sex hormones are responsible for bringing fungal cells together in 
a physiological state for mating (Gooday and Adams, 1993); additionally, fungi 
appear to interact with mammalian hormones at a level closely analogous to the 
interaction of mammalian cells with these chemical molecules. Therefore in this 
study the effects of steroids on C  albicans biofilm development and geim-tube 
formation was investigated.
7.1 Biofilm formation in the presence of steroids
The steroids used were progesterone, corticosterone, hydrocortisone, 
dexamethasone and prednisolone. The effects of different concentrations of all 
these compounds were evaluated against biofilms grown on catheter disks. 
Steroids were added individually at time zero of biofilm formation by C. albicans 
GDH 2346. The effect of a wide range of steroid concentrations (0.01 to 1000 
pM) was explored (Fig. 61). The metabolic activity (XTT reduction) of C. 
albicans biofilms was not affected by any of these compounds. For example, 1 
mM progesterone or hydrocortisone slightly inliibited biofilm fbnuation (by 
14%), but this inhibition was not significant (P>0.05). Similar results were found 
for all steroids tested at all concentrations.
7.2 Effect of steroids on germ-tube formation by C albicans
As shown previously, steroids did not significantly affect the metabolic 
activity of C. albicans biofilms. In these experiments the effect of steroids on
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germ-tube formation was investigated. Germ tubes were allowed to form for 5h in 
10 mM proline + 2.5 mM N-acetylglucosamine buffered with 50 mM potassium 
phosphate (pH 6.5) in the presence or absence of different steroids. Five different 
concentrations o f each steroid were tested. None of the steroids significantly 
inliibited germ-tube formation at 0.01 or 0.1 pM. However, at 1 pM, progesterone 
and dexamethasone inhibited gemi-tube formation by 34 and 25 %, respectively 
(P<0.05; Table 22). At 100 to 1000 pM, all steroids inhibited germ-tube 
formation. In particular, corticosterone and prednisolone at 1000 pM inhibited 
germ-tube fomiation by 64-65 % (F*<0.01 ; Table 22).
Figure 61
Effect of steroids on biofilm formation by C. albicans GDH 2346
Biofilm formation, as measured by XTT reduction, is expressed as a percentage of 
that of control biofilms incubated in the absence of steroids. Steroids were added at 
time zero of biofilm formation. Most results are means ± SEM from at least two 
independent experiments with a total of seven or more replicates. The mean (± SEM) 
control value (A492) for C. albicans GDH 2346 ranged from 1.943 ± 0.125 to 2.241 ± 
0.235.
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Table 22. Effect of steroids on germ-tube formation by C. albicans GDH 2346
Steroid
Germ-tube formation (%)  ^after 5h in
0.01 0.1 1 100 1000
tiM jrM |aM jaM p,M
Progesterone 85 ± 7 75 ± 5 66 ±8'^ 6 76  5 c 50 6  8
Corticosterone 111 ± 5 108 ± 6 92 ± 6 61 6 5 " 3 5 6 5
Dexamethasone 100 ± 5 87 ± 5 7 5 6 4 / 8 06  5^ 64 6  9
Prednisolone 92 ± 5 82 ± 5 89 6 8 4 4 6  5* 36 6  5
Hydrocortisone 83 ± 4 90 ± 5 94 6  5 7 9 6 4 ^ 52 6  5
Estradiol 101 ± 5 91 ± 4 85 6  3 ND ND
” Steroids were present at the concentrations indicated during germ-tube formation 
in 10 mM proline+2.5 inM N-acetylglucosamine buffered with 50 mM potassium 
phosphate (pH 6.5) for 5h. Genn-tube formation is expressed as a percentage of 
that of controls incubated in the absence of steroids. Results are means ± SEM 
from one experiment carried out in triplicate. Mean (± SEM) value for controls 
was 68 ± 8 /100 cells counted.
 ^Value significantly different at F  < 0.001 from that o f control.
 ^Value significantly different at F  < 0.01 hom that of control.
Value significantly different at F  < 0.05 for that of control.
ND, not determined.
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1. Biofilm development and germ-tube formation in C albicans
1.1 Biofilm formation using different C. albicans strains
Tétrazolium salts such as XTT have been widely used in cell biology for 
measuring the metabolic activity and viability of cells ranging from mammalian to 
mierobial ones. In this study, biofilm formation was measured using XTT 
reduction as described earlier by Baillie and Douglas (1999a). However, their 
method was modified by adding 1% glucose to enliance the XTT reduction. Since 
the XTT solution was prepared in PBS instead of YNB, an exogenous energy 
source such as glucose is required to allow the reduction of XTT by mitochondrial 
dehydrogenases. Thus, there was a correlation between XTT reduction and the 
glucose concentration used, as can be seen in Fig. 11.
Comparison of biofilm formation by six C. albicans mutants with altered 
colony morphology and different responses to famesol showed no significant 
differences as compared with the wild-type strain. These mutant strains were 
provided by Jacob M. Hornby (School of Biological Sciences, University of 
Nebraska). He and his colleagues have recently shown that 95.9% of such mutant 
strains fully or partially reverted to wild type morphology when grown on yeast 
malt agar plates supplemented with farnesol (Jensen et a l,  2006). In this study, 
the mutants were used in experiments to determine the effect o f famesol on 
biofilm metabolic activity and stmcture; the results will be discussed in Section 
2 . 1.
%
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Other C. albicans mutants were also used in this study. Biofilm formation 
by C. albicans strains defective in MDS3, or MDS3 and RIMlOl, was 
significantly less than that of the wild type. On the other hand, a C. albicans 
mutant defective in RIMlOl only produced more biofilm than the wild type. It has 
been shown that C. albicans mds3 null mutants are defective in hyphal formation 
in alkaline media at pH 8; however, such mutants can produce germ tubes in 5% 
serum (Davis et a l, 2002). Richard et a l (2005) investigated G albicans biofilm- 
defective mutants, including C  albicans mds3 null mutants, and showed that C 
albicans mds3 null mutants do not produce substantial biofilms on silicone
'squares but grow as rapidly as the wild-type strain in planktonic cultures.
Moreover, reconstitution of a wild-type allele for each insertion-bearing gene 
restored a biofilm formation ability comparable to that of the wild type (Richard 
et a l, 2005). Other studies demonstrated that mutants of C. albicans defective in 
RIMlOl have a significant reduction in virulence (Davis et a l, 2000), but that the 
RIMlOl gene is not required for biofilm formation (Richard et a l, 2005). This last 
observation was confirmed in the present study which showed that a C. albicans 
mutant defective in RIM lOl only, produced slightly more bio film than the wild-
type strain. Another important finding in this study was that the two major
'signalling pathways controlling hyphal formation (the efgl and cphl pathways) 
are not essential for biofilm formation per se, since single or double efgl/efgl and 
cphl/cphl mutants produced substantial yeast-only biofilms. Overall, the role of 
MDS3, RIMlOl, EFGl and CPHl in biofilm formation of G albicans remains 
unclear.
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1.2 Germ-tube formation In C. albicans
C. albicans can form gemi tubes in the presence of different inducers. In this 
study, two-germ tube inducers were investigated individually or in combination, 
and with static incubation or with gentle shaking, to determine the optimum 
genuination response of C. albicans. Proline and N-acetylglucosamine stimulated 
germ-tube fonnation to the same extent and maximal enhancement of germ-tube 
fonnation was observed using a combination of proline and N-acetylglucosamine 
with gentle shaking. This observation is consistent with a previous report which 
showed that germ-tube formation in the presence of proline and N- 
acetylglucosamine was greater than that in serum (Hornby et a l, 2001). However, 
semm has been described as the ’ magic potion ' for germ-tube formation in C. 
albicans (Ernst, 2000) and still remains as a standard method of identifying C. 
albicans in most clinical laboratories (Kim et a l, 2002a; Hudson et a l, 2004).
The quomm sensing molecule, famesol, is known to inhibit germ-tube 
formation in C  albicans. In this study, the optimal conditions determined for 
germ-tube formation were used to evaluate the effect of famesol. The results 
showed that famesol eompletely blocked germ-tube formation in the presence of 
proline and N-acetylglucosamine. These findings eorrespond with those of 
Homby et al. (2001) who reported that famesol prevents mycelial development in 
assays using three chemically distinct triggers for geim-tube formation: L-proline, 
N-acetylglucosamine, and semm. Moreover, it was shown that in serum (2 to 
20%), up to 250pM farnesol was required to block germ-tube fonnation when 
added at any time up to 30 min after inoculation; famesol did not block
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germination when it was added after 90 min (Mosel et a i , 2005). This appears to 
be similar to the effect of farnesol on biofilm formation, where farnesol has to be 
added at an early stage to show an inhibitory effect (Ramage et a l,  2002a; Fig. 
19).
Germ-tube formation was also inliibited by propranolol, but the inhibitory 
effect of propranolol was less than that of famesol and germ-tube fomiation was 
not blocked at concentrations up to ImM. The effect o f propranolol has been 
investigated previously; it was reported that propranolol inhibition of 
morphological changes in C  albicans was due to binding with phosphatidic acid 
(Baker et a l,  2002), which is derived from phosphatidylcholine by the action of 
phospholipase D. Phospholipase D secretion is thought to be one pathway from 
multiple parallel pathways that control dimorphic behaviour in C  albicans 
(McLain and Dolan, 1997). Previous reports on phospholipase activity in C. 
albicans have focused on secreted enzymes that may facilitate tissue invasion, and 
so augment virulence (Ibrahim et a l, 1995). Recently, Dolan et a l (2004) 
confmned that phospholipase D is required for vimlence by demonstrating that a 
C. albicans mutant defective in the secretion of phospholipase D (PLDl) was less 
vimlent in vivo. Moreover, this strain was not able to form hyphae when gi’own on 
solid Spider medium (Dolan et a l, 2004).
Famesol activity has been described in other eukaiyotic cells; evidence has 
been produced that farnesol causes apoptosis in tumorigenic cells. However, 
exogenous di acyl glycerol (DAG) was able to prevent induction of apoptosis by 
farnesol (Taylor et a l, 2005). Another report showed that farnesol inliibited the
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confimied by the results o f this study, because the effect o f famesol on germ-tube 
fomiation by C. albicans was reduced by adding DAG analogues such as 1- 
oleoyl-2-acetyl-sn-glycerol (OAG). Overall, these findings support the idea that 
famesol inhibits the phospholipase D pathway in C. albicans, as in S. cerevisiae 
(Machida et a l,  1999) and other eukaryotic cells (Taylor et a l, 2005).
2. Quorum sensing in C. albicans biofilms
2.1 The role of farnesol
In the light o f recent research, it became important to understand quorum 
sensing in the dimorphic organism C. albicans. The ability of C. albicans to 
undergo dramatic changes in cellular moiphology is essential for vimlence. 
Morphological changes in C. albicans are modulated by enviromnental factors 
such as pH, temperature, glucose levels, and inoculum size (Odds, 1988). The 
inoculum size effect has been studied in detail. For example, C. albicans is known 
to develop as budding yeasts when inoculated at > 1 0  ^ cells/ml, and as mycelia 
when inoculated at < 10  ^ cells/ml. This dramatic change results from the 
production of famesol, which is continuously excreted by C. albicans during 
growth in amounts roughly proportional to the cell density (Homby et a l, 2001).
In the present study, the effect of famesol on biofilm formation was 
investigated by using a catheter disk model system and by scanning electron
*
■growth of S. cerevisiae and there was a significant loss of intracellular DAG in 
famesol-treated cells; coaddition of DAG analogues to the growth medium 
abolished the effect of famesol (Machida et a l,  1999). These observations were
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microscopy. The results showed that 1 mM farnesol inhibited biofilm formation 
by 27 % when added at the beginning of the adhesion period and again at time 
zero of biofilm formation. This effect was less than that demonstrated in an earlier 
study by Ramage and colleagues (2002a) who showed that 300 pM farnesol 
inhibited biofilm formation by 85% when added at time zero. However, both 
obseiwations confirm that farnesol inliibits biofilm formation in two different 
model systems (catheter disk and multiwell plate) and in two different C. albicans 
strains.
In this study, the biofilm structure of various C  albicans strains was 
investigated after gi'owth in the presence or absence of famesol, propranolol or 
OAG. Biofilms were grown in different media to deteimine the effect of these 
compounds in environments such as minimal defined conditions (YNB medium), 
maximal defined conditions (RPMI 1640 medium) and hyphal stimulating 
conditions (Homby medium). The results showed that farnesol-treated biofilms 
consist o f yeast cells only, compared with control biofilms which consist of a 
mixture of yeasts and hyphae. This result differs fiom previous observations. 
Ramage et a l (2002a) showed by scanning electron microscopy that cells treated 
with 300 pM farnesol produced sparse biofilms which were composed 
predominantly o f yeast cells and pseudohyphae. Similarly, confocal scanning 
laser microscopy revealed that cells exposed to 40 pM farnesol formed poor
' ' i f
biofilms consisting of yeast cells and pseudohyphae (Cao et a l, 2005). A possible
explanation for the difference between this study and the other obseiwations could 
be the famesol concentration used; here, a higher farnesol concentration (1 mM) 
was employed to evaluate the effect on biofilm metabolic activity and to
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investigate biofilm architecture. Biofilms grown in YNB, RPMI 1640 or Homby 
medium in the presence of 1 mM famesol consisted uniformly of yeast cells.
The effects of farnesol on biofilm formation were fiirther investigated in this 
study by using six C. albicans mutants with altered colony morphology and 
different responses to farnesol. The results showed that farnesol at tliree 
concentrations (50 pM, 100 pM or 1 mM), added for the adhesion period only, or 
for adhesion and again at time zero of biofilm fonnation, did not significantly 
affect biofilm fomiation by these mutant strains as compared with the parental 
strain. However, scamiing electron microscopy indicated that the farnesol 
responses of these strains were different. For example, the architecture of C. 
albicans H48 and H51 biofilms appeared to be unaffected by famesol, because 
both farnesol-treated and untreated biofilms retained a mainly hyphal stmcture. 
Other mutant strains such as C. albicans H I21 and H253 showed a complete 
response to famesol by producing yeast-only biofilms. On the other hand, 
biofilms of C. albicans HI contained mainly yeasts with a few hyphae which 
indicated a partial response to farnesol. These findings coiTespond with recent 
observations by Jensen et al. (2006), who characterized a collection of 1,111 C. 
albicans mutants that were altered in their colony morphology and in their 
response to farnesol, including those used here. They found that 95.9% of the 
moiphological mutants responded reversibly to famesol by changing their colony 
morphology when grown on yeast malt agar plates supplemented with 10, 50 or 
100 pM famesol. C. albicans H253 and H121 reverted to the wild-type 
moiphology on yeast malt agar plates supplemented with farnesol; on the other 
hand C. albicans HI had a partial famesol response (Jensen et al., 2006). A
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possible explanation for C. albicans H48 and H51 biofilm stmcture, which 
remained unaffected by famesol, would be that these strains are included in the 
remaining 4.1% of C. albicans mutants designated by Jensen et al. as farnesol 
non-responders.
Previous work demonstrated that quorum sensing molecules could be 
isolated from planktonic cell cultures. For example, supernatant recovered from 
planktonic cells grown in glucose-phosphate-proline medium inliibited germ-tube 
fonnation in two coniplementaiy bioassays, both assessing the percent genn-tube 
fonnation at 37°C but differing in whether or not the cells were provided with a 
complete growth medium during the bioassay (Homby et a l,  2001). In this study, 
the inhibitory effect of quomm sensing molecules present in culture supernatant 
was investigated using two assays of germ-tube formation. In the first assay (Fig 
28 and 29), supematant recovered from biofilms grown in RPMI 1640 (in tissue 
culture flasks) was examined against planktonic cells also gi’own in RPMI 1640. 
In the second assay (Fig. 30), supematants recovered from planktonic cells and 
biofilms grown in YNB were examined against planktonic cells grown in YNB. 
The results showed that all recovered supematants contained a quorum sensing 
activity (ie. farnesol, and/or possibly other, similar, quorum sensing molecules) 
which inliibited the formation of geiin tubes and hyphae by planktonic cells. 
Moreover, in the second assay, when the inhibitory effect of supernatants fr om 
planktonic cells and biofilms was calculated as a function of cell dry weight, it 
became clear that biofilms produce more quomm sensing molecules than do 
planktonic cells.
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The finding that biofilms produce more quorum sensing molecules than 
planktonic cells lends weight to the suggestion that farnesol could provide a novel 
target for the development of antifungal drugs intended to prevent mycelial 
gi'owth or biofilm production in C. albicans. Homby et a l (2003) showed that C. 
albicans synthesizes farnesol from farnesyl pyrophosphate ( an intermediate in the 
highly conserved sterol biosynthetic pathway); compounds that block the sterol 
pathway beyond famesyl pyrophosphate, such as zaragozic acid B, caused an 
eightfold increase in the amount of famesol produced by C. albicans. Moreover, 
antifungal agents such as fluconazole, ketoconazole, miconazole and clotrimazole 
have been found to elevate farnesol production in C. albicans by 10- to 45-fold, 
suggesting that increased farnesol production could he used to screen dmgs that 
target the sterol biosynthetic pathway (Hornby and Nickerson, 2004). However, 
another report showed that anaerobically grown C. albicans did not produce 
famesol and such cells were resistant to the highest tested levels of amphotericin 
B and four of the azole antifungals (Dumitru et a l, 2004).
A histidine kinase two-component signal pathway appears to play a role in 
regulating morphogenesis and vimlence in C. albicans (Calera and Calderone,
1999). Recently, it was reported that a mutant lacking the histidine kinase protein 
Cliklp, but not the Slnlp or N iklp histidine kinase, is refractory to the inhibitory 
effect of famesol both in cell suspension and during the formation of a biofilm 
(Kmppa et a l,  2004). Chklp therefore functions as a putative cytoplasmic 
famesol sensor. In the present study, no significant differences were observed 
between biofilms formed by C. albicans CAF2-1 and two mutant strains up to 24h 
of incubation. However, at later time periods (48 to 72h), C. albicans Chk21
■=fï;r-
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experiments Cao et a l  demonstrated a negative correlation between famesol
f f
(chkllchkl) showed significantly increased biofilm formation compared with C. 
albicans CAF2-1 (wild-type) and Chk23 {chkl/CHKI). This finding supports the 
conclusion that strain Clik21 is unaffected by farnesol. Biofilm formation by both 
C  albicans CAF2-1 and Chk23 would be responsive to endogenous famesol 
levels and at the quorum sensing threshold reached during the later stages of 
biofilm formation, some of the newly formed yeast cells might be released into 
the medium. In vivo, such cell detachment would allow the organism to colonize a 
new, nutrient-rich substrate area (Ramage et a l, 2002a). With strain Chk21, 
however, which is um*esponsive to famesol, biofilm formation continues to Iincrease. Recent work also indicates that cell detachment firom these biofilms is 11
significantly less than that from biofilms formed by the wild-type strain (B.P.
Krom, personal communication). I
Analysis of gene expression in C  albicans biofilms may lead to new 
insights into the molecular mechanism of farnesol action. In a recent study, Cao et
' Ia l (2005) investigated global gene expression in C  albicans biofilms grown in 
the presence or absence of famesol using cDNA micro array analysis. A total of 
274 genes were identified as responsive in famesol-treated biofilms, with 104 
genes up-regulated and 170 genes down-regulated. Several genes involved in 
hyphal formation were differentially expressed; the TUPl gene was up-regulated 
while the PDE2 and CRKl genes were down-regulated. Some genes related to 
dmg resistance were also differentially expressed. Interestingly, the cell surface
■
4,::
hydrophobicity-associated gene CSHl was down-regulated. In further ■
concentration and cell surface hydrophobicity in farnesol-treated biofilm cells.
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The authors concluded that a decrease in cell surface hydrophobicity might 
contribute to the inhibition of biofilm fonnation (Cao et a l,  2005).
2.2 The role of tyrosol
Tyrosol was identified in a recent study (Chen et a l, 2004) as an 
autoregulatory molecule that can play an important role in growth and 
moiphogenesis in C. albicans. Supernatant recovered from high-density cultures 
contained tyrosol and this compound allowed highly diluted cultures to resume 
exponential growth without a substantial lag. The tyrosol activity was specific to 
the lag phase and had no effect on the exponential growth of C. albicans. 
Moreover, tyrosol accelerated the conversion of yeasts to filaments (Chen et a l,
2004). Previously, tyrosol had been isolated fi*om Candida species (Narayanan 
and Rao, 1976; Cremer et a l,  1999) and S. cerevisiae (Sentheshanmuganathan 
and Elsden, 1958; Batrakov et a l,  1993) but its quomm sensing activity was not 
investigated. Later work showed that some fungi can interact with tyrosol. For 
example, a recent report demonstrated that saprobic fungi are able to remove 
tyrosol fi'om a dry olive residue obtained from olive oil extraction (Sampedro et 
a l, 2004). Another study showed that tyrosol and other components produced by 
Enterobacter cloacae had antifungal activity against potato dry rot caused by 
Gibberellapulicaris and Fusarium sambucinum (Slininger et a l,  2004).
The results of this study demonstrated that tyrosol was produced by both 
planktonic cells and biofilms of C. albicans. Moreover, biofilms produced 
sigiificantly more tyrosol than planktonic cells for four different C. albicans 
strains, including the morphological mutants C. albicans JKC 19 {cphl/cphl),
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HLC 52 {efgl/efgl) and HLC 54 {cphl/cphl efgl/efgl), and the wild-type strain 
C  albicans SC5314. Tyiosol was detected at a coneentration of 8.7 pM in 
planktonic cultures of C  albicans SC5314 after 24h of incubation; this is a higher 
concentration of tyrosol than that detected with the same strain in a previous 
report (Chen et a l,  2004). These differences in tyi'osol production could be due to 
differences in the incubation temperature used. Here, 37°C was used as it is the 
standard incubation temperature for planktonic cells and biofilms (Baillie and 
Douglas, 1999a; Baillie and Douglas, 1999b), whereas 30®C was used in the 
earlier study (Chen et a l, 2004). Another possible reason for the low values of 
tyi'osol reported by Chen and his colleagues might be some loss of tyi'osol during 
the sample clean-up procedure. There was no infonnation in their report about the 
efficiency of the method used for extracting tyrosol. In contrast, the method 
developed here has been carefully evaluated and shown to have high levels of 
accuracy and precision (92.8 ± 0.8 % recovery of tyiosol). Overall, the results 
revealed a conelation between tyi'osol production and cell diy weight for 
planktonic cells and biofilms of all strains tested. These findings are similar to 
those of Chen et al. (2004) and support their suggestion that tyrosol, like famesol, 
could act as a quorum sensing molecule.
As tyrosol appears to be a positive quorum-sensing molecule, whereas 
farnesol is a negative quorum-sensing molecule (Homby et a l,  2001; Oh et a l, 
2 0 0 1 ), it was o f interest to investigate how the two interact during biofilm 
formation. The inhibitoiy effect of 50 pM farnesol on biofilm formation was 
abolished by tyrosol at concentrations of 100 to 1000 pM (Fig. 40). On the other 
hand, tyrosol did not counteract higher famesol concentrations which
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demonstrates the complex response of C. albicans to these two quorum-sensing 
molecules during biofilm development.
C. albicans biofilms grown on catheter disks consist of a dense network of 
yeasts, germ tubes, pseudohyphae, hyphae and extracellular material, as shown by 
scamiing electron microscopy (Hawser and Douglas, 1994). Moreover, such 
biofilms comprise two layers: a thin, basal yeast layer and a thicker, hyphal layer. 
Similar results were found in this study with C. albicans biofilms formed on 
polystyrene disks obtained from fiat-bottom, tissue culture flasks. Other studies 
have shown that C. albicans biofilms formed on acrylic material also have this 
structure (Chandra et a l, 2001a; Ramage et a l, 2001a). Taken together, all these 
reports indicate a unifonriity of structure with C. albicans biofilms giown on 
different plastic surfaces. However, biofilms formed on cylindrical cellulose 
filters were quite different in appearance. For example, Baillie and Douglas 
(1999b) evaluated and compared biofilms produced by two wild-type strains with 
those formed by two morphological mutants incapable of yeast or hyphal growth; 
they showed that a hypha-negative mutant and both wild types produced 
exclusively yeast-form biofilms, whereas the yeast-negative mutant generated a 
dense hyphal mat on the top of the filter. The authors suggested that the structure 
of a C. albicans biofilm depends on the nature of the contact surface (Baillie and 
Douglas, 1999b), Recently, Kumamoto (2005) demonstrated that C. albicans 
biofilms exhibit contact-dependent cellular behaviour. Physical contact by C. 
albicans results in activation of the MAP kinase Mkclp. A C. albicans mkcl null 
mutant grown on a polystyrene surface produced an abnormal biofilm with 
reduced filamentation compared with wild-type sti-ains (Kumamoto, 2005).
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The early stages of biofilm formation by C. albicans appear to be sensitive 
to the enhancing effect of tyrosol on hyphal development. It has been shown that 
germ-tube fonuation is stimulated by tyrosol (Chen et a l, 2004). This finding was 
confirmed here; scanning electron microscopy revealed that tyrosol-treated 
biofilms showed more hyphal development at early stages of biofilm formation as 
compared with untreated biofilms. However, there were no differences between 
mature (48-h) biofilms grown with and without tyrosol. A possible reason for this 
would be that tyrosol has a time-dependent effect similar to that of famesol, where 
only the early stages of germ-tube formation and biofilm development are 
responsive (Ramage et a l,  2002a; Mosel et a l, 2005), Another possible reason 
might be that during the early stages of biofilm formation, minimal endogenous 
tyrosol is produced (up to 0.1 pM at 5h), whereas later there is a rapid increase to 
a sufficient concentration. This could explain why mature biofilms (48h) do not 
respond to exogenous tyrosol.
In general, the discovery of the C. albicans quomm-sensing molecules, 
famesol and tyrosol, could lead to the development of novel signal interference 
approaches for controlling Candida infection and biofilm formation. Further 
investigation of these quomm-sensing systems should produce more infonnation 
about the variety of signals that are employed by Candida, and about their 
biosynthesis, as well as how the infoimation encoded in these chemical signals is 
processed.
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3. Effect of COX inhibitors on Candida biofilms
Microbial biofilms are notoriously resistant to antimicrobial agents of 
various types, including biocides, antibiotics and antiseptics (Mah and O'Toole, 
2001; Gilbert et a l,  2002), For example, clinically important antifringal agents 
such as amphotericin B, fluconazole and itraconazole are all much less active 
against C. albicans biofilms than against planktonic cells (Hawser and Douglas, 
1995). Drug resistance has been demonstrated for Candida biofilms gi'owing on 
surfaces such as cellulose (Baillie and Douglas, 1998b; Baillie and Douglas, 
1999a), polystyrene (Ramage et a l, 2001a; Ramage et a l,  2002a), and denture 
acrylic (Chandra et a l,  2001b), as well as polyvinyl chloride (Hawser and 
Douglas, 1995). Recently, however, it has been reported that the newly introduced 
antifungal agent, caspofnngin, is active against C. albicans biofilms in vitro 
(Bachmann et a l,  2002; Kuhn et a l, 2002b; Ramage et a l ,  2002a) . The results 
presented here show that aspirin, one of the oldest and most widely used anti­
inflammatory drugs, also dramatically decreases biofilm foimation by C. albicans. 
Moreover, some aspirin concentrations (50-200 pM) producing significant levels 
of antibiofilm activity in vitro fall within the range of those frequently achieved 
by therapeutic doses o f aspirin in humans (Xu et a l,  1999; Wu, 2000). Other 
nonsteroidal anti-inflammatoiy drugs, particularly etodolac and diclofenac, also 
inhibited biofilm formation to a significant but lesser extent.
Aspirin (acetylsalicylic acid) has a short half-life in circulating blood 
(about 20 min) and is rapidly deacetylated to form salicylic acid in vivo (Wu,
2000). Sodium salicylate and related compounds such as aspirin are known to
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have a variety of effects on microorganisms. Growth of certain bacteria in the 
presence of salicylate can induce multiple resistance to antibiotics. Paradoxically, 
it can also reduce resistance to some antibiotics (Price et a l,  2000). Escherichia 
coli, for example, exhibits increased resistance to chloramphenicol, ampicillin, 
nalidixic acid and tetracycline after such treatment (Rosner, 1985). On the other 
hand, E. coli cells grown in the presence of salicylate are more sensitive to 
aminoglycosides (Aumercier et a l, 1990). The activity of antifungal agents can 
also be affected by salicylate. A combination of fluconazole with either sodium 
salicylate or ibuprofen results in synergistic activity against C  albicans (Scott et 
a l,  1995; Pina-Vaz et a l, 2000).
Sodium salicylate inhibits biofilm formation by P, aeruginosa and S. 
epidermidis on contact lenses and medical polyiuers such as polyethylene and 
polystyrene. Bacterial adhesion also decreases in a dose-dependent mamier 
(Farber et a l, 1995). Some strains of S. epidermidis secrete mucoid extracellular 
polymers (polysaccharides, proteins and teichoic acid) that promote biofdm 
formation and become important components o f the biofilm matrix. Salicylate 
can inliibit the production of some of these components by as much as 95% 
(Farber and Wolff, 1992; Muller et a l,  1998). It has been suggested that coating 
catheters with salicylate, or incorporating it into contact lens solutions, might 
decrease the incidence of some device-related infections (Farber and Wolff, 1992; 
Farber a/., 1995).
In mammalian systems, all of the classic NSAIDs such as aspirin, 
diclofenac and indomethacin inliibit both the COX-1 and COX-2 isoenzymes
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(Dannhardt and Kiefer, 2001). The cyclooxygenase active site is created by a long 
hydrophobic channel that is also the site of dmg binding. Aspirin is the only 
known NSAID that covalently binds to a serine residue and inhibits COX-1 more 
than COX-2 (Damihardt and Kiefer, 2001). In this study, seven out of the nine 
COX inhibitors tested decreased biofilm formation by C. albicans, with aspirin, 
diclofenac and etodolac, a preferential COX-2 inhibitor, producing the greatest 
effects. Aspirin and etodolac also significantly reduced the viability of biofilm 
cells. Indeed, aspirin appears to show an even greater effect on viability than on 
biofilm formation; presumably aspirin-treated biofilm cells are largely incapable 
of cell division but still retain some metabolic activity, including that measured in 
the XTT assay. Nothing is Imown of cyclooxygenase enzymes in C. albicans, but 
the complex effects of COX inhibitors on viability, biofilm formation and 
morphogenesis demonstrated here, and those on prostaglandin production 
described earlier (Noven* et a l, 2 0 0 1 ), suggest the existence of one or more 
cyclooxygenase-dependent pathways in this organism. At relatively high 
concentrations (1 mM), however, the toxicity of aspirin for C. albicans is such 
that the drug probably has multiple, non-specific effects on fungal physiology.
Prostaglandin secretion by C. albicans is likely to be an important factor 
in the pathogenesis of many infections. In experiments with mammalian cells, 
purified fungal prostaglandin down-modulated ehemokine production, tumour 
necrosis factor alpha production, and splenocyte proliferation while up-regulating 
interleukin 10 production (Noverr et a l,  2001). Its role in fungal biology is less 
clear. Synthetic PGE2 enhanced biofilm fonuation and germ-tube formation by C. 
albicans, whereas COX inhibitors adversely affected both processes. Moreover,
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exposure to some COX iiiliibitors (indomethacin and etodolac) produced biofilms 
that consisted almost entirely of yeast cells. Recently, famesol has been identified 
as an extraeellular quomm-sensing molecule in C. albicans that prevents mycelial 
development (Hornby et a l, 2001) and inhibits biofilm formation (Ramage et a l, 
2002a). Fungal prostaglandin(s) may represent signalling molecules of a similar 
type. 3(R)-Hydroxyoxylipins which, like prostaglandins, are derived from 
arachidonic acid, have also been identified in C. albicans (Deva et a l,  2001). The 
synthesis of these compounds appears to take place in hyphae but not yeast cells, 
and is suppressed by aspirin (Deva et a l, 2000; Deva et a l, 2001). It is not yet 
clear whether 3(R)-hydroxyoxylipins are excreted from the cell or how they relate 
to fungal prostaglandins. However, it seems likely that a range of biologically 
active lipid molecules are involved in the regulation of biofilm formation, 
morphogenesis and other major physiological processes in C. albicans.
4. Combined effect of COX inhibitors and antifungal agents on 
Candida
The use of combination therapy may be one approach to improve the 
treatment of infectious diseases, to reduce dose toxicity and to enhance efficacy 
and safety (Baddley and Pappas, 2005). In invasive mycoses such a strategy has 
been used in vivo to promote the effectiveness of each antifungal agent (Nivoix et 
a l,  2006). Many dmgs have been investigated, including antifimgal and non­
antimicrobial agents such as COX inhibitors (Scott et a l, 1995; Pina-Vaz et a l,
2005). In this study, aspirin was found to inhibit biofilm fonuation of C. albicans 
(Table 7, 10 and 11). Consequently, the combined effect of aspirin or other COX
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iiiliibitors and amphotericin B was investigated with both planktonic cultures and 
biofilms. Using NCCLS methodology, it was shown that aspirin did not affect 
planktonic growth of C. albicans as evaluated visually. To further investigate this 
aspect, the effects of aspirin and other COX inhibitors were detennined with 
different media and buffers, and at different pH values. The activity of these COX 
inhibitors on planktonic growth was assessed by optical density and viability 
measurements.
The results showed that aspirin did not affect planktonic cell optical density 
in buffered YNB or RPMI 1640 (using the NCCLS protocol). However, COX 
iiiliibitors reduced the optical density and viability in YNB by up to 42% and 
95%, respectively (Fig. 48), but in buffered YNB by only 15% and 10%, 
respectively (Fig. 49). Similar results were obtained for aspirin with planktonic 
cells gi'own in different buffered media (Fig. 50). These experiments eliminated 
possible interference by media composition or buffer type on COX inhibitor 
activity. Thus, it appears that aspirin activity is pH-dependent (Fig. 51). For 
biofilm formation (as measured by metabolic activity and viability) similar results 
was found. Taken together, all these results demonstrated that the effect of aspirin 
was pH-dependent. Growth experiments using buffered medium showed that the 
inhibition of biofilm development was minimal (35% inhibition) at pH 7 and 
maximal (>85% inhibition) at low pH values.
The effect of pH on aspirin activity appears similar to that of pH on 
fluconazole activity described in earlier reports. For example, the interpretation of 
end points in azole antifungal drug susceptibility testing is problematic, in part
2 1 7 __________ Discussion
due to incomplete gi'owth inhibition of Candida species. This can cause the MICs 
(in RPMI 1640, pH 7) of fluconazole for Candida isolates to be low (<1 pg/ml) 
after 24 h of gi'owth but much higher (>64 jag/ml) after 48 h. Such isolates are 
considered to be resistant to fluconazole by the NCCLS protocol (Marr et a l, 
1999). However, growing evidence suggests that these Candida strains are 
susceptible in vivo. For example, Rex et a l  (1998) showed that mice infected with 
a fluconazole-resistant strain of C. albicans (MIC >64 pg/ml) responded to 
fluconazole administration in a manner similar to that of a susceptible strain. 
Further investigations by Marr et al (1999) demonstrated that 65% of C. albicans 
strains showed a higher MIC in RPMI 1640 (pH 7) than in unbuffered YNB or 
RPMI 1640 (pH 4.5) where the MIC was 32 to 64-fold lower.
Another study demonstrated that the activity of flurbiprofen (a COX 
inliibitor) required to inhibit the growth of some fungi including C  albicans 
depends on the pH value of the growth medium; a lower MIC50 was attained at pH 
4 (Chowdhury et a l, 2003). Other reports confirm that pH values appear to play 
an important role in the in vitro activity of many antifungal agents. For example. 
Te Dorsthorst et a l (2004) investigated 21 Aspergillus isolates by testing in vitro 
susceptibilities against three antifungal agents in RPMI 1640 and YNB at pH 5.0 
and 7.0. They showed that the MICs of aiuphotericin B and itraconazole were 
higher, while those of flucytosine were lower, at pH 5.0 than at pH 7.0. Later 
studies by the same workers confiimed that the in vitro activities of amphotericin 
B and flucytosine against yeast and mould isolates were pH-dependent. The in 
vitro activity of amphotericin B decreased when the pH was lowered, while the in 
vitro activity o f flucytosine increased (Te Dorsthorst et a l,  2005). Both reports
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suggested that the poor correlation between in vitro results and clinical outcome 
could be due to a difference between the pH of the in vitro susceptibility test and 
that at the site of infection.
Despite the effect of pH on COX inhibitor activity, a recent report showed 
that resistance to azole antifungal agents, particularly fluconazole, which was 
related to efflux pumps exporting dmgs, could be reversed by exposure of C. 
albicans to fluconazole in the presence of ibuprofen; this reduced resistance to 
fluconazole in 6 8 % of the C. albicans strains tested (fluconazole-resistant strains) 
(Pina-Vaz et a i, 2005). Drug export via efflux pumps has been described as a 
meehanism of resistance to azoles for C. albicans gi'own in planktonic cultures 
(Clark et a l,  1996), as well as in biofilms (Ramage et a l, 2002c; Mukherjee et a l,
2003).
A synergistic effect has also been shown with sodium salicylate combined 
with fluconazole against C. albicans in vitro, and it was suggested that sodium 
salicylate could be useful a chemotherapeutic agent for the management of 
infections due to fluconazole-resistant C, albicans strains (Yucesoy et a l, 2000). 
Furthermore, salicylic acid completely inhibited the gi'owth of bio films of P. 
aeruginosa, Haemophilus influenzae, S. epidermidis and Streptococcus 
pneumoniae on contact lenses as detennined by viable counts (Bandara et a l,
2004).
C. albicans and C. glabrata are known to be the organisms responsible for 
most cases of vaginal Candida infection (Fidel, 2004; Fidel, 2005; Goswami et 
a l, 2006). In addition, C. glabrata is recognized to have a naturally reduced
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susceptibility to azole antifungal agents, particularly fluconazole (Sobel, 1998; 
Fidel et a l, 1999). Aspirin activity was therefore investigated in this study at pH
4,2 in VS medium, and YNB buffered with acetic acid. The results showed that 
aspirin in this acidie environment inliibited the metabolic activity of mature 
biofilms of C. albicans and C. glabrata more than did fluconazole. Moreover, this 
inhibitory effect was confirmed by examining the viability o f mature biofilms 
treated with aspirin. These differences between aspirin and fluconazole activity 
against mature bio films grown in an acidic environment could be due to the 
limited activity of fluconazole (fungistatic) in a naiTOW pH range. For instance, 
Moosa et al (2004) evaluated the effect of fluconazole on C  albicans (planktonic 
cultures) under in vitro conditions resembling the vaginal microenvironment. 
They observed that fluconazole was fungicidal for C. albicans in VS medium, but 
not in other media at the same pH, 4.2. Subsequently, the components of VS 
medium were analysed and acetic acid, present at 17 mM, a concentration 
achieved in the vagina, was identified as the component responsible for the 
synergistic, fungicidal effect (Moosa et a l, 2004).
Overall, the results of this study demonstrate that aspirin possesses potent 
antibiofilm activity in vitro and could be useful in combined therapy with 
conventional antifungal agents for the management of some biofilm-associated 
infections in acidic environments. Several organs in the body have an acidic 
environment, including the vagina (Thinkliamrop et a l,  1999), stomach and 
collecting ducts of the kidney (Goenka et a l,  1996).
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5. Prostaglandin production in planktonic cells and biofîlms of C
albicans
Tlu'oughout the entire gi'owth period (48h) for planktonic cultures and 
biofilms there was little correlation between prostaglandin concentration and cell 
density, suggesting that prostaglandin does not function as a quomm sensing 
molecule. During the process of quorum sensing, signal molecules accumulate in 
cultures and at a tlireshold population density (quomm) interact with cellular 
receptors that control expression of specific target genes. In C. albicans two 
signal molecules have been identified: famesol, which acts as a negative signal 
and inliibits the foimation of hyphae (Hornby et al., 2001), and tyrosol which acts 
as a positive signal and promotes hyphal foimation (Chen et a l, 2004). Like 
prostaglandins, both of these molecules are relatively hydrophobic and of low 
molecular mass.
The results of this study clearly showed that bio films produce more 
prostaglandins than planktonic cells. In vivo, such a localized concentration of 
prostaglandin could significantly enhance fungal colonization and pathogenesis. 
Experiments with maimnalian cells have already shown that purified C. albicans 
prostaglandin down-modulates ehemokine production, tumor necrosis factor alpha 
production, and splenocyte proliferation, but up-regulates interleukin 10 
production (Noverr et a l,  2003). Pathogen-host interactions of this type could 
contribute to the persistence of Candida infections like cluonic vaginitis which is 
now thought to be biofilm-associated (Domingue et a l, 1991; Costeiton et a l, 
2003).
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Previous experiments demonstrated that aspirin, diclofenac and etodolac at a 
concentration of ImM inhibited the growth of Candida biofilms (Table 7). At a 
relatively at low concentration (50 pM) aspirin showed a similar effect (Fig. 44). 
Therefore, as expected 50 pM aspirin, diclofenac and etodolac reduced 
prostaglandin production by both biofilms and planktonic cells. Taken together 
with the earlier findings, these results demonstrate a strong correlation between 
decreased prostaglandin levels and decreased biofilm fonuation following 
exposure to COX inhibitors, thus supporting the notion that cyclooxygenase- 
dependent synthesis of prostaglandins may play a role in regulating biofilm 
development.
Prostaglandin production was also detennined in a mutant with defined 
defects in two filamentation pathways (cphl/cphl efgl/efgl) and its wild-type 
strain C  albicans SC5314. The mutant is a URA3/ura3 heterozygote constructed 
in strain CAI4, which is derived fiom the clinical isolate SC5314 and contains 
deletions of both cliromosomal copies of URA3 (Lo et al., 1997). In the mutant, 
the mitogen-activated protein (MAP) kinase and Ras-cAMP pathways, involving 
transcription factors Cphl and Efgl, respectively, are blocked. The mutant strain 
produced substantial yeast-only biofilms as confirmed by scamiing electron 
microscopy. This finding is in marked contrast to previous reports that such 
mutants fail to produce any biofilms (Lewis et a i, 2002; Ramage et al., 2002), 
although in these other studies the gi'owth medium used was RPMI-1640, not 
yeast nitrogen base.
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Overall, the experiments with the morphological mutant demonstrate that the 
genetic defects of this strain did not affect its ability to secrete prostaglandin. 
Moreover, bio films of this strain, consisting entirely of yeast cells, produced 
significantly more prostaglandin than did planktonic cells. Thus, although 
prostaglandin h'om either fungal or mammalian sources can promote germ-tube 
foiination in C. albicans (Kalo-Klein and Witkin, 1990; Noverr et a l, 2001), its 
exact role in fungal morphogenesis and biofilm development is obviously 
complex and remains unclear.
6. Biofilm formation in the presence of steroids
Hormones are important biochemical signalling molecules that regulate can 
control physiological events in muiticelluiar organisms; however, it is now clear 
that analogous hormones or pheromones can act as regulatory messengers 
between unicellular organisms such as yeasts (Gooday and Adams, 1993). 
Additionally, several investigations have been reported concerning the influence 
of mammalian hormones such as steroids on the pathogenic C. albicans. For 
instance, steroid compounds such as hydrocortisone, corticosterone, prednisolone 
and dexamethasone have been shown to inhibit the activity of neutrophils against 
C. albicans, but did not affect the growth of fungus (Nohmi et a l,  1994; Nohmi 
et a l, 1995).
Estrogen was found to reduce the ability of vaginal epithelial cells to inliibit 
the growth of C. albicans (Fidel et a l, 2000). Moreover, the estrogen hormonal 
status of rats affected vaginal infection with C. albicans. For example. Kinsman 
and Collard (1986) obseiwed in an in vivo animal model that four hours after
223 Discussion
infection, viable counts were higher and gemi tubes were longer in those animals 
in estrous than in other animals (Kinsman and Collard, 1986). Subsequent studies 
suggested that honuone interaction with C. albicans could be affected by surface 
hydrophobicity. For example, Braun (1994) demonstrated that corticosterone 
incoi*poration by C. albicans is dependent on the hydrophobicity of the cell 
surface, and that hydrophobic yeast cells and hyphae incorporated significantly 
more [^H] corticosterone than did hydrophilic forms of C. albicans .
There has also been some controversy about the influence of hormones 
administered in combination with antifungal agents for the treatment of Candida 
corneal infections. Many studies have demonstrated that treatment with 
corticosteroids in combination with antifungal agents has a negative effect on 
fungal infections (Stover et a l, 1983; Stern and Buttress, 1991). However, 
Krislmamurthy et al (1998) examined the expression of CDRl {Candida drug 
resistance gene) in the presence of estradiol and progesterone, and showed that 
estradiol and progesterone were both able to enhance CDRl expression levels 
about 4.5-fold (Krislmamurthy et a l, 1998), On the other hand, Schreiber et a l 
(2003) showed that the administration of additional prednisolone was clearly the 
most effective treatment to reduce C  albicans comeal infection in a rabbit model 
(Schreiber et a l,  2003).
In the light of this information, it was of interest to investigate the role of 
these honuones against C. albicans bio films and germ-tube formation. Overall, 
the results of these experiments indicate that biofilm metabolic activity was not 
affected by steroids. This is consistent with previous observations which showed
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that steroid compounds did not have a direct effect on growth of C. albicans 
planktonic cells (Nohmi et a l,  1994). However, steroids could play an important 
role in Candida vimlence, because microorganisms possess the ability to 
recognize hormones within the host and utilize them to adapt to their 
suiTOundings. Steroids may therefore seiwe as enviromnental factors which could 
induce Candida virulence. Recent data confimi that C. albicans can become 
pathogenic, producing signs and symptoms o f disease in certain conditions, and 
that steroid therapy was one of the most important predisposing factors (Cheng et 
a l, 2005).
Although there are no published data on the interaction between hormones 
and microbial biofilms, Roberts et a l  (2002; 2005) reported evidence for a direct 
role of stress hoiiirones upon growth of the oral bacteria commonly found within 
bio films of subgingival plaque (below the gum margin). They demonstrated that 
there was a broad variation in the growth responses of 43 microorganisms to 
noradrenaline or adrenaline, with half o f the species showing significant gi'owth 
enhancement. The authors concluded that stress hormones might directly 
modulate the growth and composition of the subgingival biofilm (Roberts et a l, 
2002; Roberts et a l,  2005). Biofilm formation by C. albicans, as tested in this 
study, was not similarly affected by steroids although only five steroid compounds 
were investigated. This could be an area worthy of further, more detailed, 
experimentation.
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7. Overall conclusions
Community behaviour by C. albicans was recognized recently when 
famesol and tyrosol were identified as quorum sensing molecules. The data 
presented in this thesis demonstrate that famesol inhibits hyphal formation and 
tyrosol promotes hyphal formation in both planktonic cells and biofilms. Specific 
signalling pathways mediate different environmental signals to regulate 
morphogenesis. Two of the best studied pathways are the mitogen-activated 
protein (MAP) kinase and Ras-cAMP pathways, involving transcription factors 
Cphl and Efgl, respectively. Signals include chemical parameters (such as pH), 
morphogens (such as semm), nutrient starvation and physical parameters. 
Operation of these pathways results in activation or repression of hypha-specific 
genes in response to an environmental signal. For example, famesol in the 
surrounding medium decreases the expression of a hypha-specific wall protein. 
Other signal molecules produced by C. albicans include prostaglandins. Unlike 
famesol and tyrosol, prostaglandins are not quomm-sensing molecules but they 
act as signals to stimulate hyphal production. Figure 62 illustrates possible 
interactions between these various signalling pathways during moiphogenesis and 
biofilm formation in C. albicans.
Figure 62
Operation of different signalling pathways during morphogenesis and biofilm 
formation in C albicans
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Appendix 1. Composition of Growth Media 
App. 1.1 Yeast Nitrogen Base (YNB; Difco)
Chemical Wt/litre
Ammonium sulfate 5 g
Monopotassium phosphate 1 gMagnesium sulfate 0.5 g
Sodium chloride 0 . 1  g
L-Histidine monohydro chloride 1 0  mg
LD Methionine 2 0  mg
LD-Trypotophan 2 0  mg
Inoslitol 2 0 0 0  pg
Boric acid 500 pg
Niacin 400 pg
Manganese sulfate 400 pg
Pyridoxine HCL 400 pg
Zinc sulfate 400 pg
Thiamine HCL 400 pg
Calcium pantothenate 400 pg
Ferric chloride 2 0 0  pg
Sodium molybdate 2 0 0  pg
Riboflavin 2 0 0  pg
p-Aminobenzoic acid 2 0 0  pg
Potassium Iodide 1 0 0  pg
Copper sulfate 40 pg
Folic acid 2  pg
Biotin 2  pg
Glucose was added to a final concentration of 50 mM.
Final pH 5.4 ±0.1.
App. 1.2 Sabouraud Dextrose Broth (SDB;Oxoid)
Chemical g/litre
Neopeptone 1 0
Bacto dextrose 40
Final pH 5.6 ± 0.2.
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App. 1.3 Sabouraud Dextrose Agar (SDA;Oxoid)
Chemical g/litre
Neopeptone 10
Bacto dextrose 40
Agar 15
Final pH 5.6 ± 0.2.
App. 1.4 Vagina-simulative medium (VS)
Chemical g/litre
NaCl 3.51
KOH 1.40
Ca (0FI)2 0.222
Bovine serum albumin 0.018
Lactic acid 2.00
Acetic acid 1.00
Glycerol 0.16
Urea 0.4
Glucose 5.0
The pH was adjusted to 4.2 using HCl.
App. 1.5 RPMÏ 1640 with HEPES (Sigma)
Chemical g/litre
Ca(N03)2-4H20 0.1
MgS0 4  (anhyd) 0.04884
NaCl 6.0
Na2HP0 4  (anhyd) 0.8
AMINO ACIDS
L-Arginine (free base) 0.2
L-Asparagine (anhyd) 0.05
L-Aspartic acid 0.02 I
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L“Cystine*2HCl 0.0652
L-Glutamic acid 0 . 0 2
L-Glutamine 0.3
Glycine 0 . 0 1
L-Histidine (free base) 0.015
Hydroxy-L-Proline 0 . 0 2
L-Isoleucine 0.05
L-Leucine 0.05
L-Lysine-HCl 0.04
L-Methionine 0.015
L-Phenylalanine 0.015
L-Proline 0 . 0 2
L-Serine 0.03
L-Threonine 0 . 0 2
L-Tryptophan 0.005
L-T yi'osine*2N a*2 H2 0 0.02883
L-Valine 0 . 0 2
VITAMINS
D-Biotin 0 . 0 0 0 2
Choline chloride 0.003
Folic acid 0 . 0 0 1
myo-Inositol 0.035
Niacinamide 0 . 0 0 1
p-Amino benzoic acid 0 . 0 0 1
D-Pantothenic acid '^C a 0.00025
Pyridoxine«HCl 0 . 0 0 1
Riboflavin 0 . 0 0 0 2
Thiamine*HCl 0 . 0 0 1
Vitamin B 12 0.000005
OTHER
D-Glucose 2 . 0
Glutathione (reduced) 0 . 0 0 1
HEPES 5.96
Phenol Red'Na 0.0053
NaHCO) 2 . 0
Final pH 7.0
App. 1.6 RPM I1640 with L-Glutaniine (Cambrex)
Chemical mg/litre
Inorganic salts
C a (N 0 3 )2 * 4 H 2 0
KCl
M g S 0 4 -7 H 2 0
si
I
1 0 0 s
400
1 0 0
■■1
y
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NaCl 6000
NaHCOs 2000
Na2HP04*7H20 1512
Other Components
Glucose 2000
Glutathione 1
Phenol red'Na 5
Amino acids
L-Arginine 200
L-Asparagine’HaO 50
L-Aspartic acid 20
L-Cystine 50
L-Glutamic acid 20
L-Glutamine 300
Glycine 10
L-Histidine 15
Hydroxy L*proline 20
L-Isoleucine 50
L-Leucine 50
L-Lysine*HCl 40
L-Methionine 15
L-Phenylalanine 15
L-Proline 20
L-Serine 30
L-Threonine 20
L-Tryptophan 5
L-Tyrosine 20
L-Valine 20
Vitamins
P- Aminobenzoic acid 1
D-Biotin 0.2
D-Ca Pantothenate 0.25
Choline chloride 3
Folic acid 1
i-Inositol 35
Nicotinamide 1
PyridoxincHCl 1
Riboflavin 0 . 2 0
Thiamine-HCl 1
Vitamin B ]2 0.01
Final pH 7.0
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App. 1.7 Yeast peptone dextrose (YPD) medium
Chemical g/litre
Yeast extract 1 0
Peptone 2 0
Dextrose 2 0
Final pH 6.0
App. 1.8 Hornby medium
Solution Volume
0.05 M potassium phosphate buffer 0.5 ml
20% glucose in 30 mM MgS0 4 0.5 ml
0.3 M L-proline 0.17 ml
O.lMGlcNAc 0.13 ml
Distilled water 3.7 ml
Final pH 6.5
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j:
(i) lOmM proline (Sigma)
(ii) 2.5mM N-acetylglucosamine (Sigma)
(iii) lOmM proline + 2.5mM N-acetylglucosamine
(iv) 5% foetal bovine serum
One tablet was dissolved in 200 ml distilled water.
App. 1.9 Germ-tube inducers
The following inducers were prepared in 50 mM potassium phosphate 
buffer (pH 6.5)
■Ï--
Appendix 2. buffers
App. 2.1 0.01 M phosphate buffered saline pH 7.2 ± 0.2 (Sigma)
-----------------------------------------------------------------------------------------------
One tablet contains:
10 mM phosphate buffer 
2.7 mM potassium chloride 
137 mM sodium chloride
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App. 2.2 O.IM citric acid -  0.2M disodium hydrogen phosphate buffer
Solution g/litre
(i) O.IM citric acid 2 1 . 0 1
(ii) 0.2M Nai HPO4 28.4
Two solutions (i & ii) were mixed to give the appropriate pH;
(i) O.IM citric acid (ii) 0 .2 M Naz HPO4
For pH: ml ml
3 79.45 20.55
4 61.45 38.55
5 48.50 51.50
6  36.85 63.51
7 17.65 82.35
App. 2.3 Tris male ate -  sodium hydroxide buffer (pH 8)
Solution g/litre
(i) Tris-maleate
0.02 M Tris 2.4
0,2 M Maleic acid 23.4
(i) 0.2 M NaOH
NaOH 8 . 0
For pH 8 , 25ml Tris-maleate and 34.5 ml 0.2M NaOH were mixed 
together and diluted with distilled water to 1 0 0  ml.
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App. 2.4 1 M phosphate buffer
Chemical g/litre
K2HPO4 133
ICH2PO4 32.2
The chemicals were dissolved in ultra pure water, final pH 7.4
App. 2.5 (lOx) EIA (electroimmunoassay) buffer
The following chemicals were dissolved in 1 0 0  ml of
1 M phosphate buffer solution:
Chemical g/100 ml
Bovine serum albumin (BSA) 1 . 0
NaCl 23.4
Ethylenediamine tetraacetic acid (EDTA) 0.37
NaNs 0 . 1
Final pH 7.4
